,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,GO_Biological_Process_2021,canonical glycolysis (GO:0061621),7/24,5.5446477819776495e-08,3.13083622159047e-05,0,0,26.734808774995148,446.6811118334856,GPI;PGAM1;PGK1;ALDOC;ENO2;PFKP;HK1
1,GO_Biological_Process_2021,glucose catabolic process to pyruvate (GO:0061718),7/24,5.5446477819776495e-08,3.13083622159047e-05,0,0,26.734808774995148,446.6811118334856,GPI;PGAM1;PGK1;ALDOC;ENO2;PFKP;HK1
2,GO_Biological_Process_2021,glycolytic process through glucose-6-phosphate (GO:0061620),7/25,7.599117042695318e-08,3.13083622159047e-05,0,0,25.24825815914925,413.8858258354256,GPI;PGAM1;PGK1;ALDOC;ENO2;PFKP;HK1
3,GO_Biological_Process_2021,glycolytic process (GO:0006096),6/29,4.646916621640119e-06,0.0014358972360867,0,0,16.876716247139587,207.23437405089123,GPI;PGAM1;PGK1;ALDOC;ENO2;HK1
4,GO_Biological_Process_2021,pyruvate metabolic process (GO:0006090),7/55,2.1545004070321945e-05,0.0053259250061835,0,0,9.453657865786578,101.58301945970302,GPI;PGAM1;PGK1;ALDOC;ENO2;PCK1;HK1
5,GO_Biological_Process_2021,carbohydrate catabolic process (GO:0016052),6/41,3.762140398009013e-05,0.0066428650456273,0,0,11.083646616541351,112.91949805644953,GPI;PGAM1;PGK1;ALDOC;ENO2;HK1
6,GO_Biological_Process_2021,gluconeogenesis (GO:0006094),6/41,3.762140398009013e-05,0.0066428650456273,0,0,11.083646616541351,112.91949805644953,GPI;PGAM1;PGK1;ALDOC;ENO2;PCK1
7,GO_Biological_Process_2021,hexose biosynthetic process (GO:0019319),6/44,5.680405533789755e-05,0.0087762265497051,0,0,10.207063711911358,99.78326310883764,GPI;PGAM1;PGK1;ALDOC;ENO2;PCK1
8,GO_Biological_Process_2021,glucose metabolic process (GO:0006006),6/62,0.00039172504968191954,0.0537969068229836,0,0,6.919877819548872,54.28609804799004,GPI;PGAM1;PGK1;ALDOC;ENO2;PCK1
9,GO_Biological_Process_2021,histone H4-K12 acetylation (GO:0043983),2/6,0.003447238059301,0.4260786241296084,0,0,31.95779220779221,181.20649593388407,JADE1;JADE2
10,GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),3/21,0.0039878362111445,0.4480877779067885,0,0,10.679695982627578,59.000049854304194,PXDNL;HBQ1;MPO
11,GO_Biological_Process_2021,regulation of anion transport (GO:0044070),2/8,0.0063041434540528,0.6181136245392658,0,0,21.303030303030305,107.93282921110205,CA2;STC1
12,GO_Biological_Process_2021,adherens junction organization (GO:0034332),4/49,0.0069343564523077,0.6181136245392658,0,0,5.7066085693536674,28.369075014500687,CDH12;ANG;CDH9;CDH18
13,GO_Biological_Process_2021,negative regulation of bone resorption (GO:0045779),2/9,0.0080227453496882,0.6181136245392658,0,0,18.258812615955478,88.1074365546773,TNFAIP3;CARTPT
14,GO_Biological_Process_2021,plasminogen activation (GO:0031639),2/9,0.0080227453496882,0.6181136245392658,0,0,18.258812615955478,88.1074365546773,PGK1;PLAT
15,GO_Biological_Process_2021,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",2/9,0.0080227453496882,0.6181136245392658,0,0,18.258812615955478,88.1074365546773,ALDOC;PFKP
16,GO_Biological_Process_2021,B cell homeostasis (GO:0001782),2/10,0.0099263857511192,0.6181136245392658,0,0,15.97564935064935,73.68862263509924,DOCK10;TNFAIP3
17,GO_Biological_Process_2021,positive regulation of cell activation (GO:0050867),2/10,0.0099263857511192,0.6181136245392658,0,0,15.97564935064935,73.68862263509924,PLA2G4A;CAPN3
18,GO_Biological_Process_2021,fructose 6-phosphate metabolic process (GO:0006002),2/10,0.0099263857511192,0.6181136245392658,0,0,15.97564935064935,73.68862263509924,PFKP;HK1
19,GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),3/29,0.0100018385847777,0.6181136245392658,0,0,7.390628915058882,34.033745230449426,PXDNL;HBQ1;MPO
20,GO_Biological_Process_2021,negative regulation of bone remodeling (GO:0046851),2/11,0.0120089533837887,0.6453507122766491,0,0,14.1998556998557,62.7932215375227,TNFAIP3;CARTPT
21,GO_Biological_Process_2021,negative regulation of interleukin-17 production (GO:0032700),2/11,0.0120089533837887,0.6453507122766491,0,0,14.1998556998557,62.7932215375227,DDIT3;IL12A
22,GO_Biological_Process_2021,Notch signaling involved in heart development (GO:0061314),2/11,0.0120089533837887,0.6453507122766491,0,0,14.1998556998557,62.7932215375227,GALNT11;SNAI1
23,GO_Biological_Process_2021,positive regulation of protein maturation (GO:1903319),2/12,0.0142644808921906,0.705622239013785,0,0,12.77922077922078,54.31146704320471,TFR2;ANGPTL8
24,GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),3/33,0.0142722944784341,0.705622239013785,0,0,6.403908794788274,27.21299461803248,TNFAIP3;IL12A;ANG
25,GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),7/170,0.0169816776785404,0.7120007964825781,0,0,2.767600072890725,11.279687038711751,SLITRK1;AMIGO2;CDH12;LRRC4C;CDH9;MYPN;CDH18
26,GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),8/212,0.0178762156453015,0.7120007964825781,0,0,2.5303207375665497,10.182729726118437,GPI;IPMK;PGK1;PLA2G4A;ALDOC;PLPP1;PFKP;HK1
27,GO_Biological_Process_2021,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),3/36,0.0180547332218872,0.7120007964825781,0,0,5.82084690553746,23.36690164232114,CDH12;CDH9;CDH18
28,GO_Biological_Process_2021,synaptic membrane adhesion (GO:0099560),2/14,0.0192712479668301,0.7120007964825781,0,0,10.648268398268398,42.05151369918778,SLITRK1;LRRC4C
29,GO_Biological_Process_2021,histone H4-K5 acetylation (GO:0043981),2/15,0.0220112459999045,0.7120007964825781,0,0,9.828671328671328,37.508192964655606,JADE1;JADE2
30,GO_Biological_Process_2021,histone H4-K8 acetylation (GO:0043982),2/15,0.0220112459999045,0.7120007964825781,0,0,9.828671328671328,37.508192964655606,JADE1;JADE2
31,GO_Biological_Process_2021,synaptonemal complex assembly (GO:0007130),2/15,0.0220112459999045,0.7120007964825781,0,0,9.828671328671328,37.508192964655606,SYCE3;SYCE1
32,GO_Biological_Process_2021,synaptonemal complex organization (GO:0070193),2/15,0.0220112459999045,0.7120007964825781,0,0,9.828671328671328,37.508192964655606,SYCE3;SYCE1
33,GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),4/69,0.0222702829545692,0.7120007964825781,0,0,3.946706887883359,15.01525461207511,BNIP3L;CPEB1;FAM162A;PGK1
34,GO_Biological_Process_2021,hexose metabolic process (GO:0019318),3/41,0.0254792893085015,0.7120007964825781,0,0,5.053660209154809,18.54637373359319,ALDOC;PCK1;HK1
35,GO_Biological_Process_2021,histone H3 acetylation (GO:0043966),3/42,0.0271326224845659,0.7120007964825781,0,0,4.92382861438236,17.760340870125926,BRPF1;JADE1;JADE2
36,GO_Biological_Process_2021,cell surface receptor signaling pathway involved in heart development (GO:0061311),2/17,0.0279373643674681,0.7120007964825781,0,0,8.517316017316018,30.4731703006656,GALNT11;SNAI1
37,GO_Biological_Process_2021,cellular glucose homeostasis (GO:0001678),3/43,0.0288419188978658,0.7120007964825781,0,0,4.800488599348534,17.022174614256965,CARTPT;PCK1;HK1
38,GO_Biological_Process_2021,"synaptic transmission, glutamatergic (GO:0035249)",2/18,0.0311130293525237,0.7120007964825781,0,0,7.984577922077922,27.70751218469436,NAPA;SLC17A6
39,GO_Biological_Process_2021,neural crest cell development (GO:0014032),3/45,0.0324277246579778,0.7120007964825781,0,0,4.571428571428571,15.67424696121368,SEMA3B;SEMA3E;NRG1
40,GO_Biological_Process_2021,zymogen activation (GO:0031638),3/45,0.0324277246579778,0.7120007964825781,0,0,4.571428571428571,15.67424696121368,PGK1;PLAT;PRSS12
41,GO_Biological_Process_2021,diol metabolic process (GO:0034311),2/19,0.0344236702368572,0.7120007964825781,0,0,7.514514896867838,25.31648231731918,PRKG2;PLPP1
42,GO_Biological_Process_2021,histone H4-K16 acetylation (GO:0043984),2/19,0.0344236702368572,0.7120007964825781,0,0,7.514514896867838,25.31648231731918,JADE1;JADE2
43,GO_Biological_Process_2021,negative regulation of axon extension involved in axon guidance (GO:0048843),2/20,0.0378643688325934,0.7120007964825781,0,0,7.096681096681096,23.23272245033935,SEMA3B;SEMA3E
44,GO_Biological_Process_2021,glucose transmembrane transport (GO:1904659),2/20,0.0378643688325934,0.7120007964825781,0,0,7.096681096681096,23.23272245033935,SLC2A14;SLC2A3
45,GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),4/82,0.0386229805481591,0.7120007964825781,0,0,3.2867437573319926,10.694761242827523,CDH12;ANG;CDH9;CDH18
46,GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),3/49,0.0402613831340384,0.7120007964825781,0,0,4.17306330548081,13.405392090669515,TNFAIP3;IL12A;ANG
47,GO_Biological_Process_2021,sensory perception (GO:0007600),3/51,0.0445041338583271,0.7120007964825781,0,0,3.998778501628665,12.444891279233746,ADORA2A;SCN9A;ASIC3
48,GO_Biological_Process_2021,negative regulation of lymphocyte activation (GO:0051250),2/22,0.0451168597267577,0.7120007964825781,0,0,6.386363636363637,19.788143080994487,GPNMB;TNFAIP3
49,GO_Biological_Process_2021,synapse organization (GO:0050808),5/126,0.0465873565532902,0.7120007964825781,0,0,2.651266766020864,8.129913591527412,PPFIBP1;SLITRK1;SEMA3E;LRRC4C;PPFIA4
50,GO_Biological_Process_2021,ameboidal-type cell migration (GO:0001667),3/52,0.0467056319480523,0.7120007964825781,0,0,3.9169713488001054,12.001171394918584,ITGA4;SEMA3B;SEMA3E
51,GO_Biological_Process_2021,acylglycerol biosynthetic process (GO:0046463),2/23,0.0489194015753988,0.7120007964825781,0,0,6.081941867656154,18.352753445150903,PLA2G4A;ANG
52,GO_Biological_Process_2021,glucose 6-phosphate metabolic process (GO:0051156),2/23,0.0489194015753988,0.7120007964825781,0,0,6.081941867656154,18.352753445150903,GPI;HK1
53,GO_Biological_Process_2021,hexose transmembrane transport (GO:0008645),2/23,0.0489194015753988,0.7120007964825781,0,0,6.081941867656154,18.352753445150903,SLC2A14;SLC2A3
54,GO_Biological_Process_2021,regulation of axon extension involved in axon guidance (GO:0048841),2/24,0.0528334953660874,0.7120007964825781,0,0,5.805194805194805,17.070813358958546,SEMA3B;SEMA3E
55,GO_Biological_Process_2021,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),2/27,0.0652021540906028,0.7120007964825781,0,0,5.107792207792208,13.945614914068672,CAPZB;ARHGAP24
56,GO_Biological_Process_2021,sarcomere organization (GO:0045214),2/28,0.0695200482400727,0.7120007964825781,0,0,4.911088911088911,13.093651100768684,CAPN3;MYPN
57,GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),4/101,0.0721415660007123,0.7120007964825781,0,0,2.64038811400849,6.941910125489257,ANXA4;PGK1;ALDOC;PCK1
58,GO_Biological_Process_2021,homologous chromosome pairing at meiosis (GO:0007129),2/29,0.0739288097534393,0.7120007964825781,0,0,4.728956228956229,12.31728851149992,SYCE3;SYCE1
59,GO_Biological_Process_2021,cell junction assembly (GO:0034329),4/102,0.0742158465794252,0.7120007964825781,0,0,2.613311991463252,6.796643252231371,SLITRK1;CDH12;CDH9;CDH18
60,GO_Biological_Process_2021,protein localization to site of double-strand break (GO:1990166),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SLF2
61,GO_Biological_Process_2021,negative regulation of CREB transcription factor activity (GO:0032792),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,DDIT3
62,GO_Biological_Process_2021,negative regulation of heterochromatin assembly (GO:0031452),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,TET1
63,GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,CA2
64,GO_Biological_Process_2021,cardiac endothelial cell differentiation (GO:0003348),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,NRG1
65,GO_Biological_Process_2021,cardiac muscle cell myoblast differentiation (GO:0060379),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,NRG1
66,GO_Biological_Process_2021,cell-cell adhesion mediated by integrin (GO:0033631),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,ITGA4
67,GO_Biological_Process_2021,negative regulation of response to food (GO:0032096),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,CARTPT
68,GO_Biological_Process_2021,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,DDIT3
69,GO_Biological_Process_2021,regulation of germinal center formation (GO:0002634),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,TNFAIP3
70,GO_Biological_Process_2021,cellular response to salt stress (GO:0071472),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,CAPN3
71,GO_Biological_Process_2021,negative regulation of vitamin D biosynthetic process (GO:0010957),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SNAI1
72,GO_Biological_Process_2021,regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SLF2
73,GO_Biological_Process_2021,regulation of mononuclear cell proliferation (GO:0032944),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,IL12A
74,GO_Biological_Process_2021,oxaloacetate metabolic process (GO:0006107),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,PCK1
75,GO_Biological_Process_2021,endocardial cell differentiation (GO:0060956),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,NRG1
76,GO_Biological_Process_2021,endothelin receptor signaling pathway (GO:0086100),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,EDNRB
77,GO_Biological_Process_2021,regulation of synaptic vesicle priming (GO:0010807),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,NAPA
78,GO_Biological_Process_2021,glucose import across plasma membrane (GO:0098708),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SLC2A3
79,GO_Biological_Process_2021,glycerol biosynthetic process (GO:0006114),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,PCK1
80,GO_Biological_Process_2021,regulation of voltage-gated sodium channel activity (GO:1905150),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,FGF11
81,GO_Biological_Process_2021,response to salt stress (GO:0009651),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,CAPN3
82,GO_Biological_Process_2021,histone H4-K20 methylation (GO:0034770),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,KMT5B
83,GO_Biological_Process_2021,histone H4-K20 trimethylation (GO:0034773),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,KMT5B
84,GO_Biological_Process_2021,positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SLF2
85,GO_Biological_Process_2021,positive regulation of maintenance of sister chromatid cohesion (GO:0034093),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,SLF2
86,GO_Biological_Process_2021,positive regulation of mononuclear cell proliferation (GO:0032946),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,IL12A
87,GO_Biological_Process_2021,sensory perception of sour taste (GO:0050915),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,ASIC3
88,GO_Biological_Process_2021,late endosome to Golgi transport (GO:0034499),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,GCC2
89,GO_Biological_Process_2021,positive regulation of phospholipase A2 activity (GO:0032430),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,ANG
90,GO_Biological_Process_2021,membrane raft distribution (GO:0031580),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,MAL
91,GO_Biological_Process_2021,mRNA cleavage (GO:0006379),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,RNASE4
92,GO_Biological_Process_2021,protein K29-linked deubiquitination (GO:0035523),1/5,0.0751414522316401,0.7120007964825781,0,0,15.927184466019416,41.225652108301766,TNFAIP3
93,GO_Biological_Process_2021,multivesicular body assembly (GO:0036258),2/30,0.078424605568423,0.7120007964825781,0,0,4.559833024118738,11.607590991007068,CHMP1A;VPS37C
94,GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),3/66,0.0828278987906706,0.7120007964825781,0,0,3.0443617186288194,7.583475609514597,CDH12;CDH9;CDH18
95,GO_Biological_Process_2021,negative regulation of axon extension (GO:0030517),2/31,0.0830036989145478,0.7120007964825781,0,0,4.402373488580385,10.956935775326192,SEMA3B;SEMA3E
96,GO_Biological_Process_2021,activation of protein kinase B activity (GO:0032148),2/31,0.0830036989145478,0.7120007964825781,0,0,4.402373488580385,10.956935775326192,NRG1;ANG
97,GO_Biological_Process_2021,multivesicular body organization (GO:0036257),2/31,0.0830036989145478,0.7120007964825781,0,0,4.402373488580385,10.956935775326192,CHMP1A;VPS37C
98,GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),2/32,0.0876624472805498,0.7120007964825781,0,0,4.255411255411255,10.358784494284608,SEMA3B;SEMA3E
99,GO_Biological_Process_2021,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,IL12A
100,GO_Biological_Process_2021,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,NRG1
101,GO_Biological_Process_2021,regulation of epinephrine secretion (GO:0014060),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,CARTPT
102,GO_Biological_Process_2021,negative regulation of sequestering of triglyceride (GO:0010891),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,ABHD5
103,GO_Biological_Process_2021,cellular response to iron ion (GO:0071281),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,TFR2
104,GO_Biological_Process_2021,negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,TNFAIP3
105,GO_Biological_Process_2021,negative regulation of vitamin metabolic process (GO:0046137),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,SNAI1
106,GO_Biological_Process_2021,neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,SLC17A6
107,GO_Biological_Process_2021,dehydroascorbic acid transport (GO:0070837),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,SLC2A14
108,GO_Biological_Process_2021,regulation of NK T cell activation (GO:0051133),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,IL12A
109,GO_Biological_Process_2021,regulation of transmission of nerve impulse (GO:0051969),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,CARTPT
110,GO_Biological_Process_2021,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,DDIT3
111,GO_Biological_Process_2021,regulation of vitamin D biosynthetic process (GO:0060556),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,SNAI1
112,GO_Biological_Process_2021,glycosylceramide catabolic process (GO:0046477),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,GALC
113,GO_Biological_Process_2021,hepatocyte differentiation (GO:0070365),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,PCK1
114,GO_Biological_Process_2021,hexose import across plasma membrane (GO:0140271),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,SLC2A3
115,GO_Biological_Process_2021,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,IL12A
116,GO_Biological_Process_2021,positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,IL12A
117,GO_Biological_Process_2021,medium-chain fatty acid biosynthetic process (GO:0051792),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,OXSM
118,GO_Biological_Process_2021,tRNA pseudouridine synthesis (GO:0031119),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,PUS10
119,GO_Biological_Process_2021,type B pancreatic cell proliferation (GO:0044342),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,ANGPTL8
120,GO_Biological_Process_2021,mitochondrial protein catabolic process (GO:0035694),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,BNIP3L
121,GO_Biological_Process_2021,valine metabolic process (GO:0006573),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,BCAT1
122,GO_Biological_Process_2021,monoterpenoid metabolic process (GO:0016098),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,CYP2E1
123,GO_Biological_Process_2021,protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/6,0.08948031840285,0.7120007964825781,0,0,12.741100323624597,30.75365997151672,TNFAIP3
124,GO_Biological_Process_2021,regulation of interleukin-17 production (GO:0032660),2/33,0.0923973004384969,0.7120007964825781,0,0,4.117930456640134,9.80750002569554,DDIT3;IL12A
125,GO_Biological_Process_2021,negative chemotaxis (GO:0050919),2/33,0.0923973004384969,0.7120007964825781,0,0,4.117930456640134,9.80750002569554,SEMA3B;SEMA3E
126,GO_Biological_Process_2021,histone acetylation (GO:0016573),3/71,0.0979312571096344,0.7120007964825781,0,0,2.8197930638053266,6.551759588651184,BRPF1;JADE1;JADE2
127,GO_Biological_Process_2021,response to metal ion (GO:0010038),3/71,0.0979312571096344,0.7120007964825781,0,0,2.8197930638053266,6.551759588651184,PPP5C;TFR2;CAPN3
128,GO_Biological_Process_2021,cell junction organization (GO:0034330),3/72,0.1010772309947174,0.7120007964825781,0,0,2.778784874663645,6.368614777291636,PPFIBP1;SEMA3E;PPFIA4
129,GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),2/35,0.1020815695391435,0.7120007964825781,0,0,3.867965367965368,8.82663153890268,GPNMB;JADE1
130,GO_Biological_Process_2021,cellular response to virus (GO:0098586),2/35,0.1020815695391435,0.7120007964825781,0,0,3.867965367965368,8.82663153890268,IL12A;LGALS8
131,GO_Biological_Process_2021,positive regulation of immunoglobulin production (GO:0002639),2/35,0.1020815695391435,0.7120007964825781,0,0,3.867965367965368,8.82663153890268,GPI;KMT5B
132,GO_Biological_Process_2021,semaphorin-plexin signaling pathway (GO:0071526),2/35,0.1020815695391435,0.7120007964825781,0,0,3.867965367965368,8.82663153890268,SEMA3B;SEMA3E
133,GO_Biological_Process_2021,angiotensin-activated signaling pathway (GO:0038166),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CA2
134,GO_Biological_Process_2021,negative regulation of cytoplasmic translation (GO:2000766),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CPEB1
135,GO_Biological_Process_2021,calcium ion export (GO:1901660),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,SLC35G1
136,GO_Biological_Process_2021,regulation of chromatin assembly or disassembly (GO:0001672),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,SPTY2D1
137,GO_Biological_Process_2021,cardiolipin acyl-chain remodeling (GO:0035965),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,PLA2G4A
138,GO_Biological_Process_2021,cellular amino acid biosynthetic process (GO:0008652),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,BCAT1
139,GO_Biological_Process_2021,negative regulation of protein sumoylation (GO:0033234),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CAPN3
140,GO_Biological_Process_2021,negative regulation of ruffle assembly (GO:1900028),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,ARHGAP24
141,GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,IL12A
142,GO_Biological_Process_2021,pexophagy (GO:0000425),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,NBR1
143,GO_Biological_Process_2021,phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,GNA11
144,GO_Biological_Process_2021,endothelial cell morphogenesis (GO:0001886),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,STC1
145,GO_Biological_Process_2021,positive regulation of catecholamine secretion (GO:0033605),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CARTPT
146,GO_Biological_Process_2021,regulation of striated muscle cell differentiation (GO:0051153),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,NRG1
147,GO_Biological_Process_2021,positive regulation of cilium movement (GO:0003353),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,TACR3
148,GO_Biological_Process_2021,positive regulation of cilium-dependent cell motility (GO:2000155),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,TACR3
149,GO_Biological_Process_2021,positive regulation of flagellated sperm motility (GO:1902093),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,TACR3
150,GO_Biological_Process_2021,hemostasis (GO:0007599),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,GPI
151,GO_Biological_Process_2021,response to lead ion (GO:0010288),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,PPP5C
152,GO_Biological_Process_2021,histone H3-K14 acetylation (GO:0044154),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,BRPF1
153,GO_Biological_Process_2021,iron import into cell (GO:0033212),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,TFR2
154,GO_Biological_Process_2021,positive regulation of NK T cell activation (GO:0051135),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,IL12A
155,GO_Biological_Process_2021,smooth muscle cell migration (GO:0014909),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,PLAT
156,GO_Biological_Process_2021,leucine metabolic process (GO:0006551),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,BCAT1
157,GO_Biological_Process_2021,lipid hydroxylation (GO:0002933),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CYP2E1
158,GO_Biological_Process_2021,marginal zone B cell differentiation (GO:0002315),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,DOCK10
159,GO_Biological_Process_2021,tachykinin receptor signaling pathway (GO:0007217),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,TACR3
160,GO_Biological_Process_2021,terpenoid metabolic process (GO:0006721),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,CYP2E1
161,GO_Biological_Process_2021,monoacylglycerol biosynthetic process (GO:0006640),1/7,0.1035975848403304,0.7120007964825781,0,0,10.617044228694716,24.071400753445328,PLA2G4A
162,GO_Biological_Process_2021,cytosolic transport (GO:0016482),4/116,0.1063053782121422,0.7120007964825781,0,0,2.2850140056022408,5.121720422293945,EEA1;TMEM87B;GCC2;TBC1D10B
163,GO_Biological_Process_2021,regulation of defense response to virus by host (GO:0050691),2/36,0.1070243287037566,0.7120007964825781,0,0,3.7540106951871657,8.389084319304711,APOBEC3G;TNFAIP3
164,GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/37,0.1120298753454055,0.7120007964825781,0,0,3.646567717996289,7.982299171770059,GPNMB;JADE1
165,GO_Biological_Process_2021,neural crest cell migration (GO:0001755),2/37,0.1120298753454055,0.7120007964825781,0,0,3.646567717996289,7.982299171770059,SEMA3B;SEMA3E
166,GO_Biological_Process_2021,negative regulation of appetite (GO:0032099),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,CARTPT
167,GO_Biological_Process_2021,negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,PKIG
168,GO_Biological_Process_2021,regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,PDK1
169,GO_Biological_Process_2021,regulation of acyl-CoA biosynthetic process (GO:0050812),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,PDK1
170,GO_Biological_Process_2021,benzene-containing compound metabolic process (GO:0042537),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,CYP2E1
171,GO_Biological_Process_2021,carbohydrate phosphorylation (GO:0046835),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,HK1
172,GO_Biological_Process_2021,regulation of dendritic cell chemotaxis (GO:2000508),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,IL12A
173,GO_Biological_Process_2021,cellular response to angiotensin (GO:1904385),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,CA2
174,GO_Biological_Process_2021,diacylglycerol biosynthetic process (GO:0006651),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,ANG
175,GO_Biological_Process_2021,regulation of nitric oxide metabolic process (GO:0080164),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TMEM106A
176,GO_Biological_Process_2021,platelet activating factor metabolic process (GO:0046469),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,PLA2G4A
177,GO_Biological_Process_2021,ER overload response (GO:0006983),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,DDIT3
178,GO_Biological_Process_2021,fructose metabolic process (GO:0006000),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,ALDOC
179,GO_Biological_Process_2021,regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TNFAIP3
180,GO_Biological_Process_2021,galactosylceramide metabolic process (GO:0006681),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,GALC
181,GO_Biological_Process_2021,positive regulation of dendritic cell chemotaxis (GO:2000510),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,IL12A
182,GO_Biological_Process_2021,regulation of vascular wound healing (GO:0061043),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TNFAIP3
183,GO_Biological_Process_2021,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TMEM106A
184,GO_Biological_Process_2021,self proteolysis (GO:0097264),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,CAPN3
185,GO_Biological_Process_2021,short-chain fatty acid catabolic process (GO:0019626),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,PCK1
186,GO_Biological_Process_2021,snRNA transcription by RNA polymerase III (GO:0042796),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,SNAPC5
187,GO_Biological_Process_2021,positive regulation of peptide secretion (GO:0002793),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TFR2
188,GO_Biological_Process_2021,SREBP signaling pathway (GO:0032933),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,INSIG2
189,GO_Biological_Process_2021,positive regulation of triglyceride catabolic process (GO:0010898),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,ABHD5
190,GO_Biological_Process_2021,mitochondrial RNA processing (GO:0000963),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TRMT10A
191,GO_Biological_Process_2021,mitochondrial tRNA processing (GO:0090646),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TRMT10A
192,GO_Biological_Process_2021,vascular associated smooth muscle contraction (GO:0014829),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,EDNRB
193,GO_Biological_Process_2021,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,NRG1
194,GO_Biological_Process_2021,progesterone receptor signaling pathway (GO:0050847),1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,TRERF1
195,GO_Biological_Process_2021,"wound healing, spreading of epidermal cells (GO:0035313)",1/8,0.1174966647628637,0.7120007964825781,0,0,9.0998613037448,19.485945513680495,ARHGAP24
196,GO_Biological_Process_2021,cellular response to ketone (GO:1901655),2/39,0.1222169409108786,0.7120007964825781,0,0,3.449104949104949,7.249872392682177,PCK1;TRERF1
197,GO_Biological_Process_2021,negative regulation of NF-kappaB transcription factor activity (GO:0032088),3/79,0.1241773953372318,0.7120007964825781,0,0,2.521944111092062,5.260886704498447,ANXA4;DDIT3;TNFAIP3
198,GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),4/123,0.1243487490965929,0.7120007964825781,0,0,2.1498324820124126,4.481680892974572,CAPZB;GPNMB;TNFAIP3;LRRC4C
199,GO_Biological_Process_2021,carboxylic acid metabolic process (GO:0019752),2/40,0.1273924655320762,0.7120007964825781,0,0,3.358168147641832,6.919447297501808,PLA2G4A;SLC2A3
200,GO_Biological_Process_2021,positive regulation of double-strand break repair (GO:2000781),2/40,0.1273924655320762,0.7120007964825781,0,0,3.358168147641832,6.919447297501808,SLF2;KMT5B
201,GO_Biological_Process_2021,protein O-linked glycosylation via threonine (GO:0018243),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,GALNT11
202,GO_Biological_Process_2021,ATF6-mediated unfolded protein response (GO:0036500),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,DDIT3
203,GO_Biological_Process_2021,negative regulation of leukocyte proliferation (GO:0070664),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,TNFAIP3
204,GO_Biological_Process_2021,regulation of DNA-templated transcription in response to stress (GO:0043620),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,DDIT3
205,GO_Biological_Process_2021,regulation of glucan biosynthetic process (GO:0010962),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,PPP1R3E
206,GO_Biological_Process_2021,cellular response to sterol depletion (GO:0071501),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,INSIG2
207,GO_Biological_Process_2021,Notch receptor processing (GO:0007220),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,GALNT11
208,GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,CA2
209,GO_Biological_Process_2021,DNA cytosine deamination (GO:0070383),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,APOBEC3G
210,GO_Biological_Process_2021,epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,SNAI1
211,GO_Biological_Process_2021,positive regulation of blood pressure (GO:0045777),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,CARTPT
212,GO_Biological_Process_2021,regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,DDIT3
213,GO_Biological_Process_2021,regulation of smooth muscle cell apoptotic process (GO:0034391),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,IL12A
214,GO_Biological_Process_2021,positive regulation of memory T cell differentiation (GO:0043382),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,PCK1
215,GO_Biological_Process_2021,positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,BNIP3L
216,GO_Biological_Process_2021,short-chain fatty acid metabolic process (GO:0046459),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,OXSM
217,GO_Biological_Process_2021,L-ascorbic acid metabolic process (GO:0019852),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,SLC2A3
218,GO_Biological_Process_2021,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.1311809191989758,0.7120007964825781,0,0,7.961974110032362,16.172185422589365,IL12A
219,GO_Biological_Process_2021,response to insulin (GO:0032868),3/84,0.1417326063013435,0.7120007964825781,0,0,2.365665339606708,4.622067814283052,CPEB1;INSIG2;PCK1
220,GO_Biological_Process_2021,lipid modification (GO:0030258),2/43,0.143212669528809,0.7120007964825781,0,0,3.111973392461197,6.047885502322521,CYP2E1;PLPP1
221,GO_Biological_Process_2021,myofibril assembly (GO:0030239),2/43,0.143212669528809,0.7120007964825781,0,0,3.111973392461197,6.047885502322521,CAPN3;MYPN
222,GO_Biological_Process_2021,regulation of actin filament-based movement (GO:1903115),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,STC1
223,GO_Biological_Process_2021,apical protein localization (GO:0045176),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,MAL
224,GO_Biological_Process_2021,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,TNFAIP3
225,GO_Biological_Process_2021,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,IL12A
226,GO_Biological_Process_2021,"complement activation, lectin pathway (GO:0001867)",1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,COLEC10
227,GO_Biological_Process_2021,regulation of memory T cell differentiation (GO:0043380),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PCK1
228,GO_Biological_Process_2021,DNA dealkylation (GO:0035510),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,ASCC1
229,GO_Biological_Process_2021,DNA dealkylation involved in DNA repair (GO:0006307),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,ASCC1
230,GO_Biological_Process_2021,phosphatidylcholine catabolic process (GO:0034638),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PLA2G4A
231,GO_Biological_Process_2021,ESCRT complex disassembly (GO:1904896),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,CHMP1A
232,GO_Biological_Process_2021,ESCRT III complex disassembly (GO:1904903),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,CHMP1A
233,GO_Biological_Process_2021,ether lipid biosynthetic process (GO:0008611),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PLA2G4A
234,GO_Biological_Process_2021,positive regulation of establishment of protein localization to telomere (GO:1904851),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,CCT7
235,GO_Biological_Process_2021,positive regulation of mRNA 3'-end processing (GO:0031442),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,CPEB1
236,GO_Biological_Process_2021,modulation by symbiont of host process (GO:0044003),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PGK1
237,GO_Biological_Process_2021,primary miRNA processing (GO:0031053),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PUS10
238,GO_Biological_Process_2021,muscle cell migration (GO:0014812),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,PLAT
239,GO_Biological_Process_2021,protein K11-linked deubiquitination (GO:0035871),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,TNFAIP3
240,GO_Biological_Process_2021,protein localization to endosome (GO:0036010),1/10,0.1446536576340862,0.7120007964825781,0,0,7.076950737144912,13.682668285085878,RAB35
241,GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),4/131,0.1464302621804288,0.7120007964825781,0,0,2.0135865369769954,3.8685145160897614,BNIP3L;CPEB1;FAM162A;PGK1
242,GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),2/44,0.1485748462332989,0.7120007964825781,0,0,3.0377241805813235,5.791926726834264,ITGA4;TNFAIP3
243,GO_Biological_Process_2021,intracellular steroid hormone receptor signaling pathway (GO:0030518),2/44,0.1485748462332989,0.7120007964825781,0,0,3.0377241805813235,5.791926726834264,TRERF1;PLPP1
244,GO_Biological_Process_2021,glucose homeostasis (GO:0042593),3/86,0.1489754117588772,0.7120007964825781,0,0,2.3084258859542404,4.395182887190238,CARTPT;PCK1;HK1
245,GO_Biological_Process_2021,regulation of cell motility (GO:2000145),4/133,0.1521754251988689,0.7120007964825781,0,0,1.9821654760095253,3.7318651825452167,DOCK10;OSGIN1;NRG1;FUT3
246,GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),5/182,0.1532921051239675,0.7120007964825781,0,0,1.8072612762804483,3.389355859211593,GPNMB;DDIT3;ANXA4;TNFAIP3;IL12A
247,GO_Biological_Process_2021,action potential (GO:0001508),2/45,0.1539770406434306,0.7120007964825781,0,0,2.9669284204167927,5.550979992738152,GNA11;SCN9A
248,GO_Biological_Process_2021,"retrograde transport, endosome to Golgi (GO:0042147)",3/88,0.1563349640795424,0.7120007964825781,0,0,2.2538800536501244,4.182647754612852,TMEM87B;GCC2;TBC1D10B
249,GO_Biological_Process_2021,regulation of biosynthetic process (GO:0009889),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,PCK1
250,GO_Biological_Process_2021,cellular glucan metabolic process (GO:0006073),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,GBE1
251,GO_Biological_Process_2021,regulation of establishment of protein localization to telomere (GO:0070203),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,CCT7
252,GO_Biological_Process_2021,negative regulation of steroid biosynthetic process (GO:0010894),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,SNAI1
253,GO_Biological_Process_2021,cellular response to UV-A (GO:0071492),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,OPN1SW
254,GO_Biological_Process_2021,cytidine to uridine editing (GO:0016554),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,APOBEC3G
255,GO_Biological_Process_2021,PERK-mediated unfolded protein response (GO:0036499),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,DDIT3
256,GO_Biological_Process_2021,regulation of protein localization to Cajal body (GO:1904869),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,CCT7
257,GO_Biological_Process_2021,enteric nervous system development (GO:0048484),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,EDNRB
258,GO_Biological_Process_2021,regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,NBR1
259,GO_Biological_Process_2021,regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,TNFAIP3
260,GO_Biological_Process_2021,inositol phosphate biosynthetic process (GO:0032958),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,IPMK
261,GO_Biological_Process_2021,interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,IL12A
262,GO_Biological_Process_2021,positive regulation of protein localization to Cajal body (GO:1904871),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,CCT7
263,GO_Biological_Process_2021,tetrahydrobiopterin metabolic process (GO:0046146),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,PRKG2
264,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,DDIT3
265,GO_Biological_Process_2021,vasoconstriction (GO:0042310),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,EDNRB
266,GO_Biological_Process_2021,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.157918138840558,0.7120007964825781,0,0,6.368932038834951,11.755000860858848,PLPP1
267,GO_Biological_Process_2021,negative regulation of cold-induced thermogenesis (GO:0120163),2/47,0.1648914831762385,0.7120007964825781,0,0,2.834776334776335,5.1095927777950525,DDIT3;ARRDC3
268,GO_Biological_Process_2021,phosphatidic acid biosynthetic process (GO:0006654),2/48,0.1703988999389982,0.7120007964825781,0,0,2.7730095990965555,4.907154169458835,PLA2G4A;ABHD5
269,GO_Biological_Process_2021,histone H4 acetylation (GO:0043967),2/48,0.1703988999389982,0.7120007964825781,0,0,2.7730095990965555,4.907154169458835,JADE1;JADE2
270,GO_Biological_Process_2021,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,IL12A
271,GO_Biological_Process_2021,autophagy of peroxisome (GO:0030242),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,NBR1
272,GO_Biological_Process_2021,cardiocyte differentiation (GO:0035051),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,NRG1
273,GO_Biological_Process_2021,regulation of flagellated sperm motility (GO:1901317),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,TACR3
274,GO_Biological_Process_2021,regulation of glycogen metabolic process (GO:0070873),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,PPP1R3E
275,GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,TMEM106A
276,GO_Biological_Process_2021,regulation of natural killer cell activation (GO:0032814),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,IL12A
277,GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,EDNRB
278,GO_Biological_Process_2021,gas transport (GO:0015669),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,CA2
279,GO_Biological_Process_2021,regulation of triglyceride catabolic process (GO:0010896),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,ABHD5
280,GO_Biological_Process_2021,positive regulation of leukocyte proliferation (GO:0070665),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,IL12A
281,GO_Biological_Process_2021,sensory perception of taste (GO:0050909),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,ASIC3
282,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,PDK1
283,GO_Biological_Process_2021,keratan sulfate catabolic process (GO:0042340),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,GALNS
284,GO_Biological_Process_2021,smooth muscle cell differentiation (GO:0051145),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,EDNRB
285,GO_Biological_Process_2021,sphingoid metabolic process (GO:0046519),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,PLPP1
286,GO_Biological_Process_2021,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,CCT7
287,GO_Biological_Process_2021,macrophage chemotaxis (GO:0048246),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,EDNRB
288,GO_Biological_Process_2021,maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,INSIG2
289,GO_Biological_Process_2021,mesoderm morphogenesis (GO:0048332),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,SNAI1
290,GO_Biological_Process_2021,microtubule anchoring (GO:0034453),1/12,0.1709775716126468,0.7120007964825781,0,0,5.789644012944984,10.225801787803793,GCC2
291,GO_Biological_Process_2021,regulation of lipid metabolic process (GO:0019216),3/92,0.1713794261906024,0.7120007964825781,0,0,2.1521428832851446,3.796111703848615,ANGPTL8;PCK1;PLPP1
292,GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),3/94,0.1790519888123372,0.7120007964825781,0,0,2.104628270752049,3.620127049213206,BNIP3L;GPNMB;AMIGO2
293,GO_Biological_Process_2021,phosphatidic acid metabolic process (GO:0046473),2/50,0.181502535739734,0.7120007964825781,0,0,2.6571969696969697,4.53446850958879,PLA2G4A;ABHD5
294,GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),4/143,0.1821105328651191,0.7120007964825781,0,0,1.8386232190718013,3.131435420512766,DDIT3;ANXA4;BHLHE40;TNFAIP3
295,GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),4/143,0.1821105328651191,0.7120007964825781,0,0,1.8386232190718013,3.131435420512766,ARRDC2;ARRDC3;CHMP1A;SLC7A14
296,GO_Biological_Process_2021,pseudouridine synthesis (GO:0001522),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,PUS10
297,GO_Biological_Process_2021,pteridine-containing compound metabolic process (GO:0042558),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,PRKG2
298,GO_Biological_Process_2021,DNA deamination (GO:0045006),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,APOBEC3G
299,GO_Biological_Process_2021,regulation of protein exit from endoplasmic reticulum (GO:0070861),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,GCC2
300,GO_Biological_Process_2021,positive regulation of calcium ion import (GO:0090280),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,STC1
301,GO_Biological_Process_2021,glucan biosynthetic process (GO:0009250),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,GBE1
302,GO_Biological_Process_2021,glucose import (GO:0046323),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,SLC2A3
303,GO_Biological_Process_2021,glycogen biosynthetic process (GO:0005978),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,GBE1
304,GO_Biological_Process_2021,Golgi ribbon formation (GO:0090161),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,GCC2
305,GO_Biological_Process_2021,response to iron ion (GO:0010039),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,TFR2
306,GO_Biological_Process_2021,response to UV-B (GO:0010224),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,IL12A
307,GO_Biological_Process_2021,mature B cell differentiation involved in immune response (GO:0002313),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,DOCK10
308,GO_Biological_Process_2021,transport along microtubule (GO:0010970),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,BORCS5
309,GO_Biological_Process_2021,mitochondrial outer membrane permeabilization (GO:0097345),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,BNIP3L
310,GO_Biological_Process_2021,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,ITGA4
311,GO_Biological_Process_2021,negative regulation of adenylate cyclase activity (GO:0007194),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,EDNRB
312,GO_Biological_Process_2021,protein localization to mitochondrion (GO:0070585),1/13,0.1838351154563208,0.7120007964825781,0,0,5.306903991370011,8.98838838517707,HK1
313,GO_Biological_Process_2021,regulation of cell migration (GO:0030334),9/408,0.1844594279649086,0.7120007964825781,0,0,1.4456323533085205,2.4435895807177768,DOCK10;GPNMB;SEMA3B;SNAI1;OSGIN1;STC1;SEMA3E;ARHGAP4;FUT3
314,GO_Biological_Process_2021,regulation of axonogenesis (GO:0050770),2/51,0.1870943091517524,0.7120007964825781,0,0,2.602835939570633,4.362723840566387,SLITRK1;LRRC4C
315,GO_Biological_Process_2021,negative regulation of cyclase activity (GO:0031280),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,EDNRB
316,GO_Biological_Process_2021,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,SNAI1
317,GO_Biological_Process_2021,regulation of cAMP-dependent protein kinase activity (GO:2000479),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,PKIG
318,GO_Biological_Process_2021,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,SEMA3E
319,GO_Biological_Process_2021,cardiolipin metabolic process (GO:0032048),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,PLA2G4A
320,GO_Biological_Process_2021,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,TET1
321,GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,NRG1
322,GO_Biological_Process_2021,regulation of histone methylation (GO:0031060),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,TET1
323,GO_Biological_Process_2021,regulation of lamellipodium organization (GO:1902743),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,CAPZB
324,GO_Biological_Process_2021,regulation of lipase activity (GO:0060191),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,ANGPTL8
325,GO_Biological_Process_2021,ovarian follicle development (GO:0001541),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,ANG
326,GO_Biological_Process_2021,peptidyl-serine dephosphorylation (GO:0070262),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,PPP5C
327,GO_Biological_Process_2021,positive regulation of glycogen biosynthetic process (GO:0045725),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,PPP1R3E
328,GO_Biological_Process_2021,heterochromatin organization (GO:0070828),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,SNAI1
329,GO_Biological_Process_2021,response to UV-A (GO:0070141),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,OPN1SW
330,GO_Biological_Process_2021,striated muscle cell development (GO:0055002),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,CAPN3
331,GO_Biological_Process_2021,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,MPO
332,GO_Biological_Process_2021,positive regulation of transmembrane transport (GO:0034764),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,CA2
333,GO_Biological_Process_2021,monoacylglycerol metabolic process (GO:0046462),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,PLA2G4A
334,GO_Biological_Process_2021,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,NUDT12
335,GO_Biological_Process_2021,ncRNA transcription (GO:0098781),1/14,0.196493881366796,0.7120007964825781,0,0,4.898431665421957,7.97035565776603,ANG
336,GO_Biological_Process_2021,regulation of proteolysis (GO:0030162),2/54,0.2040040540797939,0.7120007964825781,0,0,2.4522977022977024,3.898210223353809,CAPN3;PLAT
337,GO_Biological_Process_2021,androgen receptor signaling pathway (GO:0030521),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PLPP1
338,GO_Biological_Process_2021,regulation of cytoplasmic translation (GO:2000765),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,CPEB1
339,GO_Biological_Process_2021,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,APOBEC3G
340,GO_Biological_Process_2021,"phototransduction, visible light (GO:0007603)",1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,GNA11
341,GO_Biological_Process_2021,placenta development (GO:0001890),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,ANG
342,GO_Biological_Process_2021,regulation of secretion (GO:0051046),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,NRG1
343,GO_Biological_Process_2021,regulation of sequestering of triglyceride (GO:0010889),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,ABHD5
344,GO_Biological_Process_2021,fibrinolysis (GO:0042730),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PLAT
345,GO_Biological_Process_2021,glucuronate metabolic process (GO:0019585),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,UGT2B4
346,GO_Biological_Process_2021,positive regulation of glycogen metabolic process (GO:0070875),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PPP1R3E
347,GO_Biological_Process_2021,icosanoid biosynthetic process (GO:0046456),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PLA2G4A
348,GO_Biological_Process_2021,integrated stress response signaling (GO:0140467),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,DDIT3
349,GO_Biological_Process_2021,positive regulation of natural killer cell activation (GO:0032816),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,IL12A
350,GO_Biological_Process_2021,steroid hormone mediated signaling pathway (GO:0043401),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PLPP1
351,GO_Biological_Process_2021,macrophage migration (GO:1905517),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,EDNRB
352,GO_Biological_Process_2021,medium-chain fatty acid metabolic process (GO:0051791),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,OXSM
353,GO_Biological_Process_2021,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,CCT7
354,GO_Biological_Process_2021,prostanoid biosynthetic process (GO:0046457),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,PLA2G4A
355,GO_Biological_Process_2021,mRNA methylation (GO:0080009),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,WTAP
356,GO_Biological_Process_2021,myoblast differentiation (GO:0045445),1/15,0.2089569326358909,0.7120007964825781,0,0,4.548312528895053,7.12096140997213,NRG1
357,GO_Biological_Process_2021,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),2/55,0.2096787313090243,0.7120007964825781,0,0,2.4059054153393777,3.758454363892761,TNFAIP3;CAPN3
358,GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),2/55,0.2096787313090243,0.7120007964825781,0,0,2.4059054153393777,3.758454363892761,PLPP1;FUT3
359,GO_Biological_Process_2021,negative regulation of metabolic process (GO:0009892),2/56,0.2153692414304257,0.7120007964825781,0,0,2.3612313612313613,3.625437753348752,DDIT3;ARRDC3
360,GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),2/57,0.221073737724152,0.7120007964825781,0,0,2.3181818181818183,3.498736722316954,PLA2G4A;CYP2E1
361,GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),2/57,0.221073737724152,0.7120007964825781,0,0,2.3181818181818183,3.498736722316954,ANGPTL8;CAPN3
362,GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,IL12A
363,GO_Biological_Process_2021,negative regulation of lyase activity (GO:0051350),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,EDNRB
364,GO_Biological_Process_2021,regulation of cellular carbohydrate metabolic process (GO:0010675),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,PDK1
365,GO_Biological_Process_2021,regulation of defense response to virus (GO:0050688),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,TNFAIP3
366,GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,DDIT3
367,GO_Biological_Process_2021,cellular response to sterol (GO:0036315),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,INSIG2
368,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,SNAI1
369,GO_Biological_Process_2021,regulation of isotype switching (GO:0045191),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,KMT5B
370,GO_Biological_Process_2021,dendrite self-avoidance (GO:0070593),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,MYPN
371,GO_Biological_Process_2021,dendritic spine morphogenesis (GO:0060997),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,DOCK10
372,GO_Biological_Process_2021,regulation of phosphate metabolic process (GO:0019220),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,PGAM1
373,GO_Biological_Process_2021,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,PLAT
374,GO_Biological_Process_2021,polyol biosynthetic process (GO:0046173),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,IPMK
375,GO_Biological_Process_2021,regulation of Rac protein signal transduction (GO:0035020),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,ARHGAP24
376,GO_Biological_Process_2021,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,KMT5B
377,GO_Biological_Process_2021,positive regulation of endothelial cell apoptotic process (GO:2000353),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,ITGA4
378,GO_Biological_Process_2021,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,KMT5B
379,GO_Biological_Process_2021,positive regulation of isotype switching (GO:0045830),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,KMT5B
380,GO_Biological_Process_2021,male meiosis I (GO:0007141),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,HSF2BP
381,GO_Biological_Process_2021,mesenchyme development (GO:0060485),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,CRELD1
382,GO_Biological_Process_2021,"mRNA cis splicing, via spliceosome (GO:0045292)",1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,WBP4
383,GO_Biological_Process_2021,necroptotic process (GO:0070266),1/16,0.2212272854003253,0.7120007964825781,0,0,4.24487594390507,6.403669857225148,IPMK
384,GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),3/105,0.2227369171293833,0.7120007964825781,0,0,1.8766047135466564,2.8182173030421027,ARHGAP24;TBC1D10B;ARHGAP45
385,GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),3/106,0.2268124331892441,0.7120007964825781,0,0,1.8582903766484296,2.757018861023401,CPEB1;INSIG2;PCK1
386,GO_Biological_Process_2021,selective autophagy (GO:0061912),2/59,0.232517566200307,0.7120007964825781,0,0,2.2366142629300523,3.2627494096018235,NBR1;LGALS8
387,GO_Biological_Process_2021,detection of visible light (GO:0009584),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,GNA11
388,GO_Biological_Process_2021,epithelial cell morphogenesis (GO:0003382),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,STC1
389,GO_Biological_Process_2021,stem cell development (GO:0048864),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,NRG1
390,GO_Biological_Process_2021,midbody abscission (GO:0061952),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,CHMP1A
391,GO_Biological_Process_2021,preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,PIGV
392,GO_Biological_Process_2021,negative regulation of amyloid-beta formation (GO:1902430),1/17,0.2333079096532855,0.7120007964825781,0,0,3.979368932038835,5.791558410833886,RTN1
393,GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),2/60,0.2382534656606133,0.7120007964825781,0,0,2.197939991043439,3.1527695000757845,GALNT11;SNAI1
394,GO_Biological_Process_2021,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),2/60,0.2382534656606133,0.7120007964825781,0,0,2.197939991043439,3.1527695000757845,AMIGO2;MYPN
395,GO_Biological_Process_2021,RNA methylation (GO:0001510),2/60,0.2382534656606133,0.7120007964825781,0,0,2.197939991043439,3.1527695000757845,TRMT10A;WTAP
396,GO_Biological_Process_2021,base conversion or substitution editing (GO:0016553),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,APOBEC3G
397,GO_Biological_Process_2021,negative regulation of interleukin-8 production (GO:0032717),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,ANXA4
398,GO_Biological_Process_2021,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,GPNMB
399,GO_Biological_Process_2021,cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,PCK1
400,GO_Biological_Process_2021,negative regulation of signal transduction by p53 class mediator (GO:1901797),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,SNAI1
401,GO_Biological_Process_2021,regulation of mRNA polyadenylation (GO:1900363),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,CPEB1
402,GO_Biological_Process_2021,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,PLA2G4A
403,GO_Biological_Process_2021,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,PLA2G4A
404,GO_Biological_Process_2021,regulation of presynapse assembly (GO:1905606),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,SLITRK1
405,GO_Biological_Process_2021,regulation of presynapse organization (GO:0099174),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,SLITRK1
406,GO_Biological_Process_2021,positive chemotaxis (GO:0050918),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,GPNMB
407,GO_Biological_Process_2021,regulation of protein sumoylation (GO:0033233),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,CAPN3
408,GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,APOBEC3G
409,GO_Biological_Process_2021,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,GNA11
410,GO_Biological_Process_2021,regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,CCT7
411,GO_Biological_Process_2021,regulation of vascular endothelial cell proliferation (GO:1905562),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,ITGA4
412,GO_Biological_Process_2021,rRNA transcription (GO:0009303),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,ANG
413,GO_Biological_Process_2021,positive regulation of nervous system process (GO:0031646),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,CARTPT
414,GO_Biological_Process_2021,leukocyte tethering or rolling (GO:0050901),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,ITGA4
415,GO_Biological_Process_2021,positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,DDIT3
416,GO_Biological_Process_2021,triglyceride biosynthetic process (GO:0019432),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,PCK1
417,GO_Biological_Process_2021,programmed necrotic cell death (GO:0097300),1/18,0.2452017295975243,0.7120007964825781,0,0,3.7450980392156863,5.264387020278373,IPMK
418,GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),2/63,0.2554975498337364,0.7120007964825781,0,0,2.089525228869491,2.8512458941033207,DDIT3;BHLHE40
419,GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),2/63,0.2554975498337364,0.7120007964825781,0,0,2.089525228869491,2.8512458941033207,CAPN3;PLA2G4A
420,GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,CAPZB
421,GO_Biological_Process_2021,negative regulation of calcium ion transport (GO:0051926),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,STC1
422,GO_Biological_Process_2021,regulation of bicellular tight junction assembly (GO:2000810),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,SNAI1
423,GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,CAPZB
424,GO_Biological_Process_2021,cellular glucuronidation (GO:0052695),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,UGT2B4
425,GO_Biological_Process_2021,neural crest cell differentiation (GO:0014033),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,NRG1
426,GO_Biological_Process_2021,regulation of lymphocyte proliferation (GO:0050670),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,IL12A
427,GO_Biological_Process_2021,cytoplasmic translational initiation (GO:0002183),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,EIF4A2
428,GO_Biological_Process_2021,regulation of mitotic spindle assembly (GO:1901673),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,CHMP1A
429,GO_Biological_Process_2021,epoxygenase P450 pathway (GO:0019373),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,CYP2E1
430,GO_Biological_Process_2021,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,IL12A
431,GO_Biological_Process_2021,glycerolipid catabolic process (GO:0046503),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,PLA2G4A
432,GO_Biological_Process_2021,positive regulation of establishment of protein localization (GO:1904951),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,CCT7
433,GO_Biological_Process_2021,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,KLK14
434,GO_Biological_Process_2021,heart trabecula morphogenesis (GO:0061384),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,NRG1
435,GO_Biological_Process_2021,response to fatty acid (GO:0070542),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,PPP5C
436,GO_Biological_Process_2021,leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,ITGA4
437,GO_Biological_Process_2021,sphingosine metabolic process (GO:0006670),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,PLPP1
438,GO_Biological_Process_2021,leukotriene biosynthetic process (GO:0019370),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,PLA2G4A
439,GO_Biological_Process_2021,striated muscle cell differentiation (GO:0051146),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,NRG1
440,GO_Biological_Process_2021,maintenance of protein localization in organelle (GO:0072595),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,HK1
441,GO_Biological_Process_2021,mesenchymal cell development (GO:0014031),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,NRG1
442,GO_Biological_Process_2021,positive regulation of triglyceride metabolic process (GO:0090208),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,ABHD5
443,GO_Biological_Process_2021,prostaglandin biosynthetic process (GO:0001516),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,PLA2G4A
444,GO_Biological_Process_2021,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.2569116245754598,0.7120007964825781,0,0,3.536857245595109,4.80667079179423,RTN1
445,GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),3/114,0.2598732325985575,0.7120007964825781,0,0,1.7236552513425478,2.322731169501296,SLF2;TFR2;NRG1
446,GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),3/115,0.2640529149033896,0.7120007964825781,0,0,1.7081782224290367,2.274619961254914,OXSM;PLPP1;FUT3
447,GO_Biological_Process_2021,tRNA modification (GO:0006400),2/65,0.267008583479173,0.7120007964825781,0,0,2.02298495155638,2.6712999882718744,TRMT10A;PUS10
448,GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),3/116,0.2682409026399035,0.7120007964825781,0,0,1.6929751232308092,2.227734856760648,NAPA;SLF2;NRG1
449,GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),3/116,0.2682409026399035,0.7120007964825781,0,0,1.6929751232308092,2.227734856760648,GALC;PLPP1;FUT3
450,GO_Biological_Process_2021,protein targeting to lysosome (GO:0006622),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,GCC2
451,GO_Biological_Process_2021,branched-chain amino acid catabolic process (GO:0009083),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,BCAT1
452,GO_Biological_Process_2021,branched-chain amino acid metabolic process (GO:0009081),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,BCAT1
453,GO_Biological_Process_2021,negative regulation of lipid storage (GO:0010888),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,ABHD5
454,GO_Biological_Process_2021,cardiac epithelial to mesenchymal transition (GO:0060317),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,SNAI1
455,GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,CARTPT
456,GO_Biological_Process_2021,early endosome to late endosome transport (GO:0045022),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,EEA1
457,GO_Biological_Process_2021,energy reserve metabolic process (GO:0006112),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,GBE1
458,GO_Biological_Process_2021,positive regulation of alpha-beta T cell activation (GO:0046635),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,IL12A
459,GO_Biological_Process_2021,regulation of tissue remodeling (GO:0034103),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,GPNMB
460,GO_Biological_Process_2021,positive regulation of hormone secretion (GO:0046887),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,TFR2
461,GO_Biological_Process_2021,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,IL12A
462,GO_Biological_Process_2021,positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,TMEM106A
463,GO_Biological_Process_2021,positive regulation of protein processing (GO:0010954),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,ANGPTL8
464,GO_Biological_Process_2021,mesoderm formation (GO:0001707),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,SNAI1
465,GO_Biological_Process_2021,mitotic cytokinetic process (GO:1902410),1/20,0.2684404297418134,0.7120007964825781,0,0,3.350536535513541,4.406378558844449,CHMP1A
466,GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,GNA11
467,GO_Biological_Process_2021,anterior/posterior axis specification (GO:0009948),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,DDIT3
468,GO_Biological_Process_2021,autonomic nervous system development (GO:0048483),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,EDNRB
469,GO_Biological_Process_2021,cellular response to steroid hormone stimulus (GO:0071383),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,TRERF1
470,GO_Biological_Process_2021,neuron apoptotic process (GO:0051402),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,FAM162A
471,GO_Biological_Process_2021,regulation of lipoprotein lipase activity (GO:0051004),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,ANGPTL8
472,GO_Biological_Process_2021,endocardial cushion development (GO:0003197),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,CRELD1
473,GO_Biological_Process_2021,regulation of transposition (GO:0010528),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,APOBEC3G
474,GO_Biological_Process_2021,response to progesterone (GO:0032570),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,TRERF1
475,GO_Biological_Process_2021,sensory perception of pain (GO:0019233),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,SCN9A
476,GO_Biological_Process_2021,positive regulation of smoothened signaling pathway (GO:0045880),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,TXNDC15
477,GO_Biological_Process_2021,NAD biosynthetic process (GO:0009435),1/21,0.2797909365950337,0.7207091077501236,0,0,3.182847896440129,4.05403350050483,NUDT12
478,GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),3/120,0.2850634820622148,0.7207091077501236,0,0,1.634761546813664,2.051696656290469,CAPZB;TNFAIP3;ARHGAP4
479,GO_Biological_Process_2021,apoptotic process (GO:0006915),5/231,0.2887149517708581,0.7207091077501236,0,0,1.4118671115624546,1.75398426061742,ADORA2A;FAM162A;JADE1;CAPN3;MAL
480,GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),2/69,0.2900154123246616,0.7207091077501236,0,0,1.9018220585384764,2.354115684494197,CPNE8;CAPN3
481,GO_Biological_Process_2021,negative regulation of B cell activation (GO:0050869),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,TNFAIP3
482,GO_Biological_Process_2021,regulation of adenylate cyclase activity (GO:0045761),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,EDNRB
483,GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,TNFAIP3
484,GO_Biological_Process_2021,regulation of centrosome cycle (GO:0046605),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,CHMP1A
485,GO_Biological_Process_2021,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,DDIT3
486,GO_Biological_Process_2021,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,RAB35
487,GO_Biological_Process_2021,cellular response to osmotic stress (GO:0071470),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,CAPN3
488,GO_Biological_Process_2021,neuronal action potential (GO:0019228),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,SCN9A
489,GO_Biological_Process_2021,organelle fusion (GO:0048284),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,EEA1
490,GO_Biological_Process_2021,peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,PPP5C
491,GO_Biological_Process_2021,regulation of platelet activation (GO:0010543),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,PLA2G4A
492,GO_Biological_Process_2021,phosphatidylserine acyl-chain remodeling (GO:0036150),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,PLA2G4A
493,GO_Biological_Process_2021,exogenous drug catabolic process (GO:0042738),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,CYP2E1
494,GO_Biological_Process_2021,female gonad development (GO:0008585),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,ANG
495,GO_Biological_Process_2021,regulation of vacuole organization (GO:0044088),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,ENO2
496,GO_Biological_Process_2021,positive regulation of lipid catabolic process (GO:0050996),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,ABHD5
497,GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,VPS37C
498,GO_Biological_Process_2021,mRNA modification (GO:0016556),1/22,0.2909658938246858,0.7207091077501236,0,0,3.031129603945138,3.7420786944258726,WTAP
499,GO_Biological_Process_2021,epithelium development (GO:0060429),3/122,0.2935086646216922,0.7255534189448231,0,0,1.607122327758465,1.97008788158627,ANXA4;PGK1;ALDOC
500,GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),2/70,0.2957562752199639,0.727548650492668,0,0,1.8737585943468296,2.2826493672797525,IL12A;ANG
501,GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection assembly (GO:0120032),2/70,0.2957562752199639,0.727548650492668,0,0,1.8737585943468296,2.2826493672797525,CAPZB;TBC1D10B
502,GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/71,0.3014903334996041,0.727548650492668,0,0,1.846508563899868,2.2139957583044936,GPNMB;JADE1
503,GO_Biological_Process_2021,fatty acid biosynthetic process (GO:0006633),2/71,0.3014903334996041,0.727548650492668,0,0,1.846508563899868,2.2139957583044936,OXSM;CYP2E1
504,GO_Biological_Process_2021,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,KLK14
505,GO_Biological_Process_2021,regulation of interleukin-4 production (GO:0032673),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,DDIT3
506,GO_Biological_Process_2021,oligosaccharide biosynthetic process (GO:0009312),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,FUT3
507,GO_Biological_Process_2021,diacylglycerol metabolic process (GO:0046339),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,ANG
508,GO_Biological_Process_2021,drug catabolic process (GO:0042737),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,CYP2E1
509,GO_Biological_Process_2021,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,TNFAIP3
510,GO_Biological_Process_2021,positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,ITGA4
511,GO_Biological_Process_2021,positive regulation of natural killer cell mediated immunity (GO:0002717),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,IL12A
512,GO_Biological_Process_2021,positive regulation of protein autophosphorylation (GO:0031954),1/23,0.3019680078501122,0.727548650492668,0,0,2.8932038834951457,3.4644212819803437,GPNMB
513,GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),3/125,0.3062056056454854,0.7311638900320745,0,0,1.5673626314946334,1.854971305757752,IL12A;ANG;RAPGEF4
514,GO_Biological_Process_2021,carbohydrate biosynthetic process (GO:0016051),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,FUT3
515,GO_Biological_Process_2021,cardiac muscle cell differentiation (GO:0055007),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,NRG1
516,GO_Biological_Process_2021,neuromuscular junction development (GO:0007528),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,PPFIBP1
517,GO_Biological_Process_2021,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,TNFAIP3
518,GO_Biological_Process_2021,phospholipid catabolic process (GO:0009395),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,PLA2G4A
519,GO_Biological_Process_2021,regulation of ruffle assembly (GO:1900027),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,ARHGAP24
520,GO_Biological_Process_2021,positive regulation of neuron apoptotic process (GO:0043525),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,DDIT3
521,GO_Biological_Process_2021,leukotriene metabolic process (GO:0006691),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,PLA2G4A
522,GO_Biological_Process_2021,lipid translocation (GO:0034204),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,ATP10B
523,GO_Biological_Process_2021,mammary gland development (GO:0030879),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,NRG1
524,GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,DDIT3
525,GO_Biological_Process_2021,"wound healing, spreading of cells (GO:0044319)",1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,ARHGAP24
526,GO_Biological_Process_2021,protein K48-linked deubiquitination (GO:0071108),1/24,0.3127999435192308,0.7311638900320745,0,0,2.767271703953848,3.216099516586545,TNFAIP3
527,GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),2/73,0.3129334124813652,0.7311638900320745,0,0,1.7943113224803366,2.084567825761172,SLC17A6;PPFIA4
528,GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),2/73,0.3129334124813652,0.7311638900320745,0,0,1.7943113224803366,2.084567825761172,TNFAIP3;IL12A
529,GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),2/74,0.3186402143369515,0.735125058481275,0,0,1.7693001443001444,2.0235356015493275,TFR2;RAPGEF4
530,GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),3/129,0.3231657425317893,0.735125058481275,0,0,1.5172948658290677,1.7139210355641397,CPEB1;INSIG2;PCK1
531,GO_Biological_Process_2021,acylglycerol homeostasis (GO:0055090),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,ANGPTL8
532,GO_Biological_Process_2021,regulation of calcium ion import (GO:0090279),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,STC1
533,GO_Biological_Process_2021,negative regulation of ion transport (GO:0043271),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,STC1
534,GO_Biological_Process_2021,cellular response to hexose stimulus (GO:0071331),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,PCK1
535,GO_Biological_Process_2021,phosphatidylglycerol metabolic process (GO:0046471),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,PLA2G4A
536,GO_Biological_Process_2021,endosome transport via multivesicular body sorting pathway (GO:0032509),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,CHMP1A
537,GO_Biological_Process_2021,regulation of protein processing (GO:0070613),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,ANGPTL8
538,GO_Biological_Process_2021,regulation of spindle assembly (GO:0090169),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,CHMP1A
539,GO_Biological_Process_2021,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.3234643246985458,0.735125058481275,0,0,2.651833872707659,2.9930359237917226,FAM162A
540,GO_Biological_Process_2021,actomyosin structure organization (GO:0031032),2/76,0.3300190653152328,0.735125058481275,0,0,1.7213057213057212,1.908247875289172,CAPN3;MYPN
541,GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),2/76,0.3300190653152328,0.735125058481275,0,0,1.7213057213057212,1.908247875289172,PLA2G4A;PLPP1
542,GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),3/131,0.3316493415504673,0.735125058481275,0,0,1.4934344462540716,1.6482693514702798,CPNE8;TFR2;CAPN3
543,GO_Biological_Process_2021,regulation of biomineral tissue development (GO:0070167),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,NBR1
544,GO_Biological_Process_2021,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,TNFAIP3
545,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,SNAI1
546,GO_Biological_Process_2021,negative regulation of protein transport (GO:0051224),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,IL12A
547,GO_Biological_Process_2021,regulation of glycogen biosynthetic process (GO:0005979),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,PPP1R3E
548,GO_Biological_Process_2021,negative regulation of transposition (GO:0010529),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,APOBEC3G
549,GO_Biological_Process_2021,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,PLA2G4A
550,GO_Biological_Process_2021,endothelial cell development (GO:0001885),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,STC1
551,GO_Biological_Process_2021,positive regulation of histone methylation (GO:0031062),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,TET1
552,GO_Biological_Process_2021,meiosis I (GO:0007127),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,HSF2BP
553,GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,SCN9A
554,GO_Biological_Process_2021,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.3339637349658846,0.735125058481275,0,0,2.545631067961165,2.791851810425802,IL12A
555,GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),2/77,0.3356891078610717,0.735125058481275,0,0,1.6982683982683984,1.8537785324798188,ITGA4;ANG
556,GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.341344946707612,0.735125058481275,0,0,1.6758373205741626,1.8012934167943138,PGK1;SEMA3E
557,GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,TNFAIP3
558,GO_Biological_Process_2021,regulation of cardiac muscle cell contraction (GO:0086004),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,STC1
559,GO_Biological_Process_2021,regulation of cell junction assembly (GO:1901888),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,SNAI1
560,GO_Biological_Process_2021,nucleobase-containing small molecule interconversion (GO:0015949),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,NME3
561,GO_Biological_Process_2021,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,TNFAIP3
562,GO_Biological_Process_2021,dendritic spine organization (GO:0097061),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,DOCK10
563,GO_Biological_Process_2021,entrainment of circadian clock by photoperiod (GO:0043153),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,BHLHE40
564,GO_Biological_Process_2021,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,CAPN3
565,GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,GPNMB
566,GO_Biological_Process_2021,positive regulation of muscle cell differentiation (GO:0051149),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,NRG1
567,GO_Biological_Process_2021,positive regulation of striated muscle cell differentiation (GO:0051155),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,NRG1
568,GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),1/27,0.3443007181490842,0.735125058481275,0,0,2.447597709733632,2.609726148351675,CHMP1A
569,GO_Biological_Process_2021,regulation of ion transport (GO:0043269),2/79,0.3469856614712604,0.735125058481275,0,0,1.6539888682745825,1.7507006098083917,CA2;STC1
570,GO_Biological_Process_2021,protein transport (GO:0015031),7/369,0.3479377913685926,0.735125058481275,0,0,1.2334846744342942,1.3022287188464678,NAPA;TFR2;ARRDC2;ARRDC3;CHMP1A;GCC2;TBC1D10B
571,GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),2/80,0.3526103635390024,0.735125058481275,0,0,1.6327006327006326,1.7019134537042873,CHMP1A;BRINP3
572,GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),2/80,0.3526103635390024,0.735125058481275,0,0,1.6327006327006326,1.7019134537042873,IL12A;FUT3
573,GO_Biological_Process_2021,glycerophospholipid metabolic process (GO:0006650),2/80,0.3526103635390024,0.735125058481275,0,0,1.6327006327006326,1.7019134537042873,PLA2G4A;PIGV
574,GO_Biological_Process_2021,organic substance transport (GO:0071702),3/136,0.352835836934671,0.735125058481275,0,0,1.4369229262080283,1.4969178802586385,ARRDC2;ARRDC3;CHMP1A
575,GO_Biological_Process_2021,receptor clustering (GO:0043113),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,ITGA4
576,GO_Biological_Process_2021,regulation of B cell activation (GO:0050864),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,TNFAIP3
577,GO_Biological_Process_2021,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,SNAI1
578,GO_Biological_Process_2021,cellular response to acid chemical (GO:0071229),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,CPEB1
579,GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,GPI
580,GO_Biological_Process_2021,cytosolic calcium ion transport (GO:0060401),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,SLC35G1
581,GO_Biological_Process_2021,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,TNFAIP3
582,GO_Biological_Process_2021,photoperiodism (GO:0009648),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,BHLHE40
583,GO_Biological_Process_2021,regulation of small molecule metabolic process (GO:0062012),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,PDK1
584,GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,CARTPT
585,GO_Biological_Process_2021,positive regulation of defense response to virus by host (GO:0002230),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,APOBEC3G
586,GO_Biological_Process_2021,glycerophospholipid catabolic process (GO:0046475),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,PLA2G4A
587,GO_Biological_Process_2021,glycogen metabolic process (GO:0005977),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,GBE1
588,GO_Biological_Process_2021,GPI anchor metabolic process (GO:0006505),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,PIGV
589,GO_Biological_Process_2021,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,RNASE4
590,GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,TMEM106A
591,GO_Biological_Process_2021,leukocyte cell-cell adhesion (GO:0007159),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,ITGA4
592,GO_Biological_Process_2021,macromolecule catabolic process (GO:0009057),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,CAPN3
593,GO_Biological_Process_2021,transcription by RNA polymerase III (GO:0006383),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,SNAPC5
594,GO_Biological_Process_2021,protein localization to Golgi apparatus (GO:0034067),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,GCC2
595,GO_Biological_Process_2021,protein localization to lysosome (GO:0061462),1/28,0.3544777790087701,0.735125058481275,0,0,2.3568260817451754,2.4442869963919223,GCC2
596,GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),2/81,0.3582181952223031,0.7382906692396904,0,0,1.6119513397994412,1.6548501917465337,ANXA4;DDIT3
597,GO_Biological_Process_2021,actin filament polymerization (GO:0030041),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,ANG
598,GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,DDIT3
599,GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,CARTPT
600,GO_Biological_Process_2021,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,KMT5B
601,GO_Biological_Process_2021,negative regulation of transferase activity (GO:0051348),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,EIF4A2
602,GO_Biological_Process_2021,determination of bilateral symmetry (GO:0009855),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,GALNT11
603,GO_Biological_Process_2021,regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,IL12A
604,GO_Biological_Process_2021,regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,ARRDC3
605,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,DDIT3
606,GO_Biological_Process_2021,transition metal ion homeostasis (GO:0055076),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,TFR2
607,GO_Biological_Process_2021,production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,0.3644973838196466,0.7382906692396904,0,0,2.2725381414701804,2.2935270878734726,PUS10
608,GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),2/83,0.3693799673129378,0.7382906692396904,0,0,1.5719897386564052,1.5655908648627714,TNFAIP3;TMEM106A
609,GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),2/83,0.3693799673129378,0.7382906692396904,0,0,1.5719897386564052,1.5655908648627714,PLA2G4A;CYP2E1
610,GO_Biological_Process_2021,regulation of small GTPase mediated signal transduction (GO:0051056),3/141,0.373942265368922,0.7382906692396904,0,0,1.3845064438464807,1.3618751134375244,ARHGAP24;ARHGAP45;ARHGAP4
611,GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,TNFAIP3
612,GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,IL12A
613,GO_Biological_Process_2021,peptidyl-lysine trimethylation (GO:0018023),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,KMT5B
614,GO_Biological_Process_2021,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,PLA2G4A
615,GO_Biological_Process_2021,estrogen metabolic process (GO:0008210),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,UGT2B4
616,GO_Biological_Process_2021,positive regulation of DNA recombination (GO:0045911),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,KMT5B
617,GO_Biological_Process_2021,Golgi to plasma membrane protein transport (GO:0043001),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,GCC2
618,GO_Biological_Process_2021,heterotypic cell-cell adhesion (GO:0034113),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,ITGA4
619,GO_Biological_Process_2021,positive regulation of phosphate metabolic process (GO:0045937),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,ANG
620,GO_Biological_Process_2021,long-chain fatty acid biosynthetic process (GO:0042759),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,CYP2E1
621,GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,SLC17A6
622,GO_Biological_Process_2021,morphogenesis of an epithelium (GO:0002009),1/30,0.374361960883141,0.7382906692396904,0,0,2.1940631625934603,2.1557375738800304,KLK14
623,GO_Biological_Process_2021,protein localization to organelle (GO:0033365),3/142,0.3781489556641587,0.7382906692396904,0,0,1.3744756637686593,1.336632360540725,FAM149B1;RAB35;GCC2
624,GO_Biological_Process_2021,purine nucleoside bisphosphate metabolic process (GO:0034032),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,OXSM
625,GO_Biological_Process_2021,negative regulation of interleukin-6 production (GO:0032715),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,TNFAIP3
626,GO_Biological_Process_2021,regulation of cellular pH (GO:0030641),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,CA2
627,GO_Biological_Process_2021,negative regulation of osteoblast differentiation (GO:0045668),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,NBR1
628,GO_Biological_Process_2021,negative regulation of response to biotic stimulus (GO:0002832),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,TNFAIP3
629,GO_Biological_Process_2021,negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,SNAI1
630,GO_Biological_Process_2021,organelle transport along microtubule (GO:0072384),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,BORCS5
631,GO_Biological_Process_2021,phospholipid translocation (GO:0045332),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,ATP10B
632,GO_Biological_Process_2021,ribonucleoside bisphosphate metabolic process (GO:0033875),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,OXSM
633,GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,IL12A
634,GO_Biological_Process_2021,triglyceride homeostasis (GO:0070328),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,ANGPTL8
635,GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,ARRDC3
636,GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,SLC2A14
637,GO_Biological_Process_2021,prostaglandin metabolic process (GO:0006693),1/31,0.3840739012660074,0.7382906692396904,0,0,2.120819848975189,2.029455552760207,PLA2G4A
638,GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),4/203,0.3859520957118564,0.7382906692396904,0,0,1.280323184550202,1.2189214729106912,GPNMB;PGK1;TNFAIP3;SEMA3E
639,GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.38597635725198,0.7382906692396904,0,0,1.5156153370439085,1.442834218527579,DDIT3;IL12A
640,GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.3914665999581914,0.7382906692396904,0,0,1.4977081741787623,1.4046332198054328,PGK1;SEMA3E
641,GO_Biological_Process_2021,sodium ion transmembrane transport (GO:0035725),2/87,0.3914665999581914,0.7382906692396904,0,0,1.4977081741787623,1.4046332198054328,SCN9A;ASIC3
642,GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,ANG
643,GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,SEMA3E
644,GO_Biological_Process_2021,aortic valve morphogenesis (GO:0003180),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,SNAI1
645,GO_Biological_Process_2021,regulation of cell morphogenesis (GO:0022604),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,CAPZB
646,GO_Biological_Process_2021,regulation of cellular amide metabolic process (GO:0034248),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,PGAM1
647,GO_Biological_Process_2021,regulation of centrosome duplication (GO:0010824),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,CHMP1A
648,GO_Biological_Process_2021,cellular response to glucose stimulus (GO:0071333),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,PCK1
649,GO_Biological_Process_2021,regulation of intracellular protein transport (GO:0033157),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,GCC2
650,GO_Biological_Process_2021,endodermal cell differentiation (GO:0035987),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,ITGA4
651,GO_Biological_Process_2021,ERBB2 signaling pathway (GO:0038128),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,NRG1
652,GO_Biological_Process_2021,response to amino acid (GO:0043200),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,CPEB1
653,GO_Biological_Process_2021,GPI anchor biosynthetic process (GO:0006506),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,PIGV
654,GO_Biological_Process_2021,positive regulation of immune effector process (GO:0002699),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,PCK1
655,GO_Biological_Process_2021,intra-Golgi vesicle-mediated transport (GO:0006891),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,NAPA
656,GO_Biological_Process_2021,liver development (GO:0001889),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,PCK1
657,GO_Biological_Process_2021,membrane depolarization (GO:0051899),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,SCN9A
658,GO_Biological_Process_2021,protein K63-linked deubiquitination (GO:0070536),1/32,0.3936355590849159,0.7382906692396904,0,0,2.052301910429064,1.913422177728112,TNFAIP3
659,GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),2/89,0.4023802505889998,0.7493035798750691,0,0,1.4631288251977907,1.3319706513004763,GPI;STC1
660,GO_Biological_Process_2021,positive regulation of histone modification (GO:0031058),1/33,0.4030492525689539,0.7493035798750691,0,0,1.9880663430420715,1.8065489469580225,TET1
661,GO_Biological_Process_2021,keratan sulfate metabolic process (GO:0042339),1/33,0.4030492525689539,0.7493035798750691,0,0,1.9880663430420715,1.8065489469580225,GALNS
662,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.4030492525689539,0.7493035798750691,0,0,1.9880663430420715,1.8065489469580225,CCT7
663,GO_Biological_Process_2021,sodium ion transport (GO:0006814),2/90,0.407802413077945,0.7493035798750691,0,0,1.4464285714285714,1.2974066569233136,SCN9A;ASIC3
664,GO_Biological_Process_2021,regulation of amyloid-beta formation (GO:1902003),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,RTN1
665,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,TNFAIP3
666,GO_Biological_Process_2021,cellular response to amino acid stimulus (GO:0071230),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,CPEB1
667,GO_Biological_Process_2021,regulation of glucose metabolic process (GO:0010906),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,PDK1
668,GO_Biological_Process_2021,regulation of lamellipodium assembly (GO:0010591),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,CAPZB
669,GO_Biological_Process_2021,phosphatidylserine metabolic process (GO:0006658),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,PLA2G4A
670,GO_Biological_Process_2021,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,CAPN3
671,GO_Biological_Process_2021,secondary alcohol biosynthetic process (GO:1902653),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,INSIG2
672,GO_Biological_Process_2021,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,CAPN3
673,GO_Biological_Process_2021,tRNA methylation (GO:0030488),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,TRMT10A
674,GO_Biological_Process_2021,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,NRG1
675,GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,CAPN3
676,GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),1/34,0.4123172639873966,0.7493035798750691,0,0,1.9277238403451995,1.7078903924223006,SLF2
677,GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),2/92,0.4185744814502258,0.7493035798750691,0,0,1.414141414141414,1.231576369171899,GPNMB;JADE1
678,GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),2/92,0.4185744814502258,0.7493035798750691,0,0,1.414141414141414,1.231576369171899,SLF2;NRG1
679,GO_Biological_Process_2021,negative regulation of epithelial cell migration (GO:0010633),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,STC1
680,GO_Biological_Process_2021,bicarbonate transport (GO:0015701),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,CA2
681,GO_Biological_Process_2021,blood vessel diameter maintenance (GO:0097746),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,EDNRB
682,GO_Biological_Process_2021,cellular response to amyloid-beta (GO:1904646),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,ITGA4
683,GO_Biological_Process_2021,negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,ARHGAP24
684,GO_Biological_Process_2021,cellular response to hydrogen peroxide (GO:0070301),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,TNFAIP3
685,GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,GPNMB
686,GO_Biological_Process_2021,cholesterol biosynthetic process (GO:0006695),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,INSIG2
687,GO_Biological_Process_2021,regulation of lipid biosynthetic process (GO:0046890),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,PCK1
688,GO_Biological_Process_2021,regulation of mitotic spindle organization (GO:0060236),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,CHMP1A
689,GO_Biological_Process_2021,regulation of trans-synaptic signaling (GO:0099177),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,LRRC4C
690,GO_Biological_Process_2021,positive regulation of lymphocyte activation (GO:0051251),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,IL12A
691,GO_Biological_Process_2021,positive regulation of reproductive process (GO:2000243),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,TACR3
692,GO_Biological_Process_2021,protein localization to cilium (GO:0061512),1/35,0.4214418407558947,0.7493035798750691,0,0,1.870930896630497,1.6166217943767651,FAM149B1
693,GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),4/214,0.4243169753982354,0.7493035798750691,0,0,1.2125739184562714,1.039508723381792,GPNMB;DDIT3;ARRDC3;STC1
694,GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),4/214,0.4243169753982354,0.7493035798750691,0,0,1.2125739184562714,1.039508723381792,DOCK10;ARHGAP24;TBC1D10B;ARHGAP45
695,GO_Biological_Process_2021,negative regulation of cellular protein metabolic process (GO:0032269),2/94,0.4292465728630525,0.7493035798750691,0,0,1.3832580463015245,1.1698542004611328,EDNRB;PLAT
696,GO_Biological_Process_2021,aortic valve development (GO:0003176),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,SNAI1
697,GO_Biological_Process_2021,regulation of cardiac muscle contraction (GO:0055117),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,STC1
698,GO_Biological_Process_2021,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,TNFAIP3
699,GO_Biological_Process_2021,dendrite morphogenesis (GO:0048813),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,DOCK10
700,GO_Biological_Process_2021,regulation of ossification (GO:0030278),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,NBR1
701,GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,CARTPT
702,GO_Biological_Process_2021,endoderm formation (GO:0001706),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,ITGA4
703,GO_Biological_Process_2021,establishment of protein localization to plasma membrane (GO:0061951),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,GCC2
704,GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,TMEM106A
705,GO_Biological_Process_2021,membrane fusion (GO:0061025),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,NAPA
706,GO_Biological_Process_2021,transferrin transport (GO:0033572),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,TFR2
707,GO_Biological_Process_2021,transition metal ion transport (GO:0000041),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,TFR2
708,GO_Biological_Process_2021,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,IL12A
709,GO_Biological_Process_2021,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.4304251955593035,0.7493035798750691,0,0,1.8173832639852057,1.532020891545139,CCT7
710,GO_Biological_Process_2021,mRNA metabolic process (GO:0016071),2/95,0.4345438483993258,0.7551281097734207,0,0,1.368314481217707,1.1404332289366952,RNASE4;NUDT12
711,GO_Biological_Process_2021,acyl-CoA metabolic process (GO:0006637),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,OXSM
712,GO_Biological_Process_2021,regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,SEMA3E
713,GO_Biological_Process_2021,negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,IL12A
714,GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,TNFAIP3
715,GO_Biological_Process_2021,regulation of intracellular pH (GO:0051453),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,CA2
716,GO_Biological_Process_2021,regulation of protein autophosphorylation (GO:0031952),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,GPNMB
717,GO_Biological_Process_2021,positive regulation of calcium ion transport (GO:0051928),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,STC1
718,GO_Biological_Process_2021,lysosome localization (GO:0032418),1/37,0.4392695072225643,0.7551281097734207,0,0,1.7668104998202083,1.453452775148989,BORCS5
719,GO_Biological_Process_2021,negative regulation of endothelial cell migration (GO:0010596),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,STC1
720,GO_Biological_Process_2021,negative regulation of innate immune response (GO:0045824),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,TNFAIP3
721,GO_Biological_Process_2021,histone exchange (GO:0043486),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,SPTY2D1
722,GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,GPI
723,GO_Biological_Process_2021,sterol biosynthetic process (GO:0016126),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,INSIG2
724,GO_Biological_Process_2021,lysosome organization (GO:0007040),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,ATP10B
725,GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.4479769209098388,0.7623943201376283,0,0,1.718971398583049,1.3803573487095977,CARTPT
726,GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),4/221,0.4484309633819222,0.7623943201376283,0,0,1.173036956718171,0.9407762693623584,GPNMB;SEMA3B;SNAI1;SEMA3E
727,GO_Biological_Process_2021,organic anion transport (GO:0015711),2/99,0.4554636693308789,0.7667054924483209,0,0,1.3116213683223992,1.0315106241351562,SLC2A14;CA2
728,GO_Biological_Process_2021,negative regulation of cellular metabolic process (GO:0031324),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,EDNRB
729,GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,GPNMB
730,GO_Biological_Process_2021,regulation of cellular component biogenesis (GO:0044087),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,SPTY2D1
731,GO_Biological_Process_2021,negative regulation of protein secretion (GO:0050709),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,IL12A
732,GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,IL12A
733,GO_Biological_Process_2021,organophosphate biosynthetic process (GO:0090407),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,IPMK
734,GO_Biological_Process_2021,phospholipid dephosphorylation (GO:0046839),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,PLPP1
735,GO_Biological_Process_2021,endothelial cell migration (GO:0043542),1/39,0.4565495489012655,0.7667054924483209,0,0,1.6736501447794243,1.3122388588228469,LGALS8
736,GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/224,0.4586709230477888,0.7692228777300774,0,0,1.156862745098039,0.9016845860521469,PPP5C;CAPN3;TNFAIP3;TMEM106A
737,GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,PLAT
738,GO_Biological_Process_2021,negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,SEMA3E
739,GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,TNFAIP3
740,GO_Biological_Process_2021,bone development (GO:0060348),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,STC1
741,GO_Biological_Process_2021,negative regulation of protein kinase B signaling (GO:0051898),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,DDIT3
742,GO_Biological_Process_2021,digestive tract development (GO:0048565),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,EDNRB
743,GO_Biological_Process_2021,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,FGF11
744,GO_Biological_Process_2021,glycolipid biosynthetic process (GO:0009247),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,PIGV
745,GO_Biological_Process_2021,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,DDIT3
746,GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),1/40,0.4649894708467135,0.7693801686299034,0,0,1.6306530578375238,1.248657115542351,GALNS
747,GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),2/102,0.4708592197469038,0.7758584032545618,0,0,1.272077922077922,0.9581241630669428,GALNT11;TET1
748,GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.4708592197469038,0.7758584032545618,0,0,1.272077922077922,0.9581241630669428,DDIT3;PDK1
749,GO_Biological_Process_2021,cilium organization (GO:0044782),4/228,0.472222779946554,0.7758584032545618,0,0,1.135971055088702,0.8523240960564828,CFAP61;GALNT11;FAM149B1;TXNDC15
750,GO_Biological_Process_2021,regulation of cell development (GO:0060284),1/41,0.4732987346714721,0.7758584032545618,0,0,1.5898058252427183,1.1892200913753523,BHLHE40
751,GO_Biological_Process_2021,regulation of filopodium assembly (GO:0051489),1/41,0.4732987346714721,0.7758584032545618,0,0,1.5898058252427183,1.1892200913753523,CAPZB
752,GO_Biological_Process_2021,endosome organization (GO:0007032),1/41,0.4732987346714721,0.7758584032545618,0,0,1.5898058252427183,1.1892200913753523,EEA1
753,GO_Biological_Process_2021,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.4732987346714721,0.7758584032545618,0,0,1.5898058252427183,1.1892200913753523,FAM162A
754,GO_Biological_Process_2021,steroid metabolic process (GO:0008202),2/104,0.4809772799021888,0.7777161769834301,0,0,1.2470078940667175,0.912729028613508,UGT2B4;CYP2E1
755,GO_Biological_Process_2021,ATP-dependent chromatin remodeling (GO:0043044),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,SPTY2D1
756,GO_Biological_Process_2021,regulation of double-strand break repair (GO:2000779),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,SLF2
757,GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,TNFAIP3
758,GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,PPP5C
759,GO_Biological_Process_2021,determination of left/right symmetry (GO:0007368),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,GALNT11
760,GO_Biological_Process_2021,regulation of nervous system development (GO:0051960),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,BHLHE40
761,GO_Biological_Process_2021,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,SNAI1
762,GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.4814793566077214,0.7777161769834301,0,0,1.550951140579367,1.1335776596813214,AMIGO2
763,GO_Biological_Process_2021,anion transport (GO:0006820),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,SLC17A6
764,GO_Biological_Process_2021,regulation of carbohydrate catabolic process (GO:0043470),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,PGAM1
765,GO_Biological_Process_2021,regulation of cell-cell adhesion (GO:0022407),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,FUT3
766,GO_Biological_Process_2021,negative regulation of proteolysis (GO:0045861),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,PLAT
767,GO_Biological_Process_2021,cellular response to glucose starvation (GO:0042149),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,NIM1K
768,GO_Biological_Process_2021,cellular response to retinoic acid (GO:0071300),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,BRINP3
769,GO_Biological_Process_2021,negative regulation of type I interferon production (GO:0032480),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,TNFAIP3
770,GO_Biological_Process_2021,regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,PGAM1
771,GO_Biological_Process_2021,positive regulation of axonogenesis (GO:0050772),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,SLITRK1
772,GO_Biological_Process_2021,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,IL12A
773,GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,BRINP3
774,GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,TFR2
775,GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,ANG
776,GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,PCK1
777,GO_Biological_Process_2021,tRNA aminoacylation for protein translation (GO:0006418),1/43,0.4895333217581785,0.7777161769834301,0,0,1.5139466789952227,1.0814162705247774,CARS2
778,GO_Biological_Process_2021,response to calcium ion (GO:0051592),2/107,0.4959296485604965,0.7852666093642623,0,0,1.2111935683364254,0.8494357266529337,CPNE8;CAPN3
779,GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),1/44,0.4974625850584283,0.7852666093642623,0,0,1.478663355159178,1.0324544059455991,ANG
780,GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.4974625850584283,0.7852666093642623,0,0,1.478663355159178,1.0324544059455991,SEMA3E
781,GO_Biological_Process_2021,response to amyloid-beta (GO:1904645),1/44,0.4974625850584283,0.7852666093642623,0,0,1.478663355159178,1.0324544059455991,ITGA4
782,GO_Biological_Process_2021,mRNA catabolic process (GO:0006402),1/44,0.4974625850584283,0.7852666093642623,0,0,1.478663355159178,1.0324544059455991,NUDT12
783,GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),7/430,0.5011894446660117,0.7901405020499878,0,0,1.052274731019201,0.7268809906063833,ZNF263;ZNF37A;ASCC1;PLAG1;DDIT3;BHLHE40;SPTY2D1
784,GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.5052690709932667,0.7925286443498446,0,0,1.4449838187702266,0.9864386905080664,GPNMB
785,GO_Biological_Process_2021,cellular response to radiation (GO:0071478),1/45,0.5052690709932667,0.7925286443498446,0,0,1.4449838187702266,0.9864386905080664,OPN1SW
786,GO_Biological_Process_2021,chromosome condensation (GO:0030261),1/45,0.5052690709932667,0.7925286443498446,0,0,1.4449838187702266,0.9864386905080664,CHMP1A
787,GO_Biological_Process_2021,protein deacetylation (GO:0006476),1/45,0.5052690709932667,0.7925286443498446,0,0,1.4449838187702266,0.9864386905080664,TRERF1
788,GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),2/110,0.5106059128219977,0.7961932833742119,0,0,1.1773689273689274,0.7913769946371513,TNFAIP3;TMEM106A
789,GO_Biological_Process_2021,axonogenesis (GO:0007409),4/240,0.5120731206070983,0.7961932833742119,0,0,1.0775451423507256,0.7211878720908447,SLITRK1;SEMA3B;SEMA3E;MYPN
790,GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.5129546746127259,0.7961932833742119,0,0,1.4128011506652285,0.9431405436903249,TNFAIP3
791,GO_Biological_Process_2021,interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.5129546746127259,0.7961932833742119,0,0,1.4128011506652285,0.9431405436903249,IL12A
792,GO_Biological_Process_2021,defense response to bacterium (GO:0042742),3/176,0.5153634404093114,0.7961932833742119,0,0,1.102426992525089,0.730780021336024,IL12A;ANG;MPO
793,GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),2/111,0.5154355527917074,0.7961932833742119,0,0,1.166507804122483,0.7730948841628318,HMGXB4;TNFAIP3
794,GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),2/112,0.5202336271040956,0.7961932833742119,0,0,1.155844155844156,0.7553179013197989,CAPN3;SH3BGR
795,GO_Biological_Process_2021,regulation of cellular metabolic process (GO:0031323),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,ANGPTL8
796,GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,IPMK
797,GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,SNAI1
798,GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,SLITRK1
799,GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,FUT3
800,GO_Biological_Process_2021,regulation of T cell activation (GO:0050863),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,GPNMB
801,GO_Biological_Process_2021,regulation of wound healing (GO:0061041),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,TNFAIP3
802,GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,GALC
803,GO_Biological_Process_2021,histone deacetylation (GO:0016575),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,TRERF1
804,GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.5205212618421974,0.7961932833742119,0,0,1.382017728999578,0.9023532939606308,DDIT3
805,GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,BRINP3
806,GO_Biological_Process_2021,cellular response to interleukin-12 (GO:0071349),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,IL12A
807,GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,TNFAIP3
808,GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,TNFAIP3
809,GO_Biological_Process_2021,nucleus organization (GO:0006997),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,CHMP1A
810,GO_Biological_Process_2021,regulation of protein metabolic process (GO:0051246),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,ANGPTL8
811,GO_Biological_Process_2021,establishment of protein localization to mitochondrion (GO:0072655),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,HK1
812,GO_Biological_Process_2021,positive regulation of DNA repair (GO:0045739),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,SLF2
813,GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,TFR2
814,GO_Biological_Process_2021,Golgi to plasma membrane transport (GO:0006893),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,GCC2
815,GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,IPMK
816,GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,ITGA4
817,GO_Biological_Process_2021,myelination (GO:0042552),1/48,0.5279706698224623,0.7961932833742119,0,0,1.3525442401707637,0.8638896808431941,MAL
818,GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),2/114,0.5297343544790236,0.7961932833742119,0,0,1.135088126159555,0.7212118577842006,NRG1;ANG
819,GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),2/114,0.5297343544790236,0.7961932833742119,0,0,1.135088126159555,0.7212118577842006,STC1;ARHGAP4
820,GO_Biological_Process_2021,response to lipid (GO:0033993),2/114,0.5297343544790236,0.7961932833742119,0,0,1.135088126159555,0.7212118577842006,IL12A;PCK1
821,GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),2/115,0.534436678279912,0.7961932833742119,0,0,1.1249856338351911,0.7048507766792722,TFR2;TNFAIP3
822,GO_Biological_Process_2021,regulation of cellular protein metabolic process (GO:0032268),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,EDNRB
823,GO_Biological_Process_2021,cellular defense response (GO:0006968),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,ADORA2A
824,GO_Biological_Process_2021,oligosaccharide metabolic process (GO:0009311),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,FUT3
825,GO_Biological_Process_2021,regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,NBR1
826,GO_Biological_Process_2021,response to glucose (GO:0009749),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,PCK1
827,GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,TNFAIP3
828,GO_Biological_Process_2021,response to unfolded protein (GO:0006986),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,DDIT3
829,GO_Biological_Process_2021,RNA catabolic process (GO:0006401),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,NUDT12
830,GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),1/49,0.5353047075113027,0.7961932833742119,0,0,1.3242988133764833,0.827579685445765,RAB35
831,GO_Biological_Process_2021,ion transport (GO:0006811),2/116,0.5391067769512942,0.7992384894423932,0,0,1.1150603782182729,0.6889307168791874,ANO10;SLC17A6
832,GO_Biological_Process_2021,nervous system development (GO:0007399),7/447,0.5422394104739934,0.7992384894423932,0,0,1.0107260726072609,0.6186125259512668,NRSN1;EDNRB;ADORA2A;SLITRK1;MAL;NRG1;FGF11
833,GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,ANG
834,GO_Biological_Process_2021,amino acid transport (GO:0006865),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,SLC7A14
835,GO_Biological_Process_2021,regulation of cellular component movement (GO:0051270),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,NRG1
836,GO_Biological_Process_2021,regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,PGAM1
837,GO_Biological_Process_2021,organic hydroxy compound biosynthetic process (GO:1901617),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,INSIG2
838,GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.5425251558593591,0.7992384894423932,0,0,1.2972062611452349,0.7932686422257892,TFR2
839,GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),2/118,0.5483497768315153,0.8030110378802814,0,0,1.0957232422749663,0.6583564531245935,SLF2;NRG1
840,GO_Biological_Process_2021,blood circulation (GO:0008015),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,ADORA2A
841,GO_Biological_Process_2021,negative regulation of protein ubiquitination (GO:0031397),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,TNFAIP3
842,GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,NRG1
843,GO_Biological_Process_2021,regulation of smoothened signaling pathway (GO:0008589),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,TXNDC15
844,GO_Biological_Process_2021,mesenchymal cell differentiation (GO:0048762),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,SNAI1
845,GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.5496337686462119,0.8030110378802814,0,0,1.2711974110032362,0.7608155883215465,CHMP1A
846,GO_Biological_Process_2021,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,SNAI1
847,GO_Biological_Process_2021,negative regulation of protein metabolic process (GO:0051248),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,EDNRB
848,GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,DDIT3
849,GO_Biological_Process_2021,cilium movement (GO:0003341),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,CFAP61
850,GO_Biological_Process_2021,endocytic recycling (GO:0032456),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,RAB35
851,GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,CAPN3
852,GO_Biological_Process_2021,regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,CCT7
853,GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,GALC
854,GO_Biological_Process_2021,response to peptide hormone (GO:0043434),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,PCK1
855,GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),1/52,0.5566322724510143,0.8037353840531001,0,0,1.246208515768767,0.7300918199618688,SEMA3E
856,GO_Biological_Process_2021,macroautophagy (GO:0016236),2/120,0.5574624257853146,0.8039948171186101,0,0,1.077041602465331,0.6293802199598942,NBR1;VPS37C
857,GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),1/53,0.5635223674103828,0.8098995885107362,0,0,1.2221807318894695,0.7009796231018437,NRG1
858,GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.5635223674103828,0.8098995885107362,0,0,1.2221807318894695,0.7009796231018437,KMT5B
859,GO_Biological_Process_2021,positive regulation of macroautophagy (GO:0016239),1/53,0.5635223674103828,0.8098995885107362,0,0,1.2221807318894695,0.7009796231018437,BNIP3L
860,GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,WTAP
861,GO_Biological_Process_2021,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,CCNI2
862,GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,APOBEC3G
863,GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,IL12A
864,GO_Biological_Process_2021,inorganic anion transport (GO:0015698),1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,ANO10
865,GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.5703057274985734,0.8135105583219544,0,0,1.1990596568358065,0.673371157044164,PLA2G4A
866,GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),3/191,0.5706421149394292,0.8135105583219544,0,0,1.013687712246171,0.5686717459924936,HMGXB4;DDIT3;JADE1
867,GO_Biological_Process_2021,defense response to symbiont (GO:0140546),2/124,0.5752938417441473,0.8182545321009966,0,0,1.0415158611879924,0.5758273939324905,BNIP3L;APOBEC3G
868,GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),2/124,0.5752938417441473,0.8182545321009966,0,0,1.0415158611879924,0.5758273939324905,TNFAIP3;TMEM106A
869,GO_Biological_Process_2021,cellular component assembly (GO:0022607),4/261,0.5782621650403782,0.8212040337185018,0,0,0.988428575061672,0.5413899476594976,SYCE3;SYCE1;CAPN3;SH3BGR
870,GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),2/125,0.5796692573185627,0.8212040337185018,0,0,1.0329954598247282,0.5632899286248081,PGAM1;ANG
871,GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),3/194,0.5812227894721189,0.8212040337185018,0,0,0.9976124290123984,0.5413255905038484,BNIP3L;AMIGO2;OSGIN1
872,GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),7/464,0.5818503572294504,0.8212040337185018,0,0,0.9722685616482872,0.5265242443718637,EIF4A2;DDIT3;BHLHE40;CHMP1A;CAPN3;NRG1;TRERF1
873,GO_Biological_Process_2021,regulation of ATP metabolic process (GO:1903578),1/56,0.583558810137948,0.8212040337185018,0,0,1.1553398058252426,0.6222776233636755,PGAM1
874,GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),1/56,0.583558810137948,0.8212040337185018,0,0,1.1553398058252426,0.6222776233636755,GALNS
875,GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.583558810137948,0.8212040337185018,0,0,1.1553398058252426,0.6222776233636755,TMEM106A
876,GO_Biological_Process_2021,Rho protein signal transduction (GO:0007266),1/56,0.583558810137948,0.8212040337185018,0,0,1.1553398058252426,0.6222776233636755,ARHGAP4
877,GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),2/126,0.5840116065036918,0.8212040337185018,0,0,1.0246124842899036,0.5510718634682386,JADE1;OSGIN1
878,GO_Biological_Process_2021,negative regulation of growth (GO:0045926),2/126,0.5840116065036918,0.8212040337185018,0,0,1.0246124842899036,0.5510718634682386,JADE1;OSGIN1
879,GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,NBR1
880,GO_Biological_Process_2021,cellular response to peptide (GO:1901653),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,ITGA4
881,GO_Biological_Process_2021,dicarboxylic acid metabolic process (GO:0043648),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,PCK1
882,GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,IL12A
883,GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,PLA2G4A
884,GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.5900317533445614,0.8224016134142244,0,0,1.1346509477577438,0.5986179264768478,TNFAIP3
885,GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),7/468,0.5909297115456587,0.8224016134142244,0,0,0.9636319380311134,0.50692648282533,ZNF263;ZNF37A;ASCC1;PLAG1;DDIT3;BHLHE40;SPTY2D1
886,GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),2/128,0.5925969969732754,0.8224016134142244,0,0,1.0082457225314367,0.5275552091231197,CFAP61;RAB35
887,GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),4/267,0.5962177024392947,0.8224016134142244,0,0,0.9655806555828922,0.4993494625410124,HMGXB4;KLK14;TNFAIP3;IL12A
888,GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,STC1
889,GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,TFR2
890,GO_Biological_Process_2021,nucleosome assembly (GO:0006334),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,SPTY2D1
891,GO_Biological_Process_2021,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,TNFAIP3
892,GO_Biological_Process_2021,RNA modification (GO:0009451),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,APOBEC3G
893,GO_Biological_Process_2021,positive regulation of mitochondrion organization (GO:0010822),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,FAM162A
894,GO_Biological_Process_2021,membrane lipid biosynthetic process (GO:0046467),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,PLPP1
895,GO_Biological_Process_2021,muscle organ development (GO:0007517),1/58,0.5964044036339252,0.8224016134142244,0,0,1.1146880145347189,0.5761112429384591,CAPN3
896,GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.5968400058515851,0.8224016134142244,0,0,1.000255649861949,0.5162381408840119,PPP1R3E;TMEM106A
897,GO_Biological_Process_2021,central nervous system development (GO:0007417),4/268,0.5991659701932278,0.8240159195106124,0,0,0.9618736383442266,0.4926876835789806,ADORA2A;AMIGO2;MAL;PCDH18
898,GO_Biological_Process_2021,regulation of primary metabolic process (GO:0080090),2/130,0.6010498828933842,0.8240159195106124,0,0,0.992390422077922,0.5052034843201285,ANGPTL8;PLPP1
899,GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),4/269,0.6021013757877602,0.8240159195106124,0,0,0.9581945985941548,0.4861203382494832,GPNMB;SEMA3B;SNAI1;SEMA3E
900,GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.6026783100627779,0.8240159195106124,0,0,1.095413458319384,0.5546863828588946,ANG
901,GO_Biological_Process_2021,phospholipid transport (GO:0015914),1/59,0.6026783100627779,0.8240159195106124,0,0,1.095413458319384,0.5546863828588946,ATP10B
902,GO_Biological_Process_2021,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.6026783100627779,0.8240159195106124,0,0,1.095413458319384,0.5546863828588946,DDIT3
903,GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.6026783100627779,0.8240159195106124,0,0,1.095413458319384,0.5546863828588946,IL12A
904,GO_Biological_Process_2021,cellular protein catabolic process (GO:0044257),1/60,0.6088549977264024,0.8288558961990035,0,0,1.07679227689101,0.5342775572230495,BNIP3L
905,GO_Biological_Process_2021,axon guidance (GO:0007411),3/203,0.611962104035341,0.8288558961990035,0,0,0.9522801302931596,0.4676504115053853,SEMA3B;SEMA3E;MYPN
906,GO_Biological_Process_2021,defense response to virus (GO:0051607),2/133,0.6134808053640475,0.8288558961990035,0,0,0.9695152176068208,0.4737112456155558,BNIP3L;APOBEC3G
907,GO_Biological_Process_2021,RNA metabolic process (GO:0016070),2/133,0.6134808053640475,0.8288558961990035,0,0,0.9695152176068208,0.4737112456155558,WTAP;RNASE4
908,GO_Biological_Process_2021,B cell differentiation (GO:0030183),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,ITGA4
909,GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,MED26
910,GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,TFR2
911,GO_Biological_Process_2021,O-glycan processing (GO:0016266),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,GALNT11
912,GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,CCT7
913,GO_Biological_Process_2021,response to light stimulus (GO:0009416),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,OPN1SW
914,GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,DDIT3
915,GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,TFR2
916,GO_Biological_Process_2021,protein lipidation (GO:0006497),1/61,0.6149359682965099,0.8288558961990035,0,0,1.0587918015102482,0.5148238902084207,PIGV
917,GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),7/481,0.6197413869975739,0.8332903991192057,0,0,0.9365696063277212,0.4481045432009959,GALNS;GPI;PGAM1;ALDOC;SLC2A3;MPO;ARHGAP45
918,GO_Biological_Process_2021,regulation of neurogenesis (GO:0050767),1/62,0.6209227003145538,0.8332903991192057,0,0,1.0413815056501672,0.4962689828734109,BHLHE40
919,GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),1/62,0.6209227003145538,0.8332903991192057,0,0,1.0413815056501672,0.4962689828734109,TMEM106A
920,GO_Biological_Process_2021,response to retinoic acid (GO:0032526),1/62,0.6209227003145538,0.8332903991192057,0,0,1.0413815056501672,0.4962689828734109,BRINP3
921,GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),2/136,0.6256141544362922,0.8336006315570704,0,0,0.9476642760224848,0.4444748867169129,STC1;SLC35G1
922,GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,BCAT1
923,GO_Biological_Process_2021,cellular response to reactive oxygen species (GO:0034614),1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,TNFAIP3
924,GO_Biological_Process_2021,COPII vesicle coating (GO:0048208),1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,NAPA
925,GO_Biological_Process_2021,vesicle coating (GO:0006901),1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,NAPA
926,GO_Biological_Process_2021,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,NAPA
927,GO_Biological_Process_2021,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.6268166496423921,0.8336006315570704,0,0,1.0245328322371856,0.4785605214492417,OXSM
928,GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),7/485,0.6283821062895031,0.8336006315570704,0,0,0.9285388789925018,0.4314055218501034,GALNS;GPI;PGAM1;ALDOC;SLC2A3;MPO;ARHGAP45
929,GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,ANG
930,GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,SNAI1
931,GO_Biological_Process_2021,regulation of cilium assembly (GO:1902017),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,TBC1D10B
932,GO_Biological_Process_2021,regulation of innate immune response (GO:0045088),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,TNFAIP3
933,GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,OPN1SW
934,GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,MED26
935,GO_Biological_Process_2021,lipid homeostasis (GO:0055088),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,ABHD5
936,GO_Biological_Process_2021,tRNA processing (GO:0008033),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,TRMT10A
937,GO_Biological_Process_2021,protein catabolic process (GO:0030163),1/64,0.6326192495149936,0.8336006315570704,0,0,1.0082190373452509,0.4616499259356477,CAPN3
938,GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),7/488,0.6347906522926234,0.8355710822509932,0,0,0.9226034869599226,0.4192863953303715,GALNS;GPI;PGAM1;ALDOC;SLC2A3;MPO;ARHGAP45
939,GO_Biological_Process_2021,regulation of cell-matrix adhesion (GO:0001952),1/65,0.6383319113292317,0.8366683376489188,0,0,0.9924150485436892,0.4454920325728876,SEMA3E
940,GO_Biological_Process_2021,regulation of cellular catabolic process (GO:0031329),1/65,0.6383319113292317,0.8366683376489188,0,0,0.9924150485436892,0.4454920325728876,DDIT3
941,GO_Biological_Process_2021,chemical homeostasis (GO:0048878),1/65,0.6383319113292317,0.8366683376489188,0,0,0.9924150485436892,0.4454920325728876,ABHD5
942,GO_Biological_Process_2021,steroid biosynthetic process (GO:0006694),1/65,0.6383319113292317,0.8366683376489188,0,0,0.9924150485436892,0.4454920325728876,INSIG2
943,GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),2/140,0.641331041755003,0.8388202831843213,0,0,0.9200075287031808,0.408676093133366,DOCK10;SLITRK1
944,GO_Biological_Process_2021,transcription initiation from RNA polymerase II promoter (GO:0006367),2/140,0.641331041755003,0.8388202831843213,0,0,0.9200075287031808,0.408676093133366,TAF4B;MED26
945,GO_Biological_Process_2021,cellular response to nutrient levels (GO:0031669),1/66,0.6439560246307365,0.840474811450465,0,0,0.9770973363206372,0.4300448087579985,CARTPT
946,GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.6439560246307365,0.840474811450465,0,0,0.9770973363206372,0.4300448087579985,NRG1
947,GO_Biological_Process_2021,organelle assembly (GO:0070925),6/425,0.6477381639510048,0.844135957508555,0,0,0.9077534229368168,0.3942089281872318,GALNT11;FAM149B1;CHMP1A;VPS37C;CAPN3;TXNDC15
948,GO_Biological_Process_2021,peptidyl-threonine modification (GO:0018210),1/67,0.6494929575976018,0.844135957508555,0,0,0.9622437971952535,0.4152690947967788,GALNT11
949,GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.6494929575976018,0.844135957508555,0,0,0.9622437971952535,0.4152690947967788,TNFAIP3
950,GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),1/67,0.6494929575976018,0.844135957508555,0,0,0.9622437971952535,0.4152690947967788,APOBEC3G
951,GO_Biological_Process_2021,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.654944057271454,0.8476553453272431,0,0,0.9478336472974932,0.4011283706705182,PEG10
952,GO_Biological_Process_2021,regulation of translational initiation (GO:0006446),1/68,0.654944057271454,0.8476553453272431,0,0,0.9478336472974932,0.4011283706705182,EIF4A2
953,GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.654944057271454,0.8476553453272431,0,0,0.9478336472974932,0.4011283706705182,IL12A
954,GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.654944057271454,0.8476553453272431,0,0,0.9478336472974932,0.4011283706705182,CCT7
955,GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),2/144,0.6565249603391703,0.8488126056267934,0,0,0.893908907993415,0.3761520106638782,STC1;ARHGAP4
956,GO_Biological_Process_2021,synapse assembly (GO:0007416),1/69,0.6603106500811824,0.8516296434712554,0,0,0.9338473253379022,0.3875885443188478,SLITRK1
957,GO_Biological_Process_2021,positive regulation of protein transport (GO:0051222),1/69,0.6603106500811824,0.8516296434712554,0,0,0.9338473253379022,0.3875885443188478,ANG
958,GO_Biological_Process_2021,carbohydrate homeostasis (GO:0033500),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,PCK1
959,GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,OPN1SW
960,GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,APOBEC3G
961,GO_Biological_Process_2021,COPII-coated vesicle budding (GO:0090114),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,NAPA
962,GO_Biological_Process_2021,establishment of protein localization to membrane (GO:0090150),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,VPS37C
963,GO_Biological_Process_2021,snRNA transcription by RNA polymerase II (GO:0042795),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,SNAPC5
964,GO_Biological_Process_2021,sterol metabolic process (GO:0016125),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,INSIG2
965,GO_Biological_Process_2021,wound healing (GO:0042060),1/70,0.6655940417420977,0.8516296434712554,0,0,0.9202664040148212,0.3746177604320472,NRG1
966,GO_Biological_Process_2021,"transcription, DNA-templated (GO:0006351)",3/221,0.6687817311618,0.8538653559771703,0,0,0.8728446343722918,0.3511432434767359,PPP5C;TAF4B;HSF2BP
967,GO_Biological_Process_2021,regulation of glycolytic process (GO:0006110),1/71,0.6707955183283433,0.8538653559771703,0,0,0.9070735090152566,0.3621862251202019,PGAM1
968,GO_Biological_Process_2021,nucleic acid metabolic process (GO:0090304),1/71,0.6707955183283433,0.8538653559771703,0,0,0.9070735090152566,0.3621862251202019,WTAP
969,GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.6707955183283433,0.8538653559771703,0,0,0.9070735090152566,0.3621862251202019,NRG1
970,GO_Biological_Process_2021,snRNA transcription (GO:0009301),1/71,0.6707955183283433,0.8538653559771703,0,0,0.9070735090152566,0.3621862251202019,SNAPC5
971,GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),6/437,0.6739739698833449,0.8542255656470628,0,0,0.8819300280864575,0.3479776536617179,BRPF1;CAPN3;TAF4B;ARHGAP24;ARHGAP45;ARHGAP4
972,GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,ITGA4
973,GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,RAB35
974,GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,IL12A
975,GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,SLITRK1
976,GO_Biological_Process_2021,positive regulation of protein secretion (GO:0050714),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,ANG
977,GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.6759163456333555,0.8542255656470628,0,0,0.8942522448607503,0.3502660487062167,ANG
978,GO_Biological_Process_2021,brain development (GO:0007420),2/150,0.6783475943704657,0.8564224991234889,0,0,0.8574061074061075,0.3327554059592022,AMIGO2;PCDH18
979,GO_Biological_Process_2021,regulation of hydrolase activity (GO:0051336),1/73,0.6809577702055623,0.8579651416657237,0,0,0.881787126932758,0.338831100291758,TBC1D10B
980,GO_Biological_Process_2021,chromatin assembly (GO:0031497),1/73,0.6809577702055623,0.8579651416657237,0,0,0.881787126932758,0.338831100291758,SPTY2D1
981,GO_Biological_Process_2021,proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.6859210192891623,0.8607090150674158,0,0,0.8696635190849847,0.3278568765219631,TNFAIP3
982,GO_Biological_Process_2021,regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.6859210192891623,0.8607090150674158,0,0,0.8696635190849847,0.3278568765219631,TNFAIP3
983,GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.6859210192891623,0.8607090150674158,0,0,0.8696635190849847,0.3278568765219631,ITGA4
984,GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.6859210192891623,0.8607090150674158,0,0,0.8696635190849847,0.3278568765219631,PLPP1
985,GO_Biological_Process_2021,dephosphorylation (GO:0016311),2/153,0.688829543426457,0.863048035023629,0,0,0.8402425389180356,0.3132100150887031,PPP5C;PLPP1
986,GO_Biological_Process_2021,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.6908073012837198,0.863048035023629,0,0,0.8578675763141782,0.3173203810643892,RNASE4
987,GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),1/75,0.6908073012837198,0.863048035023629,0,0,0.8578675763141782,0.3173203810643892,PCK1
988,GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.6908073012837198,0.863048035023629,0,0,0.8578675763141782,0.3173203810643892,IL12A
989,GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,SLITRK1
990,GO_Biological_Process_2021,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,SNAI1
991,GO_Biological_Process_2021,chloride transport (GO:0006821),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,ANO10
992,GO_Biological_Process_2021,establishment of protein localization to organelle (GO:0072594),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,HK1
993,GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,GPNMB
994,GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,TMEM106A
995,GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),1/76,0.6956178059576907,0.863048035023629,0,0,0.84638619201726,0.3072000147079394,SLC2A3
996,GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),2/156,0.6990297454692916,0.863048035023629,0,0,0.8237476808905381,0.2949527283866893,BRPF1;TAF4B
997,GO_Biological_Process_2021,purine ribonucleotide metabolic process (GO:0009150),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,OXSM
998,GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,OPN1SW
999,GO_Biological_Process_2021,cholesterol metabolic process (GO:0008203),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,INSIG2
1000,GO_Biological_Process_2021,regulation of organelle assembly (GO:1902115),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,TBC1D10B
1001,GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,PLA2G4A
1002,GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.7003537047966828,0.863048035023629,0,0,0.8352069494123658,0.2974754745825666,TMEM106A
1003,GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),5/379,0.7023284825822069,0.8646195263661433,0,0,0.8466730954676953,0.299175376193095,GPNMB;TNFAIP3;IL12A;ANG;PLPP1
1004,GO_Biological_Process_2021,protein modification process (GO:0036211),1/78,0.7050161510071958,0.8652921947009606,0,0,0.8243180767452613,0.2881276621921178,PLAT
1005,GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.7050161510071958,0.8652921947009606,0,0,0.8243180767452613,0.2881276621921178,PKIG
1006,GO_Biological_Process_2021,cellular response to starvation (GO:0009267),2/158,0.705675187911463,0.8652921947009606,0,0,0.8131035631035631,0.2834480819036447,NIM1K;CARTPT
1007,GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),2/158,0.705675187911463,0.8652921947009606,0,0,0.8131035631035631,0.2834480819036447,PLA2G4A;PLPP1
1008,GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),5/381,0.7066725220882295,0.8656563303280987,0,0,0.8420823160097664,0.2923608027492827,BNIP3L;ANXA4;AMIGO2;CAPN3;MPO
1009,GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),2/159,0.7089519354623112,0.8666732829990552,0,0,0.8078831996029449,0.2778856022373834,TNFAIP3;IL12A
1010,GO_Biological_Process_2021,axon development (GO:0061564),1/79,0.7096062802548898,0.8666732829990552,0,0,0.8137084059414157,0.2791385981717029,SLITRK1
1011,GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),1/79,0.7096062802548898,0.8666732829990552,0,0,0.8137084059414157,0.2791385981717029,BRINP3
1012,GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.7141252107290809,0.8704721503561578,0,0,0.8033673343984269,0.2704913447586785,TNFAIP3
1013,GO_Biological_Process_2021,lipid biosynthetic process (GO:0008610),1/80,0.7141252107290809,0.8704721503561578,0,0,0.8033673343984269,0.2704913447586785,OXSM
1014,GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.718574043212039,0.8733112265585843,0,0,0.7932847896440129,0.2621699344845099,FAM162A
1015,GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.718574043212039,0.8733112265585843,0,0,0.7932847896440129,0.2621699344845099,GNA11
1016,GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.718574043212039,0.8733112265585843,0,0,0.7932847896440129,0.2621699344845099,TMEM106A
1017,GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.7229538615816694,0.8760499734460229,0,0,0.7834511966119302,0.2541593040558922,CCNI2
1018,GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.7229538615816694,0.8760499734460229,0,0,0.7834511966119302,0.2541593040558922,KLK14
1019,GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.7229538615816694,0.8760499734460229,0,0,0.7834511966119302,0.2541593040558922,ARRDC3
1020,GO_Biological_Process_2021,membrane organization (GO:0061024),3/242,0.7271081595053467,0.8761259423071445,0,0,0.795292546304499,0.253443858403455,NAPA;CHMP1A;ATP10B
1021,GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.7272657330730324,0.8761259423071445,0,0,0.7738574473123372,0.2464452336923573,GALNT11
1022,GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),1/83,0.7272657330730324,0.8761259423071445,0,0,0.7738574473123372,0.2464452336923573,NBR1
1023,GO_Biological_Process_2021,epidermis development (GO:0008544),1/83,0.7272657330730324,0.8761259423071445,0,0,0.7738574473123372,0.2464452336923573,KLK14
1024,GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.7272657330730324,0.8761259423071445,0,0,0.7738574473123372,0.2464452336923573,TMEM106A
1025,GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),2/165,0.7279784326451759,0.8761259423071445,0,0,0.7779061429368178,0.2469726424192962,DDIT3;JADE1
1026,GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.7279784326451759,0.8761259423071445,0,0,0.7779061429368178,0.2469726424192962,ADORA2A;GNA11
1027,GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),2/166,0.731045337317602,0.8777148843253109,0,0,0.7731232182451695,0.2422038873428068,NBR1;TMEM106A
1028,GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),1/84,0.7315107083873675,0.8777148843253109,0,0,0.7644948726946621,0.2390142913311652,ITGA4
1029,GO_Biological_Process_2021,vascular transport (GO:0010232),1/84,0.7315107083873675,0.8777148843253109,0,0,0.7644948726946621,0.2390142913311652,SLC2A3
1030,GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),4/320,0.7337412801095975,0.8777148843253109,0,0,0.801439563167039,0.2481247205516519,SNAPC5;TAF4B;HSF2BP;MED26
1031,GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.7356898221367492,0.8777148843253109,0,0,0.755355216520265,0.2318537807636771,TNFAIP3
1032,GO_Biological_Process_2021,B cell activation (GO:0042113),1/85,0.7356898221367492,0.8777148843253109,0,0,0.755355216520265,0.2318537807636771,ITGA4
1033,GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.7356898221367492,0.8777148843253109,0,0,0.755355216520265,0.2318537807636771,BCAT1
1034,GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.7356898221367492,0.8777148843253109,0,0,0.755355216520265,0.2318537807636771,NAPA
1035,GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.7356898221367492,0.8777148843253109,0,0,0.755355216520265,0.2318537807636771,TNFAIP3
1036,GO_Biological_Process_2021,"DNA-templated transcription, initiation (GO:0006352)",2/168,0.7370913345371282,0.8783841102616506,0,0,0.7637302456579566,0.2329709219977226,TAF4B;MED26
1037,GO_Biological_Process_2021,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.7398040928660019,0.8783841102616506,0,0,0.7464306110793832,0.2249516941378767,RTN1
1038,GO_Biological_Process_2021,regulation of neuron death (GO:1901214),1/86,0.7398040928660019,0.8783841102616506,0,0,0.7464306110793832,0.2249516941378767,GPNMB
1039,GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.7398040928660019,0.8783841102616506,0,0,0.7464306110793832,0.2249516941378767,GPI
1040,GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),1/86,0.7398040928660019,0.8783841102616506,0,0,0.7464306110793832,0.2249516941378767,SLC2A3
1041,GO_Biological_Process_2021,protein targeting to membrane (GO:0006612),1/87,0.7438545234844317,0.8805978916001181,0,0,0.7377135546022427,0.2182966676104452,VPS37C
1042,GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.7438545234844317,0.8805978916001181,0,0,0.7377135546022427,0.2182966676104452,SLC35G1
1043,GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.7438545234844317,0.8805978916001181,0,0,0.7377135546022427,0.2182966676104452,DDIT3
1044,GO_Biological_Process_2021,phosphorylation (GO:0016310),5/400,0.745735102355544,0.8805978916001181,0,0,0.8007885453413571,0.2349392132542745,NIM1K;PGK1;PRKG2;PDK1;HK1
1045,GO_Biological_Process_2021,neuron projection development (GO:0031175),2/171,0.7459433596321389,0.8805978916001181,0,0,0.7500576346730193,0.219846098361033,DOCK10;RAB35
1046,GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/171,0.7459433596321389,0.8805978916001181,0,0,0.7500576346730193,0.219846098361033,PPP5C;TMEM106A
1047,GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.7517677989390639,0.883439538241019,0,0,0.720873786407767,0.2056853176553879,FGF11
1048,GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),1/89,0.7517677989390639,0.883439538241019,0,0,0.720873786407767,0.2056853176553879,TNFAIP3
1049,GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.7517677989390639,0.883439538241019,0,0,0.720873786407767,0.2056853176553879,EDNRB
1050,GO_Biological_Process_2021,post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.7517677989390639,0.883439538241019,0,0,0.720873786407767,0.2056853176553879,NAPA
1051,GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),3/252,0.7519242671760129,0.883439538241019,0,0,0.7629606373376241,0.2175350841078572,KLK14;TNFAIP3;TXNDC15
1052,GO_Biological_Process_2021,cation transport (GO:0006812),2/174,0.7545392045129542,0.8835968405234974,0,0,0.7368619752340683,0.2075357319636581,SCN9A;ANO10
1053,GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),1/90,0.75563257316613,0.8835968405234974,0,0,0.7127377186284135,0.1997091339024779,BCAT1
1054,GO_Biological_Process_2021,negative regulation of translation (GO:0017148),1/90,0.75563257316613,0.8835968405234974,0,0,0.7127377186284135,0.1997091339024779,CPEB1
1055,GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.75563257316613,0.8835968405234974,0,0,0.7127377186284135,0.1997091339024779,WTAP
1056,GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),1/90,0.75563257316613,0.8835968405234974,0,0,0.7127377186284135,0.1997091339024779,BNIP3L
1057,GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.7594373666125999,0.8863688244883602,0,0,0.7047824523552679,0.193940221800787,SEMA3E
1058,GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.7594373666125999,0.8863688244883602,0,0,0.7047824523552679,0.193940221800787,TFR2
1059,GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),2/177,0.7628836837432942,0.8882244072195898,0,0,0.7241187384044527,0.1959825231257561,PLA2G4A;ABHD5
1060,GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.7631831071741136,0.8882244072195898,0,0,0.6970020270991145,0.1883698812676193,ANG
1061,GO_Biological_Process_2021,retinoid metabolic process (GO:0001523),1/92,0.7631831071741136,0.8882244072195898,0,0,0.6970020270991145,0.1883698812676193,OPN1SW
1062,GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),2/178,0.7656101642011451,0.8900020616496367,0,0,0.7199675324675324,0.1922904857220472,ADORA2A;TNFAIP3
1063,GO_Biological_Process_2021,cytoplasmic translation (GO:0002181),1/93,0.7668707084602452,0.8900020616496367,0,0,0.6893907415224426,0.1829898513951472,EIF4A2
1064,GO_Biological_Process_2021,visual perception (GO:0007601),1/93,0.7668707084602452,0.8900020616496367,0,0,0.6893907415224426,0.1829898513951472,CRYBB2
1065,GO_Biological_Process_2021,nucleosome organization (GO:0034728),1/94,0.7705010701384759,0.8925391965240452,0,0,0.6819431395065595,0.1777922841581142,SPTY2D1
1066,GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),1/94,0.7705010701384759,0.8925391965240452,0,0,0.6819431395065595,0.1777922841581142,GPI
1067,GO_Biological_Process_2021,sensory perception of light stimulus (GO:0050953),1/95,0.774075077638861,0.8958396965932884,0,0,0.6746539971080355,0.1727697204914775,CRYBB2
1068,GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.7775936031471251,0.8984265191898025,0,0,0.6675183103389541,0.1679150668823834,TFR2
1069,GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),7/566,0.7777640578746672,0.8984265191898025,0,0,0.7906445385146743,0.1987143271644153,BNIP3L;APOBEC3G;GPNMB;CHMP1A;JADE1;OSGIN1;PLPP1
1070,GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.7810575050675569,0.900280398640773,0,0,0.6605312837108953,0.1632215748505137,STC1
1071,GO_Biological_Process_2021,organelle organization (GO:0006996),5/420,0.7825779212193535,0.900280398640773,0,0,0.7614062808611495,0.1866677204078035,CFAP61;CAPZB;CHMP1A;TNFAIP3;ARHGAP4
1072,GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.7839443237842413,0.900280398640773,0,0,0.6921794052941594,0.1684884258486037,NAPA;CAPZB
1073,GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.7844676289127124,0.900280398640773,0,0,0.6536883194875388,0.1586828205964515,CAPZB
1074,GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.7844676289127124,0.900280398640773,0,0,0.6536883194875388,0.1586828205964515,GPNMB
1075,GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),1/98,0.7844676289127124,0.900280398640773,0,0,0.6536883194875388,0.1586828205964515,DDIT3
1076,GO_Biological_Process_2021,RNA splicing (GO:0008380),1/98,0.7844676289127124,0.900280398640773,0,0,0.6536883194875388,0.1586828205964515,WBP4
1077,GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),3/267,0.7857232443501801,0.9008849072512268,0,0,0.7190553745928339,0.1734006745511447,NAPA;CAPN3;SH3BGR
1078,GO_Biological_Process_2021,response to UV (GO:0009411),1/99,0.7878248066711901,0.9024573318309462,0,0,0.6469850075952711,0.1542926872582235,IL12A
1079,GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.7911298578918188,0.9028961259042364,0,0,0.6404171161452715,0.150045346926481,CAPZB
1080,GO_Biological_Process_2021,cell-matrix adhesion (GO:0007160),1/100,0.7911298578918188,0.9028961259042364,0,0,0.6404171161452715,0.150045346926481,ITGA4
1081,GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.7911298578918188,0.9028961259042364,0,0,0.6404171161452715,0.150045346926481,SLC7A14
1082,GO_Biological_Process_2021,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.7911298578918188,0.9028961259042364,0,0,0.6404171161452715,0.150045346926481,PEG10
1083,GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),2/189,0.7938472507332406,0.905161625374802,0,0,0.6772345301757067,0.1563492186346478,DOCK10;TBC1D10B
1084,GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.7975867954525999,0.9052500267946864,0,0,0.6276715050145791,0.1419570847939452,BNIP3L
1085,GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.7975867954525999,0.9052500267946864,0,0,0.6276715050145791,0.1419570847939452,EDNRB
1086,GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),1/102,0.7975867954525999,0.9052500267946864,0,0,0.6276715050145791,0.1419570847939452,TNFAIP3
1087,GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.7975867954525999,0.9052500267946864,0,0,0.6276715050145791,0.1419570847939452,CAPN3
1088,GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),1/102,0.7975867954525999,0.9052500267946864,0,0,0.6276715050145791,0.1419570847939452,CHMP1A
1089,GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.8007402581455423,0.9071631155526034,0,0,0.6214861349070373,0.1381058139196194,CAPZB
1090,GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.8007402581455423,0.9071631155526034,0,0,0.6214861349070373,0.1381058139196194,CPEB1
1091,GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.8038447475751705,0.909013822509525,0,0,0.6154208690734282,0.13437661041075,STC1
1092,GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.8038447475751705,0.909013822509525,0,0,0.6154208690734282,0.13437661041075,RAPGEF4
1093,GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),6/511,0.8070664708379871,0.9112353252154244,0,0,0.74980458572173,0.1607200478031799,BRPF1;DDIT3;SNAI1;CAPN3;TRERF1;RLF
1094,GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.8079514857740632,0.9112353252154244,0,0,0.6559787362896171,0.1398896070366956,ITGA4;CAPN3
1095,GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.8080209679903764,0.9112353252154244,0,0,0.6899022801302932,0.1470645858392003,GALNT11;FAM149B1;TXNDC15
1096,GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.8099098272417867,0.9125328591347752,0,0,0.6036369240252736,0.1272661984256365,PRSS12
1097,GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),2/198,0.8146771800602697,0.9170683010514512,0,0,0.6458388550225285,0.1323732903090065,DDIT3;TNFAIP3
1098,GO_Biological_Process_2021,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.8157879601810788,0.9174830926149348,0,0,0.5922935002873303,0.1205914367152633,PEG10
1099,GO_Biological_Process_2021,regulation of protein ubiquitination (GO:0031396),1/109,0.8186587236152568,0.9190392210612692,0,0,0.5867793359702744,0.1174074925415204,TNFAIP3
1100,GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.8186587236152568,0.9190392210612692,0,0,0.5867793359702744,0.1174074925415204,LRRC4C
1101,GO_Biological_Process_2021,response to endoplasmic reticulum stress (GO:0034976),1/110,0.8214848906829537,0.9213750679529318,0,0,0.5813663489801372,0.1143208869677069,DDIT3
1102,GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.8242671518022427,0.9225647103300824,0,0,0.5760517799352751,0.1113281058620948,STC1
1103,GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.8242671518022427,0.9225647103300824,0,0,0.5760517799352751,0.1113281058620948,CCNI2
1104,GO_Biological_Process_2021,proteolysis (GO:0006508),3/287,0.8247847936203406,0.9225647103300824,0,0,0.6677295040601917,0.1286265925876294,KLK14;CAPN3;PLAT
1105,GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),1/112,0.8270061870127913,0.9233781817053388,0,0,0.5708329688912214,0.1084257852423036,BNIP3L
1106,GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),1/112,0.8270061870127913,0.9233781817053388,0,0,0.5708329688912214,0.1084257852423036,PLA2G4A
1107,GO_Biological_Process_2021,histone modification (GO:0016570),1/114,0.8323572469113031,0.9285140407783128,0,0,0.5606724518143025,0.1028797768957168,TRERF1
1108,GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),2/207,0.8336101868716536,0.9290732109768836,0,0,0.6171998732974343,0.1123238270436351,DDIT3;NRG1
1109,GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.834970579675569,0.929751023854958,0,0,0.555725884290013,0.100230047325048,TNFAIP3
1110,GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),2/209,0.837573793291663,0.9318102686845144,0,0,0.6111738503042851,0.1083280639033649,CCNI2;BCAT1
1111,GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),1/117,0.8400760453783045,0.9337535900068205,0,0,0.5460886061823457,0.0951629628892876,SLITRK1
1112,GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.8425694266443413,0.9342719812014484,0,0,0.5413935219760463,0.092740285124704,ADORA2A
1113,GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.8425694266443413,0.9342719812014484,0,0,0.5413935219760463,0.092740285124704,TNFAIP3
1114,GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.8433595707039767,0.9342719812014484,0,0,0.6023500309214594,0.1026174806174319,ADORA2A;TNFAIP3
1115,GO_Biological_Process_2021,DNA repair (GO:0006281),3/298,0.8435659636090749,0.9342719812014484,0,0,0.6424667365980236,0.1092946280543114,PPP5C;ASCC1;KMT5B
1116,GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.8450240564828745,0.9350490007276928,0,0,0.5367780154681586,0.0903881481582796,FAM162A
1117,GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),1/120,0.8474405351439548,0.936884169443585,0,0,0.5322400804982187,0.0881041526672738,TNFAIP3
1118,GO_Biological_Process_2021,innate immune response (GO:0045087),3/302,0.8499516089170227,0.938820543897623,0,0,0.6337411349449305,0.1030310111744714,COLEC10;APOBEC3G;ANG
1119,GO_Biological_Process_2021,MAPK cascade (GO:0000165),3/303,0.8515122645906398,0.9397046062803848,0,0,0.6315960912052118,0.1015236244423836,PPP5C;PRKG2;NRG1
1120,GO_Biological_Process_2021,regulation of cell growth (GO:0001558),2/217,0.8525891391995422,0.9400536806874524,0,0,0.5881908788885533,0.0938032186401884,OSGIN1;JADE1
1121,GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),6/547,0.8544586712263165,0.9404462377600032,0,0,0.6985966533709504,0.1098802721563725,DDIT3;BHLHE40;CHMP1A;CAPN3;NRG1;TRERF1
1122,GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.854466929615278,0.9404462377600032,0,0,0.5190726298477373,0.0816384344432998,ANG
1123,GO_Biological_Process_2021,cellular response to lipid (GO:0071396),2/219,0.8561405340398474,0.9412679708548284,0,0,0.5827099168112992,0.0905069360878573,TNFAIP3;BRINP3
1124,GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.8567366239576714,0.9412679708548284,0,0,0.5148262162233272,0.0796048651374953,OXSM
1125,GO_Biological_Process_2021,protein targeting (GO:0006605),1/125,0.8589710325877669,0.942048088978243,0,0,0.5106482931412465,0.0776287942811791,VPS37C
1126,GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.8589710325877669,0.942048088978243,0,0,0.5106482931412465,0.0776287942811791,PCYOX1L
1127,GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.8611707024472732,0.9436232165113738,0,0,0.506537216828479,0.0757083357510637,PIGV
1128,GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),3/310,0.8620467994427091,0.9437465403996356,0,0,0.6169720633640675,0.0915868609908219,BNIP3L;FAM162A;DDIT3
1129,GO_Biological_Process_2021,cilium assembly (GO:0060271),3/314,0.8677682352879048,0.9491695033768588,0,0,0.6089110466395048,0.0863622251881026,GALNT11;FAM149B1;TXNDC15
1130,GO_Biological_Process_2021,Golgi organization (GO:0007030),1/130,0.8696326366495382,0.9495282145749374,0,0,0.490730287749931,0.06854737230033,GCC2
1131,GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.8696326366495382,0.9495282145749374,0,0,0.490730287749931,0.06854737230033,TET1
1132,GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.8756398946576867,0.955243521444749,0,0,0.4795037756202804,0.0636782700533631,IL12A
1133,GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.8775803524076152,0.956516151301422,0,0,0.4758741513979123,0.0621428627132375,IL12A
1134,GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),3/323,0.8798843288673357,0.9581824057092748,0,0,0.5915105863192183,0.0756925484382674,CPEB1;TNFAIP3;BRINP3
1135,GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.8813711886170738,0.958956680572802,0,0,0.4687762195852811,0.0591953805929424,ADORA2A
1136,GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.8832224957559813,0.9601257737505656,0,0,0.4653055396916048,0.0577807732146213,ADORA2A
1137,GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),1/139,0.886839156560122,0.962978999361977,0,0,0.4585150790300643,0.0550638311620742,PPP5C
1138,GO_Biological_Process_2021,cellular protein localization (GO:0034613),3/329,0.8874054047518543,0.962978999361977,0,0,0.5804440358905697,0.0693359842892863,NAPA;CAPN3;TBC1D10B
1139,GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.8886053963357146,0.9634353244481958,0,0,0.4551931270517566,0.0537592258136614,SH2D6
1140,GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.890344155335235,0.9639120789725188,0,0,0.451918631530282,0.0524890835055851,ABHD5
1141,GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),1/142,0.8920558596258995,0.9639120789725188,0,0,0.4486905827537928,0.0512523662763243,ARHGAP4
1142,GO_Biological_Process_2021,chromatin organization (GO:0006325),1/142,0.8920558596258995,0.9639120789725188,0,0,0.4486905827537928,0.0512523662763243,SNAI1
1143,GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),1/143,0.8937409289483416,0.9639120789725188,0,0,0.4455079994530289,0.0500480721524214,SPTY2D1
1144,GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.8937409289483416,0.9639120789725188,0,0,0.4455079994530289,0.0500480721524214,TFR2
1145,GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.8937409289483416,0.9639120789725188,0,0,0.4455079994530289,0.0500480721524214,RAB35
1146,GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),3/335,0.8945041703733649,0.9639120789725188,0,0,0.5697774812605471,0.0635220492081098,DDIT3;IL12A;TMEM106A
1147,GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),2/246,0.8970056562339765,0.9657656716944208,0,0,0.517511177347243,0.0562498999568548,DDIT3;CAPN3
1148,GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.9017809878138904,0.9692185225547552,0,0,0.4302445897452832,0.0444802327199101,SLC35G1
1149,GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.9017809878138904,0.9692185225547552,0,0,0.4302445897452832,0.0444802327199101,ARRDC3
1150,GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.9033147025181264,0.9700234338074756,0,0,0.4273156651797428,0.0434512851089117,DOCK10
1151,GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.9048245433943342,0.9700398421722952,0,0,0.424426055037901,0.0424486445690648,GPNMB
1152,GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),2/253,0.9056844481123209,0.9700398421722952,0,0,0.502897500905469,0.0498192014077214,DDIT3;JADE1
1153,GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.9056844481123209,0.9700398421722952,0,0,0.502897500905469,0.0498192014077214,GPNMB;ANG
1154,GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.9092144985740472,0.97297759327924,0,0,0.4159853517288366,0.0395910899569335,TNFAIP3
1155,GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),3/350,0.9105279196736626,0.9734603715091448,0,0,0.5447249105877273,0.0510574559866353,SLF2;DDIT3;KMT5B
1156,GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),2/258,0.9114608710433224,0.9734603715091448,0,0,0.4929484577922078,0.0456995823381771,SNAI1;BRINP3
1157,GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.91202840631682,0.9734603715091448,0,0,0.4105409153952843,0.0378043079975513,CAPN3
1158,GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.9134025857085591,0.9740859326451932,0,0,0.4078713853220587,0.0369443975979388,PCK1
1159,GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.9144121645988248,0.9743219271070236,0,0,0.5384058576240986,0.0481732520635106,DDIT3;VPS37C;TNFAIP3
1160,GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),1/158,0.9160870824896888,0.9744265352472078,0,0,0.4026343454331829,0.0352884244201995,RAB35
1161,GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.9160870824896888,0.9744265352472078,0,0,0.4026343454331829,0.0352884244201995,STC1
1162,GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.9199590778408612,0.9777037147130734,0,0,0.3950242718446602,0.0329553306668705,NRG1
1163,GO_Biological_Process_2021,double-strand break repair (GO:0006302),1/164,0.9236529523478044,0.9799442481561256,0,0,0.387694323664304,0.0307902453196651,PPP5C
1164,GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.9236529523478044,0.9799442481561256,0,0,0.387694323664304,0.0307902453196651,CRELD1
1165,GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.9248460842962826,0.9803685764924572,0,0,0.3853106006788223,0.0301035276025883,LRRC4C
1166,GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.9277972781002108,0.9815205055760408,0,0,0.4635695187165775,0.0347408363204711,GPNMB;TMEM106A
1167,GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.9277972781002108,0.9815205055760408,0,0,0.4635695187165775,0.0347408363204711,SCN9A;ASIC3
1168,GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.9283151060019352,0.9815205055760408,0,0,0.3783307172063639,0.0281417709662647,NRG1
1169,GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.929435602613139,0.9818653032733672,0,0,0.3760594852827862,0.0275191892445974,PCK1
1170,GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.9326934172908456,0.9844654686349148,0,0,0.3694051742084445,0.0257396837511326,GPNMB
1171,GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.9358012828354234,0.9844738780595648,0,0,0.3629803221366663,0.0240845174156384,BNIP3L
1172,GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.9377932991396573,0.9844738780595648,0,0,0.3588187702265372,0.0230453930241074,KMT5B
1173,GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),2/286,0.9381394736534426,0.9844738780595648,0,0,0.4437077007499542,0.0283336866548126,BNIP3L;FAM162A
1174,GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.9387660797959484,0.9844738780595648,0,0,0.3567732616605416,0.0225441267601663,BRINP3
1175,GO_Biological_Process_2021,regulation of translation (GO:0006417),1/178,0.9387660797959484,0.9844738780595648,0,0,0.3567732616605416,0.0225441267601663,EIF4A2
1176,GO_Biological_Process_2021,protein stabilization (GO:0050821),1/179,0.939723696051437,0.9844738780595648,0,0,0.3547507363368605,0.0220546359215192,CCT7
1177,GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.939723696051437,0.9844738780595648,0,0,0.3547507363368605,0.0220546359215192,ITGA4
1178,GO_Biological_Process_2021,RNA processing (GO:0006396),1/179,0.939723696051437,0.9844738780595648,0,0,0.3547507363368605,0.0220546359215192,WBP4
1179,GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.9406663834857169,0.9844738780595648,0,0,0.3527508090614886,0.0215766157105465,PCYOX1L
1180,GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.9406663834857169,0.9844738780595648,0,0,0.3527508090614886,0.0215766157105465,PPP1R3E
1181,GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),4/485,0.9449584421703504,0.9880381505659466,0,0,0.5220333455627574,0.0295545675718951,BNIP3L;ANXA4;CAPN3;MPO
1182,GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.9456708188669214,0.9880381505659466,0,0,0.4283947345171835,0.0239304477758103,CHMP1A;IL12A
1183,GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.9501144896405106,0.9909017062436672,0,0,0.3321410321921308,0.0169965820411985,NBR1
1184,GO_Biological_Process_2021,protein phosphorylation (GO:0006468),4/496,0.95101335053007,0.9909017062436672,0,0,0.5100696105000265,0.0256193571817207,NIM1K;PRKG2;PCK1;PDK1
1185,GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.9515694807796634,0.9909017062436672,0,0,0.4700545054302354,0.0233347148871478,PLAT;NRG1;SH2D6
1186,GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),2/306,0.9523259273326526,0.9909017062436672,0,0,0.4140892002734108,0.0202274052954486,NAPA;SLC17A6
1187,GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.952420086583719,0.9909017062436672,0,0,0.3269279138789677,0.0159374330992846,TET1
1188,GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.9553298081319672,0.991052563855684,0,0,0.3202240730701625,0.0146338076098658,GALNT11
1189,GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),2/314,0.9570832412942908,0.991052563855684,0,0,0.4033050283050283,0.0176909386937769,HECTD2;TNFAIP3
1190,GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.9573950709265562,0.991052563855684,0,0,0.3153721682847896,0.0137310362770349,PCYOX1L
1191,GO_Biological_Process_2021,ncRNA processing (GO:0034470),1/201,0.9573950709265562,0.991052563855684,0,0,0.3153721682847896,0.0137310362770349,PUS10
1192,GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.9580621169221336,0.991052563855684,0,0,0.313787051796036,0.0134434728832093,BHLHE40
1193,GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",26/2244,0.9583869393686548,0.991052563855684,0,0,0.721167401160797,0.0306522679049901,PLAG1;ZNF23;SPTY2D1;RLF;CHMP1A;BBX;CAPN3;ZNF226;ZNF644;ZNF564;ZNF442;ZNF263;BRPF1;ASCC1;ANXA4;NRG1;ZNF34;TRERF1;MED26;ZNF37A;DDIT3;BHLHE40;SNAI1;CREBRF;ZNF514;ZNF799
1194,GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),3/417,0.9584034769354788,0.991052563855684,0,0,0.4549874899683708,0.0193307913103547,GALNT11;ADORA2A;PLAT
1195,GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.9600014337273212,0.991052563855684,0,0,0.3091249444761723,0.0126186351222433,DDIT3
1196,GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.9606277971681813,0.991052563855684,0,0,0.3076012313521193,0.0123558040448066,TNFAIP3
1197,GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",9/948,0.9608047614127704,0.991052563855684,0,0,0.5970832050778555,0.023873806250587,ZNF263;EDNRB;DDIT3;BHLHE40;CHMP1A;SNAI1;CAPN3;NRG1;TRERF1
1198,GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),2/322,0.9613851327370267,0.991052563855684,0,0,0.3930600649350649,0.0154787791825421,GPNMB;NUDT12
1199,GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.9652991813814846,0.99425482681825,0,0,0.2959265843171217,0.0104512963435398,GPNMB
1200,GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.9663779796633758,0.99425482681825,0,0,0.2931436742680816,0.0100255834297882,ITGA4
1201,GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.9669047749478452,0.99425482681825,0,0,0.2917715450077909,0.0098196481110585,ITGA4
1202,GO_Biological_Process_2021,intracellular protein transport (GO:0006886),2/336,0.9679388169196744,0.9944907545409124,0,0,0.3763123104440469,0.0122626632339508,NAPA;TBC1D10B
1203,GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.9715622711871305,0.9960355126232452,0,0,0.4618093239755927,0.0133231593915968,PPP5C;DDIT3;NRG1;TMEM106A
1204,GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.9715728567517842,0.9960355126232452,0,0,0.3662678429442277,0.0105628052427148,SNAI1;KMT5B
1205,GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.9730490383733336,0.9960355126232452,0,0,0.2750243778352482,0.0075138857237611,ADORA2A
1206,GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),8/908,0.9731728106598893,0.9960355126232452,0,0,0.5530537159676232,0.0150395251495645,ZNF263;TFR2;PLAG1;DDIT3;CREBRF;TET1;TRERF1;RLF
1207,GO_Biological_Process_2021,regulation of autophagy (GO:0010506),1/231,0.9734716013340452,0.9960355126232452,0,0,0.2738145490361615,0.0073619494586763,DDIT3
1208,GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),6/742,0.9751294123725884,0.9969064960235894,0,0,0.5082773169336384,0.0128010080169295,BNIP3L;FAM162A;ANXA4;OSGIN1;CAPN3;MPO
1209,GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.9762502559859284,0.9972275342137252,0,0,0.2656316141630139,0.0063848053152847,GPNMB
1210,GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",11/1183,0.9782018217672128,0.9983959138763628,0,0,0.5812834590843198,0.0128110622362301,ZNF263;BRPF1;TFR2;PLAG1;DDIT3;SNAI1;CREBRF;TET1;CAPN3;TRERF1;RLF
1211,GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),6/764,0.9800497766555978,0.9992582198731508,0,0,0.4929523677267046,0.0099339347565644,GPNMB;OSGIN1;TET1;NRG1;PLPP1;FUT3
1212,GO_Biological_Process_2021,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",1/251,0.9806636089855436,0.9992582198731508,0,0,0.2516504854368932,0.0049136731367478,WBP4
1213,GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),5/684,0.9823759711722048,0.9999442920155258,0,0,0.4589922499336053,0.0081614243654988,ZNF263;EDNRB;DDIT3;BHLHE40;SNAI1
1214,GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),1/266,0.9847494473667232,0.9999442920155258,0,0,0.2372229346034072,0.0036456511500145,GPNMB
1215,GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.9849889779257286,0.9999442920155258,0,0,0.2363189527216098,0.003574283464792,TNFAIP3
1216,GO_Biological_Process_2021,"mRNA splicing, via spliceosome (GO:0000398)",1/274,0.9865638831586968,0.9999442920155258,0,0,0.2301765117299098,0.0031136433026964,WBP4
1217,GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.986982801649501,0.9999442920155258,0,0,0.2284789644012945,0.0029936832328403,TNFAIP3
1218,GO_Biological_Process_2021,DNA metabolic process (GO:0006259),1/277,0.9871873516989602,0.9999442920155258,0,0,0.2276394165376858,0.0029355100304754,KMT5B
1219,GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),23/2206,0.987317458033376,0.9999442920155258,0,0,0.6426935409986257,0.0082031166476656,ZNF263;PLAG1;ANXA4;TET1;ZNF23;ZNF34;TRERF1;MED26;RLF;EDNRB;ZNF37A;TFR2;DDIT3;BHLHE40;SNAI1;CREBRF;BBX;ZNF514;ZNF799;ZNF226;ZNF644;ZNF564;ZNF442
1220,GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.9911010035903696,0.9999442920155258,0,0,0.2098797501921182,0.0018760791906994,ITGA4
1221,GO_Biological_Process_2021,mRNA processing (GO:0006397),1/300,0.9911010035903696,0.9999442920155258,0,0,0.2098797501921182,0.0018760791906994,WBP4
1222,GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.9928730579757328,0.9999442920155258,0,0,0.200347405316542,0.0014329768008751,PPP5C
1223,GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.9936223377388158,0.9999442920155258,0,0,0.1958940129449838,0.0012533468268111,DDIT3
1224,GO_Biological_Process_2021,regulation of gene expression (GO:0010468),8/1079,0.9948144809973636,0.9999442920155258,0,0,0.4605215154494468,0.0023942561789494,ZNF263;ZNF37A;ASCC1;PLAG1;DDIT3;BHLHE40;SPTY2D1;MED26
1225,GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.9951871982951772,0.9999442920155258,0,0,0.2643902707462029,0.0012755298499448,TET1;NRG1
1226,GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),2/482,0.995700544568242,0.9999442920155258,0,0,0.2598755411255411,0.0011197321547224,TFR2;MED26
1227,GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),1/351,0.9960395282661954,0.9999442920155258,0,0,0.1788257050392972,0.0007096403347496868,CAPN3
1228,GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.9963420607230492,0.9999442920155258,0,0,0.176261452208396,0.0006459358075927593,PPP5C
1229,GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),3/625,0.9969213009604794,0.9999442920155258,0,0,0.2995695298344104,0.0009237070625237288,TET1;IL12A;NRG1
1230,GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.9971181835202793,0.9999442920155258,0,0,0.1689845184990816,0.0004876854181665717,GPNMB
1231,GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.9976565173323878,0.9999442920155258,0,0,0.1631389050842015,0.0003827618697619375,MED26
1232,GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.99950761644976,0.9999442920155258,0,0,0.1292412651635952,6.365194485036713e-05,IL12A
1233,GO_Biological_Process_2021,cellular protein modification process (GO:0006464),5/1025,0.9996783159761332,0.9999442920155258,0,0,0.300064288010286,9.654141633415682e-05,NIM1K;PPP5C;PRKG2;PLAT;PDK1
1234,GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.9997512581073894,0.9999442920155258,0,0,0.118370019022209,2.944724509352476e-05,HECTD2
1235,GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.9999442920155258,0.9999442920155258,0,0,0.0995406618644952,5.545364107660341e-06,IL12A
1236,GO_Cellular_Component_2021,catenin complex (GO:0016342),3/31,0.0120278233206415,0.9972312510038922,0,0,6.8620288506282,30.333822942920527,CDH12;CDH9;CDH18
1237,GO_Cellular_Component_2021,meiotic spindle (GO:0072687),1/5,0.0751414522316401,0.9972312510038922,0,0,15.927184466019416,41.225652108301766,TUBB8
1238,GO_Cellular_Component_2021,NURF complex (GO:0016589),1/5,0.0751414522316401,0.9972312510038922,0,0,15.927184466019416,41.225652108301766,HMGXB4
1239,GO_Cellular_Component_2021,phagocytic vesicle lumen (GO:0097013),1/5,0.0751414522316401,0.9972312510038922,0,0,15.927184466019416,41.225652108301766,MPO
1240,GO_Cellular_Component_2021,cytoplasmic side of lysosomal membrane (GO:0098574),1/5,0.0751414522316401,0.9972312510038922,0,0,15.927184466019416,41.225652108301766,BORCS5
1241,GO_Cellular_Component_2021,cytoplasmic vesicle lumen (GO:0060205),4/115,0.1038317631246644,0.9972312510038922,0,0,2.3057174821880704,5.222411711414474,GPI;PGAM1;ALDOC;ARHGAP45
1242,GO_Cellular_Component_2021,MOZ/MORF histone acetyltransferase complex (GO:0070776),1/8,0.1174966647628637,0.9972312510038922,0,0,9.0998613037448,19.485945513680495,BRPF1
1243,GO_Cellular_Component_2021,core mediator complex (GO:0070847),1/8,0.1174966647628637,0.9972312510038922,0,0,9.0998613037448,19.485945513680495,MED26
1244,GO_Cellular_Component_2021,HFE-transferrin receptor complex (GO:1990712),1/8,0.1174966647628637,0.9972312510038922,0,0,9.0998613037448,19.485945513680495,TFR2
1245,GO_Cellular_Component_2021,late endosome lumen (GO:0031906),1/9,0.1311809191989758,0.9972312510038922,0,0,7.961974110032362,16.172185422589365,IL12A
1246,GO_Cellular_Component_2021,H3 histone acetyltransferase complex (GO:0070775),1/9,0.1311809191989758,0.9972312510038922,0,0,7.961974110032362,16.172185422589365,BRPF1
1247,GO_Cellular_Component_2021,exocytic vesicle membrane (GO:0099501),2/41,0.1326187855651859,0.9972312510038922,0,0,3.271894771894772,6.610132250106194,SLC17A6;BORCS5
1248,GO_Cellular_Component_2021,synaptic vesicle membrane (GO:0030672),2/41,0.1326187855651859,0.9972312510038922,0,0,3.271894771894772,6.610132250106194,SLC17A6;BORCS5
1249,GO_Cellular_Component_2021,integral component of lysosomal membrane (GO:1905103),1/10,0.1446536576340862,0.9972312510038922,0,0,7.076950737144912,13.682668285085878,ATP10B
1250,GO_Cellular_Component_2021,ISWI-type complex (GO:0031010),1/10,0.1446536576340862,0.9972312510038922,0,0,7.076950737144912,13.682668285085878,HMGXB4
1251,GO_Cellular_Component_2021,primary lysosome (GO:0005766),1/11,0.157918138840558,0.9972312510038922,0,0,6.368932038834951,11.755000860858848,MPO
1252,GO_Cellular_Component_2021,integral component of postsynaptic density membrane (GO:0099061),1/11,0.157918138840558,0.9972312510038922,0,0,6.368932038834951,11.755000860858848,LRRC4C
1253,GO_Cellular_Component_2021,intrinsic component of postsynaptic density membrane (GO:0099146),1/11,0.157918138840558,0.9972312510038922,0,0,6.368932038834951,11.755000860858848,LRRC4C
1254,GO_Cellular_Component_2021,azurophil granule lumen (GO:0035578),3/90,0.1638050341612571,0.9972312510038922,0,0,2.2018420757048185,3.9833048831121856,GALNS;MPO;ARHGAP45
1255,GO_Cellular_Component_2021,integral component of vacuolar membrane (GO:0031166),1/12,0.1709775716126468,0.9972312510038922,0,0,5.789644012944984,10.225801787803793,ATP10B
1256,GO_Cellular_Component_2021,integral component of synaptic vesicle membrane (GO:0030285),1/13,0.1838351154563208,0.9972312510038922,0,0,5.306903991370011,8.98838838517707,SLC17A6
1257,GO_Cellular_Component_2021,pericentric heterochromatin (GO:0005721),1/14,0.196493881366796,0.9972312510038922,0,0,4.898431665421957,7.97035565776603,SNAI1
1258,GO_Cellular_Component_2021,"RNA polymerase II, core complex (GO:0005665)",1/15,0.2089569326358909,0.9972312510038922,0,0,4.548312528895053,7.12096140997213,POLR2J3
1259,GO_Cellular_Component_2021,integral component of postsynaptic specialization membrane (GO:0099060),1/15,0.2089569326358909,0.9972312510038922,0,0,4.548312528895053,7.12096140997213,LRRC4C
1260,GO_Cellular_Component_2021,secretory granule lumen (GO:0034774),7/316,0.2205327168397034,0.9972312510038922,0,0,1.449015775363944,2.1904905066904576,GALNS;GPI;PGAM1;PCYOX1L;ALDOC;MPO;ARHGAP45
1261,GO_Cellular_Component_2021,intrinsic component of synaptic vesicle membrane (GO:0098563),1/17,0.2333079096532855,0.9972312510038922,0,0,3.979368932038835,5.791558410833886,SLC17A6
1262,GO_Cellular_Component_2021,voltage-gated sodium channel complex (GO:0001518),1/17,0.2333079096532855,0.9972312510038922,0,0,3.979368932038835,5.791558410833886,SCN9A
1263,GO_Cellular_Component_2021,chromosome (GO:0005694),4/160,0.2368208135997051,0.9972312510038922,0,0,1.636835930953578,2.3577827467327643,SYCE3;SYCE1;HSF2BP;ANG
1264,GO_Cellular_Component_2021,vacuolar lumen (GO:0005775),4/161,0.2401580942903174,0.9972312510038922,0,0,1.6263269639065818,2.319886858306268,GALNS;GALC;MPO;ARHGAP45
1265,GO_Cellular_Component_2021,GABA-ergic synapse (GO:0098982),1/18,0.2452017295975243,0.9972312510038922,0,0,3.7450980392156863,5.264387020278373,SLITRK1
1266,GO_Cellular_Component_2021,condensed nuclear chromosome (GO:0000794),1/20,0.2684404297418134,0.9972312510038922,0,0,3.350536535513541,4.406378558844449,CHMP1A
1267,GO_Cellular_Component_2021,endocytic vesicle lumen (GO:0071682),1/21,0.2797909365950337,0.9972312510038922,0,0,3.182847896440129,4.05403350050483,MPO
1268,GO_Cellular_Component_2021,glutamatergic synapse (GO:0098978),2/69,0.2900154123246616,0.9972312510038922,0,0,1.9018220585384764,2.354115684494197,SLITRK1;LRRC4C
1269,GO_Cellular_Component_2021,ficolin-1-rich granule lumen (GO:1904813),3/123,0.2977376622667244,0.9972312510038922,0,0,1.5936482084690553,1.9307725476084583,GPI;PGAM1;ALDOC
1270,GO_Cellular_Component_2021,ficolin-1-rich granule (GO:0101002),4/184,0.319214566480028,0.9972312510038922,0,0,1.4168482207697894,1.61788733696301,GPI;PGAM1;SLC2A3;ALDOC
1271,GO_Cellular_Component_2021,excitatory synapse (GO:0060076),1/25,0.3234643246985458,0.9972312510038922,0,0,2.651833872707659,2.9930359237917226,SLC17A6
1272,GO_Cellular_Component_2021,sodium channel complex (GO:0034706),1/25,0.3234643246985458,0.9972312510038922,0,0,2.651833872707659,2.9930359237917226,SCN9A
1273,GO_Cellular_Component_2021,endosome lumen (GO:0031904),1/26,0.3339637349658846,0.9972312510038922,0,0,2.545631067961165,2.791851810425802,IL12A
1274,GO_Cellular_Component_2021,adherens junction (GO:0005912),3/132,0.3358902065965443,0.9972312510038922,0,0,1.4817816832058175,1.6165807535796275,CDH12;CDH9;CDH18
1275,GO_Cellular_Component_2021,myofibril (GO:0030016),1/27,0.3443007181490842,0.9972312510038922,0,0,2.447597709733632,2.609726148351675,CAPN3
1276,GO_Cellular_Component_2021,cyclin-dependent protein kinase holoenzyme complex (GO:0000307),1/30,0.374361960883141,0.9972312510038922,0,0,2.1940631625934603,2.1557375738800304,CCNI2
1277,GO_Cellular_Component_2021,transcription factor TFIID complex (GO:0005669),1/31,0.3840739012660074,0.9972312510038922,0,0,2.120819848975189,2.029455552760207,TAF4B
1278,GO_Cellular_Component_2021,lysosomal lumen (GO:0043202),2/86,0.38597635725198,0.9972312510038922,0,0,1.5156153370439085,1.442834218527579,GALNS;GALC
1279,GO_Cellular_Component_2021,nuclear membrane (GO:0031965),4/204,0.3894569212367249,0.9972312510038922,0,0,1.2738562091503267,1.2012489783551623,TEPSIN;WTAP;ANXA4;PHF11
1280,GO_Cellular_Component_2021,heterotrimeric G-protein complex (GO:0005834),1/33,0.4030492525689539,0.9972312510038922,0,0,1.9880663430420715,1.8065489469580225,GNA11
1281,GO_Cellular_Component_2021,azurophil granule (GO:0042582),3/155,0.4321588471412042,0.9972312510038922,0,0,1.2560860620606893,1.053808545903061,GALNS;MPO;ARHGAP45
1282,GO_Cellular_Component_2021,serine/threonine protein kinase complex (GO:1902554),1/37,0.4392695072225643,0.9972312510038922,0,0,1.7668104998202083,1.453452775148989,CCNI2
1283,GO_Cellular_Component_2021,neuromuscular junction (GO:0031594),1/38,0.4479769209098388,0.9972312510038922,0,0,1.718971398583049,1.3803573487095977,ASCC1
1284,GO_Cellular_Component_2021,membrane raft (GO:0045121),3/163,0.4645515257447387,0.9972312510038922,0,0,1.1927931596091206,0.9144939988935982,PGK1;MAL;PLPP1
1285,GO_Cellular_Component_2021,sarcoplasmic reticulum (GO:0016529),1/45,0.5052690709932667,0.9972312510038922,0,0,1.4449838187702266,0.9864386905080664,FSD2
1286,GO_Cellular_Component_2021,vacuolar membrane (GO:0005774),1/45,0.5052690709932667,0.9972312510038922,0,0,1.4449838187702266,0.9864386905080664,NAPA
1287,GO_Cellular_Component_2021,multivesicular body (GO:0005771),1/47,0.5205212618421974,0.9972312510038922,0,0,1.382017728999578,0.9023532939606308,CHMP1A
1288,GO_Cellular_Component_2021,microbody lumen (GO:0031907),1/49,0.5353047075113027,0.9972312510038922,0,0,1.3242988133764833,0.827579685445765,NUDT12
1289,GO_Cellular_Component_2021,peroxisomal matrix (GO:0005782),1/49,0.5353047075113027,0.9972312510038922,0,0,1.3242988133764833,0.827579685445765,NUDT12
1290,GO_Cellular_Component_2021,U2-type precatalytic spliceosome (GO:0071005),1/50,0.5425251558593591,0.9972312510038922,0,0,1.2972062611452349,0.7932686422257892,WBP4
1291,GO_Cellular_Component_2021,microbody membrane (GO:0031903),1/52,0.5566322724510143,0.9972312510038922,0,0,1.246208515768767,0.7300918199618688,NBR1
1292,GO_Cellular_Component_2021,basement membrane (GO:0005604),1/52,0.5566322724510143,0.9972312510038922,0,0,1.246208515768767,0.7300918199618688,ANG
1293,GO_Cellular_Component_2021,precatalytic spliceosome (GO:0071011),1/52,0.5566322724510143,0.9972312510038922,0,0,1.246208515768767,0.7300918199618688,WBP4
1294,GO_Cellular_Component_2021,late endosome (GO:0005770),3/189,0.5634976580277229,0.9972312510038922,0,0,1.0246926552485027,0.5877556136473379,CHMP1A;NBR1;IL12A
1295,GO_Cellular_Component_2021,peroxisomal membrane (GO:0005778),1/53,0.5635223674103828,0.9972312510038922,0,0,1.2221807318894695,0.7009796231018437,NBR1
1296,GO_Cellular_Component_2021,condensed chromosome (GO:0000793),1/54,0.5703057274985734,0.9972312510038922,0,0,1.1990596568358065,0.673371157044164,CHMP1A
1297,GO_Cellular_Component_2021,coated vesicle membrane (GO:0030662),1/55,0.5769840007874513,0.9972312510038922,0,0,1.1767949178952417,0.6471674693050772,TEPSIN
1298,GO_Cellular_Component_2021,tertiary granule lumen (GO:1904724),1/55,0.5769840007874513,0.9972312510038922,0,0,1.1767949178952417,0.6471674693050772,ALDOC
1299,GO_Cellular_Component_2021,peroxisome (GO:0005777),2/128,0.5925969969732754,0.9972312510038922,0,0,1.0082457225314367,0.5275552091231197,NBR1;NUDT12
1300,GO_Cellular_Component_2021,recycling endosome membrane (GO:0055038),1/58,0.5964044036339252,0.9972312510038922,0,0,1.1146880145347189,0.5761112429384591,RAB35
1301,GO_Cellular_Component_2021,caveola (GO:0005901),1/60,0.6088549977264024,0.9972312510038922,0,0,1.07679227689101,0.5342775572230495,PLPP1
1302,GO_Cellular_Component_2021,ficolin-1-rich granule membrane (GO:0101003),1/61,0.6149359682965099,0.9972312510038922,0,0,1.0587918015102482,0.5148238902084207,SLC2A3
1303,GO_Cellular_Component_2021,axon (GO:0030424),3/204,0.6152830745401698,0.9972312510038922,0,0,0.9474938013515484,0.460171999006806,SCN9A;PRSS12;MYPN
1304,GO_Cellular_Component_2021,platelet alpha granule lumen (GO:0031093),1/67,0.6494929575976018,0.9972312510038922,0,0,0.9622437971952535,0.4152690947967788,PCYOX1L
1305,GO_Cellular_Component_2021,motile cilium (GO:0031514),1/68,0.654944057271454,0.9972312510038922,0,0,0.9478336472974932,0.4011283706705182,CFAP61
1306,GO_Cellular_Component_2021,autophagosome (GO:0005776),1/69,0.6603106500811824,0.9972312510038922,0,0,0.9338473253379022,0.3875885443188478,NBR1
1307,GO_Cellular_Component_2021,clathrin-coated endocytic vesicle membrane (GO:0030669),1/69,0.6603106500811824,0.9972312510038922,0,0,0.9338473253379022,0.3875885443188478,RAB35
1308,GO_Cellular_Component_2021,tertiary granule membrane (GO:0070821),1/73,0.6809577702055623,0.9972312510038922,0,0,0.881787126932758,0.338831100291758,SLC2A3
1309,GO_Cellular_Component_2021,vesicle membrane (GO:0012506),1/73,0.6809577702055623,0.9972312510038922,0,0,0.881787126932758,0.338831100291758,ANXA4
1310,GO_Cellular_Component_2021,lipid droplet (GO:0005811),1/77,0.7003537047966828,0.9972312510038922,0,0,0.8352069494123658,0.2974754745825666,ABHD5
1311,GO_Cellular_Component_2021,collagen-containing extracellular matrix (GO:0062023),5/380,0.7045060250478288,0.9972312510038922,0,0,0.8443715846994535,0.295748236418231,ANXA4;SEMA3B;PLAT;ANG;CRELD1
1312,GO_Cellular_Component_2021,cilium (GO:0005929),3/237,0.7139925761677286,0.9972312510038922,0,0,0.81249477992149,0.2737154467501806,CFAP61;PDE4C;TXNDC15
1313,GO_Cellular_Component_2021,clathrin-coated vesicle (GO:0030136),1/80,0.7141252107290809,0.9972312510038922,0,0,0.8033673343984269,0.2704913447586785,RAB35
1314,GO_Cellular_Component_2021,P-body (GO:0000932),1/80,0.7141252107290809,0.9972312510038922,0,0,0.8033673343984269,0.2704913447586785,APOBEC3G
1315,GO_Cellular_Component_2021,plasma membrane raft (GO:0044853),1/82,0.7229538615816694,0.9972312510038922,0,0,0.7834511966119302,0.2541593040558922,PLPP1
1316,GO_Cellular_Component_2021,tertiary granule (GO:0070820),2/164,0.724882033913247,0.9972312510038922,0,0,0.7827481160814495,0.2518463487004211,SLC2A3;ALDOC
1317,GO_Cellular_Component_2021,nuclear chromosome (GO:0000228),1/83,0.7272657330730324,0.9972312510038922,0,0,0.7738574473123372,0.2464452336923573,CHMP1A
1318,GO_Cellular_Component_2021,coated vesicle (GO:0030135),1/84,0.7315107083873675,0.9972312510038922,0,0,0.7644948726946621,0.2390142913311652,TEPSIN
1319,GO_Cellular_Component_2021,clathrin-coated endocytic vesicle (GO:0045334),1/85,0.7356898221367492,0.9972312510038922,0,0,0.755355216520265,0.2318537807636771,RAB35
1320,GO_Cellular_Component_2021,Golgi membrane (GO:0000139),6/472,0.7431211016952762,0.9972312510038922,0,0,0.8142082674497402,0.2417353873314214,TEPSIN;GALNT11;RTN1;PLA2G4A;MANEA;FUT3
1321,GO_Cellular_Component_2021,U2-type spliceosomal complex (GO:0005684),1/89,0.7517677989390639,0.9972312510038922,0,0,0.720873786407767,0.2056853176553879,WBP4
1322,GO_Cellular_Component_2021,bounding membrane of organelle (GO:0098588),10/767,0.7548222320767624,0.9972312510038922,0,0,0.8336856010568031,0.2344932597866315,NAPA;TEPSIN;GALNT11;RTN1;RAB35;VPS37C;PLA2G4A;SLC2A3;MANEA;FUT3
1323,GO_Cellular_Component_2021,clathrin-coated vesicle membrane (GO:0030665),1/90,0.75563257316613,0.9972312510038922,0,0,0.7127377186284135,0.1997091339024779,RAB35
1324,GO_Cellular_Component_2021,platelet alpha granule (GO:0031091),1/90,0.75563257316613,0.9972312510038922,0,0,0.7127377186284135,0.1997091339024779,PCYOX1L
1325,GO_Cellular_Component_2021,specific granule membrane (GO:0035579),1/91,0.7594373666125999,0.9972312510038922,0,0,0.7047824523552679,0.193940221800787,SLC2A3
1326,GO_Cellular_Component_2021,neuron projection (GO:0043005),7/556,0.7620690187162156,0.9972312510038922,0,0,0.8054668854863628,0.2188599733429879,CPEB1;NRSN1;SCN9A;PRSS12;BRINP3;MYPN;STRN4
1327,GO_Cellular_Component_2021,cell projection membrane (GO:0031253),1/92,0.7631831071741136,0.9972312510038922,0,0,0.6970020270991145,0.1883698812676193,RAB35
1328,GO_Cellular_Component_2021,microtubule (GO:0005874),2/182,0.7762459352048493,0.9972312510038922,0,0,0.7038239538239538,0.1782686710572563,TUBB8;CCT7
1329,GO_Cellular_Component_2021,trans-Golgi network membrane (GO:0032588),1/99,0.7878248066711901,0.9972312510038922,0,0,0.6469850075952711,0.1542926872582235,TEPSIN
1330,GO_Cellular_Component_2021,phagocytic vesicle (GO:0045335),1/100,0.7911298578918188,0.9972312510038922,0,0,0.6404171161452715,0.150045346926481,MPO
1331,GO_Cellular_Component_2021,dendrite (GO:0030425),3/270,0.7920075435023277,0.9972312510038922,0,0,0.7108663031145921,0.1657629057777174,PRSS12;BRINP3;STRN4
1332,GO_Cellular_Component_2021,cell-cell junction (GO:0005911),3/271,0.7940680726897329,0.9972312510038922,0,0,0.7081773542709904,0.1632958454084508,CDH12;CDH9;CDH18
1333,GO_Cellular_Component_2021,cytoplasmic vesicle membrane (GO:0030659),4/380,0.8434168000653284,0.9972312510038922,0,0,0.6714643304130162,0.1143463590494752,TEPSIN;RAB35;VPS37C;SLC2A3
1334,GO_Cellular_Component_2021,integral component of organelle membrane (GO:0031301),2/214,0.8471124909349068,0.9972312510038922,0,0,0.5966062239647145,0.0989899679086101,RTN1;SLC17A6
1335,GO_Cellular_Component_2021,intrinsic component of endoplasmic reticulum membrane (GO:0031227),1/121,0.8498194537854125,0.9972312510038922,0,0,0.5277777777777778,0.0858859952234156,RTN1
1336,GO_Cellular_Component_2021,lytic vacuole (GO:0000323),2/219,0.8561405340398474,0.9972312510038922,0,0,0.5827099168112992,0.0905069360878573,GALC;MPO
1337,GO_Cellular_Component_2021,mitochondrial outer membrane (GO:0005741),1/126,0.8611707024472732,0.9972312510038922,0,0,0.506537216828479,0.0757083357510637,BNIP3L
1338,GO_Cellular_Component_2021,actin cytoskeleton (GO:0015629),3/316,0.8705500086453805,0.9972312510038922,0,0,0.6049578004183535,0.0838653441782519,TRMT10A;CAPZB;ANG
1339,GO_Cellular_Component_2021,trans-Golgi network (GO:0005802),2/239,0.8875901098223618,0.9972312510038922,0,0,0.5329881089374761,0.0635562899532566,TEPSIN;GCC2
1340,GO_Cellular_Component_2021,lysosomal membrane (GO:0005765),3/330,0.8886173385763391,0.9972312510038922,0,0,0.5786390939246332,0.0683306668687857,GNA11;ATP10B;BORCS5
1341,GO_Cellular_Component_2021,organelle outer membrane (GO:0031968),1/142,0.8920558596258995,0.9972312510038922,0,0,0.4486905827537928,0.0512523662763243,BNIP3L
1342,GO_Cellular_Component_2021,integral component of endoplasmic reticulum membrane (GO:0030176),1/142,0.8920558596258995,0.9972312510038922,0,0,0.4486905827537928,0.0512523662763243,RTN1
1343,GO_Cellular_Component_2021,recycling endosome (GO:0055037),1/145,0.8970328084744053,0.9972312510038922,0,0,0.4392754404890327,0.047732917701977,RAB35
1344,GO_Cellular_Component_2021,polymeric cytoskeletal fiber (GO:0099513),2/256,0.9091911269604572,0.9972312510038922,0,0,0.4968810716842213,0.0473030513039451,TUBB8;CCT7
1345,GO_Cellular_Component_2021,endocytic vesicle membrane (GO:0030666),1/158,0.9160870824896888,0.9972312510038922,0,0,0.4026343454331829,0.0352884244201995,RAB35
1346,GO_Cellular_Component_2021,specific granule (GO:0042581),1/160,0.9186886184063698,0.9972312510038922,0,0,0.3975290549754737,0.0337136602279971,SLC2A3
1347,GO_Cellular_Component_2021,early endosome (GO:0005769),2/266,0.9200196327124652,0.9972312510038922,0,0,0.4778138528138528,0.0398306914276239,EEA1;CHMP1A
1348,GO_Cellular_Component_2021,lysosome (GO:0005764),4/477,0.940134892101447,0.9972312510038922,0,0,0.5310837513299893,0.0327848152838143,GALNS;GALC;GNA11;MPO
1349,GO_Cellular_Component_2021,focal adhesion (GO:0005925),3/387,0.9410539556716254,0.9972312510038922,0,0,0.4912968241042345,0.0298486414625287,PPFIBP1;ITGA4;ARHGAP24
1350,GO_Cellular_Component_2021,cell-substrate junction (GO:0030055),3/394,0.945616739076164,0.9972312510038922,0,0,0.4823262827294917,0.0269706875165762,PPFIBP1;ITGA4;ARHGAP24
1351,GO_Cellular_Component_2021,endocytic vesicle (GO:0030139),1/189,0.948515888799418,0.9972312510038922,0,0,0.3357088755766715,0.0177444761630856,RAB35
1352,GO_Cellular_Component_2021,intracellular non-membrane-bounded organelle (GO:0043232),12/1158,0.9501664313812108,0.9972312510038922,0,0,0.6516040619839066,0.0333087738537266,SYCE3;SNAPC5;TRMT10A;SYCE1;CAPZB;CAPN3;HSF2BP;ALDOC;ANG;ABHD5;LETMD1;SPTY2D1
1353,GO_Cellular_Component_2021,spindle (GO:0005819),1/192,0.9508951367715076,0.9972312510038922,0,0,0.3303851302123045,0.0166353831811056,TUBB8
1354,GO_Cellular_Component_2021,endosome membrane (GO:0010008),2/325,0.962889388734696,0.9972312510038922,0,0,0.3893490410518274,0.014723909472164,RAB35;VPS37C
1355,GO_Cellular_Component_2021,mitochondrial inner membrane (GO:0005743),2/328,0.9643374256313818,0.9972312510038922,0,0,0.3857063182216556,0.014006546579135,PLA2G4A;CYP2E1
1356,GO_Cellular_Component_2021,nucleus (GO:0005634),57/4484,0.9651931731337569,0.9972312510038922,0,0,0.7767561790700436,0.0275181553419343,PUS10;JADE1;TNFAIP3;ZC3H6;PHF7;MPO;MYPN;DOCK10;SNAPC5;BBX;CAPN3;KMT5B;ZNF644;NUDT12;ZNF442;SLC2A14;BNIP3L;ANXA4;IPMK;PDE4C;PLA2G4A;TET1;DDIT3;CCNI2;ZNF514;ZNF799;ANG;NIM1K;WBP4;STC1;ZNF23;RLF;SYCE3;FSD2;ZNF226;TRMT10A;ZNF263;SLF2;BRPF1;APOBEC3G;WTAP;ASCC1;PHF11;ZNF34;TRERF1;OXR1;TDRD3;CPEB1;PPP5C;ZNF37A;BHLHE40;SNAI1;CREBRF;ARMC12;PKIG;FGF11;PFKP
1357,GO_Cellular_Component_2021,microtubule cytoskeleton (GO:0015630),2/331,0.965731216480588,0.9972312510038922,0,0,0.3821300280266845,0.0133247698687217,TUBB8;CCT7
1358,GO_Cellular_Component_2021,intracellular membrane-bounded organelle (GO:0043231),67/5192,0.9679202705402268,0.9972312510038922,0,0,0.7835832580548028,0.025549171125245,PUS10;SLC7A14;JADE1;TNFAIP3;ZC3H6;PHF7;MPO;MYPN;DOCK10;SNAPC5;BBX;CAPN3;KMT5B;ZNF644;NUDT12;BORCS5;ZNF442;SLC2A14;BNIP3L;ANXA4;IPMK;PDE4C;VPS37C;PLA2G4A;TET1;DDIT3;CCNI2;ZNF514;UGT2B4;ZNF799;ANG;CYP2E1;NIM1K;WBP4;STC1;ZNF23;ABHD5;RLF;SYCE3;SYCE1;ANO10;FSD2;ZNF226;SPECC1;TRMT10A;ZNF263;SLF2;BRPF1;APOBEC3G;WTAP;ASCC1;PHF11;ZNF34;TRERF1;OXR1;TDRD3;CPEB1;PPP5C;ZNF37A;BHLHE40;NBR1;SNAI1;CREBRF;ARMC12;PKIG;FGF11;PFKP
1359,GO_Cellular_Component_2021,vesicle (GO:0031982),1/226,0.9712906212263402,0.9972312510038922,0,0,0.2799712333692916,0.0081554373060147,ANXA4
1360,GO_Cellular_Component_2021,organelle inner membrane (GO:0019866),2/346,0.9719512716226296,0.9972312510038922,0,0,0.3651842343702808,0.010389348262238,PLA2G4A;CYP2E1
1361,GO_Cellular_Component_2021,nucleolus (GO:0005730),6/733,0.9728116432451064,0.9972312510038922,0,0,0.5148139433866648,0.0141907428952708,SNAPC5;TRMT10A;CAPN3;ANG;LETMD1;SPTY2D1
1362,GO_Cellular_Component_2021,nuclear lumen (GO:0031981),6/745,0.975860635456999,0.9972312510038922,0,0,0.5061338223773235,0.0123676301341106,SNAPC5;TRMT10A;CAPN3;ANG;LETMD1;SPTY2D1
1363,GO_Cellular_Component_2021,mitochondrial membrane (GO:0031966),3/469,0.9776913615069326,0.9972312510038922,0,0,0.4031259174343991,0.0090950205874969,BNIP3L;PLA2G4A;CYP2E1
1364,GO_Cellular_Component_2021,cytoskeleton (GO:0005856),4/600,0.984558699278981,0.9972312510038922,0,0,0.4187831732245471,0.0065170029146571,TRMT10A;CAPZB;ALDOC;ANG
1365,GO_Cellular_Component_2021,lytic vacuole membrane (GO:0098852),1/267,0.9849889779257286,0.9972312510038922,0,0,0.2363189527216098,0.003574283464792,GNA11
1366,GO_Cellular_Component_2021,secretory granule membrane (GO:0030667),1/274,0.9865638831586968,0.9972312510038922,0,0,0.2301765117299098,0.0031136433026964,SLC2A3
1367,GO_Cellular_Component_2021,endoplasmic reticulum membrane (GO:0005789),5/712,0.9869912289582758,0.9972312510038922,0,0,0.4401650937927516,0.0057635772672543,INSIG2;PLA2G4A;SLC35G1;CYP2E1;PIGV
1368,GO_Cellular_Component_2021,endoplasmic reticulum lumen (GO:0005788),1/285,0.9887124887073476,0.9972312510038922,0,0,0.2211358767491681,0.002510267848194,IL12A
1369,GO_Cellular_Component_2021,integral component of plasma membrane (GO:0005887),13/1454,0.9910020422413388,0.9972312510038922,0,0,0.5543218443981803,0.0050103399114432,SEMA3B;TACR3;SLC2A3;SEMA3E;PCDH18;OPN1SW;EDNRB;GPNMB;ADORA2A;TFR2;SCN9A;ASIC3;PLPP1
1370,GO_Cellular_Component_2021,mitochondrial matrix (GO:0005759),1/348,0.9958461585647532,0.9972312510038922,0,0,0.1803997276703692,0.0007509125314585516,PDK1
1371,GO_Cellular_Component_2021,intracellular organelle lumen (GO:0070013),5/848,0.9972312510038922,0.9972312510038922,0,0,0.366509149602318,0.0010161792627495,GPI;PGAM1;IL12A;ALDOC;PDK1
1372,GO_Molecular_Function_2021,alpha-(1->3)-fucosyltransferase activity (GO:0046920),2/8,0.0063041434540528,0.5875372783554954,0,0,21.303030303030305,107.93282921110205,FUT11;FUT3
1373,GO_Molecular_Function_2021,chemorepellent activity (GO:0045499),3/25,0.0065886252410609,0.5875372783554954,0,0,8.73615635179153,43.87656395977364,SEMA3B;SEMA3E;NRG1
1374,GO_Molecular_Function_2021,fucosyltransferase activity (GO:0008417),2/12,0.0142644808921906,0.5875372783554954,0,0,12.77922077922078,54.31146704320471,FUT11;FUT3
1375,GO_Molecular_Function_2021,hexose transmembrane transporter activity (GO:0015149),2/15,0.0220112459999045,0.5875372783554954,0,0,9.828671328671328,37.508192964655606,SLC2A14;SLC2A3
1376,GO_Molecular_Function_2021,glucose transmembrane transporter activity (GO:0005355),2/21,0.0414303261062344,0.5875372783554954,0,0,6.72282980177717,21.403756618390524,SLC2A14;SLC2A3
1377,GO_Molecular_Function_2021,calcium-dependent phospholipid binding (GO:0005544),3/50,0.0423559096851941,0.5875372783554954,0,0,4.084066809896735,12.912378899302078,CPNE8;ANXA4;PLA2G4A
1378,GO_Molecular_Function_2021,semaphorin receptor binding (GO:0030215),2/23,0.0489194015753988,0.5875372783554954,0,0,6.081941867656154,18.352753445150903,SEMA3B;SEMA3E
1379,GO_Molecular_Function_2021,cell adhesion mediator activity (GO:0098631),2/24,0.0528334953660874,0.5875372783554954,0,0,5.805194805194805,17.070813358958546,LRRC4C;MYPN
1380,GO_Molecular_Function_2021,NF-kappaB binding (GO:0051059),2/25,0.0568547943063738,0.5875372783554954,0,0,5.552512704686618,15.920468314650924,ANXA4;TAF4B
1381,GO_Molecular_Function_2021,ADP binding (GO:0043531),2/27,0.0652021540906028,0.5875372783554954,0,0,5.107792207792208,13.945614914068672,PPP5C;PGK1
1382,GO_Molecular_Function_2021,histone methyltransferase activity (H4-K20 specific) (GO:0042799),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,KMT5B
1383,GO_Molecular_Function_2021,syndecan binding (GO:0045545),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,GPNMB
1384,GO_Molecular_Function_2021,mannokinase activity (GO:0019158),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,HK1
1385,GO_Molecular_Function_2021,C-X3-C chemokine binding (GO:0019960),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,ITGA4
1386,GO_Molecular_Function_2021,"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor (GO:0016668)",1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,PGK1
1387,GO_Molecular_Function_2021,phosphatidylcholine flippase activity (GO:0140345),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,ATP10B
1388,GO_Molecular_Function_2021,"endoribonuclease activity, producing 3'-phosphomonoesters (GO:0016892)",1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,RNASE4
1389,GO_Molecular_Function_2021,ErbB-3 class receptor binding (GO:0043125),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,NRG1
1390,GO_Molecular_Function_2021,fructokinase activity (GO:0008865),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,HK1
1391,GO_Molecular_Function_2021,glucokinase activity (GO:0004340),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,HK1
1392,GO_Molecular_Function_2021,pyruvate dehydrogenase (acetyl-transferring) kinase activity (GO:0004740),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,PDK1
1393,GO_Molecular_Function_2021,hexokinase activity (GO:0004396),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,HK1
1394,GO_Molecular_Function_2021,histone acetyltransferase activity (H3-K23 specific) (GO:0043994),1/5,0.0751414522316401,0.5875372783554954,0,0,15.927184466019416,41.225652108301766,BRPF1
1395,GO_Molecular_Function_2021,chemoattractant activity (GO:0042056),2/32,0.0876624472805498,0.5875372783554954,0,0,4.255411255411255,10.358784494284608,COLEC10;GPNMB
1396,GO_Molecular_Function_2021,4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity (GO:0017083),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,FUT3
1397,GO_Molecular_Function_2021,interleukin-12 receptor binding (GO:0005143),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,IL12A
1398,GO_Molecular_Function_2021,sodium ion binding (GO:0031402),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,CAPN3
1399,GO_Molecular_Function_2021,arylesterase activity (GO:0004064),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,CA2
1400,GO_Molecular_Function_2021,dehydroascorbic acid transmembrane transporter activity (GO:0033300),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,SLC2A14
1401,GO_Molecular_Function_2021,primary miRNA binding (GO:0070878),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,PUS10
1402,GO_Molecular_Function_2021,G protein-coupled serotonin receptor binding (GO:0031821),1/6,0.08948031840285,0.5875372783554954,0,0,12.741100323624597,30.75365997151672,GNA11
1403,GO_Molecular_Function_2021,Hsp90 protein binding (GO:0051879),2/35,0.1020815695391435,0.5875372783554954,0,0,3.867965367965368,8.82663153890268,PPP5C;CYP2E1
1404,GO_Molecular_Function_2021,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides (GO:0016818)",1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,NUDT12
1405,GO_Molecular_Function_2021,sphingosine-1-phosphate phosphatase activity (GO:0042392),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,PLPP1
1406,GO_Molecular_Function_2021,alpha-mannosidase activity (GO:0004559),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,MANEA
1407,GO_Molecular_Function_2021,transmembrane receptor protein tyrosine kinase activator activity (GO:0030297),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,NRG1
1408,GO_Molecular_Function_2021,ceramide 1-phosphate binding (GO:1902387),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,PLA2G4A
1409,GO_Molecular_Function_2021,"oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor (GO:0016670)",1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,PCYOX1L
1410,GO_Molecular_Function_2021,oxysterol binding (GO:0008142),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,INSIG2
1411,GO_Molecular_Function_2021,phosphofructokinase activity (GO:0008443),1/7,0.1035975848403304,0.5875372783554954,0,0,10.617044228694716,24.071400753445328,PFKP
1412,GO_Molecular_Function_2021,receptor ligand activity (GO:0048018),8/307,0.1061056587582282,0.5875372783554954,0,0,1.7179561009103193,3.853925109508873,COLEC10;GPNMB;SEMA3B;OSGIN1;IL12A;GAST;NRG1;SEMA3E
1413,GO_Molecular_Function_2021,hexosyltransferase activity (GO:0016758),4/119,0.1138846221350282,0.5875372783554954,0,0,2.2250639386189257,4.8341058920109,GBE1;UGT2B4;PIGV;FUT3
1414,GO_Molecular_Function_2021,sodium channel activity (GO:0005272),2/38,0.1170950916663663,0.5875372783554954,0,0,3.5450937950937957,7.603407007931216,SCN9A;ASIC3
1415,GO_Molecular_Function_2021,"intramolecular oxidoreductase activity, interconverting aldoses and ketoses (GO:0016861)",1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,GPI
1416,GO_Molecular_Function_2021,aldehyde-lyase activity (GO:0016832),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,ALDOC
1417,GO_Molecular_Function_2021,lysophospholipid acyltransferase activity (GO:0071617),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,ABHD5
1418,GO_Molecular_Function_2021,calcium-independent phospholipase A2 activity (GO:0047499),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,PLA2G4A
1419,GO_Molecular_Function_2021,cAMP-dependent protein kinase inhibitor activity (GO:0004862),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,PKIG
1420,GO_Molecular_Function_2021,deoxycytidine deaminase activity (GO:0047844),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,APOBEC3G
1421,GO_Molecular_Function_2021,glycogen binding (GO:2001069),1/8,0.1174966647628637,0.5875372783554954,0,0,9.0998613037448,19.485945513680495,PPP1R3E
1422,GO_Molecular_Function_2021,"intramolecular transferase activity, phosphotransferases (GO:0016868)",1/9,0.1311809191989758,0.5875372783554954,0,0,7.961974110032362,16.172185422589365,PGAM1
1423,GO_Molecular_Function_2021,armadillo repeat domain binding (GO:0070016),1/9,0.1311809191989758,0.5875372783554954,0,0,7.961974110032362,16.172185422589365,STRN4
1424,GO_Molecular_Function_2021,mannosidase activity (GO:0015923),1/9,0.1311809191989758,0.5875372783554954,0,0,7.961974110032362,16.172185422589365,MANEA
1425,GO_Molecular_Function_2021,cAMP response element binding protein binding (GO:0008140),1/9,0.1311809191989758,0.5875372783554954,0,0,7.961974110032362,16.172185422589365,DDIT3
1426,GO_Molecular_Function_2021,H3 histone acetyltransferase activity (GO:0010484),1/9,0.1311809191989758,0.5875372783554954,0,0,7.961974110032362,16.172185422589365,BRPF1
1427,GO_Molecular_Function_2021,E-box binding (GO:0070888),2/41,0.1326187855651859,0.5875372783554954,0,0,3.271894771894772,6.610132250106194,BHLHE40;SNAI1
1428,GO_Molecular_Function_2021,cell-cell adhesion mediator activity (GO:0098632),2/42,0.1378930968780586,0.5875372783554954,0,0,3.189935064935065,6.320143554001186,LRRC4C;MYPN
1429,GO_Molecular_Function_2021,leucine zipper domain binding (GO:0043522),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,DDIT3
1430,GO_Molecular_Function_2021,ligand-gated sodium channel activity (GO:0015280),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,ASIC3
1431,GO_Molecular_Function_2021,lipase inhibitor activity (GO:0055102),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,ANXA4
1432,GO_Molecular_Function_2021,Lys63-specific deubiquitinase activity (GO:0061578),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,TNFAIP3
1433,GO_Molecular_Function_2021,cAMP-dependent protein kinase regulator activity (GO:0008603),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,PKIG
1434,GO_Molecular_Function_2021,phospholipase inhibitor activity (GO:0004859),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,ANXA4
1435,GO_Molecular_Function_2021,fatty acid synthase activity (GO:0004312),1/10,0.1446536576340862,0.5875372783554954,0,0,7.076950737144912,13.682668285085878,OXSM
1436,GO_Molecular_Function_2021,growth factor activity (GO:0008083),3/87,0.1526409845215433,0.5875372783554954,0,0,2.280828292228944,4.287196809922661,OSGIN1;IL12A;NRG1
1437,GO_Molecular_Function_2021,AMP binding (GO:0016208),1/11,0.157918138840558,0.5875372783554954,0,0,6.368932038834951,11.755000860858848,PFKP
1438,GO_Molecular_Function_2021,transaminase activity (GO:0008483),1/11,0.157918138840558,0.5875372783554954,0,0,6.368932038834951,11.755000860858848,BCAT1
1439,GO_Molecular_Function_2021,carbohydrate kinase activity (GO:0019200),1/11,0.157918138840558,0.5875372783554954,0,0,6.368932038834951,11.755000860858848,HK1
1440,GO_Molecular_Function_2021,carbonate dehydratase activity (GO:0004089),1/11,0.157918138840558,0.5875372783554954,0,0,6.368932038834951,11.755000860858848,CA2
1441,GO_Molecular_Function_2021,heme binding (GO:0020037),3/91,0.1675795755577109,0.5875372783554954,0,0,2.17671009771987,3.88825063596189,PXDNL;CYP2E1;HBQ1
1442,GO_Molecular_Function_2021,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",1/12,0.1709775716126468,0.5875372783554954,0,0,5.789644012944984,10.225801787803793,PDE4C
1443,GO_Molecular_Function_2021,cAMP binding (GO:0030552),1/12,0.1709775716126468,0.5875372783554954,0,0,5.789644012944984,10.225801787803793,RAPGEF4
1444,GO_Molecular_Function_2021,cytidine deaminase activity (GO:0004126),1/12,0.1709775716126468,0.5875372783554954,0,0,5.789644012944984,10.225801787803793,APOBEC3G
1445,GO_Molecular_Function_2021,phosphatidylinositol 3-kinase activity (GO:0035004),1/12,0.1709775716126468,0.5875372783554954,0,0,5.789644012944984,10.225801787803793,IPMK
1446,GO_Molecular_Function_2021,glycerophospholipid flippase activity (GO:0140333),1/12,0.1709775716126468,0.5875372783554954,0,0,5.789644012944984,10.225801787803793,ATP10B
1447,GO_Molecular_Function_2021,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,ABHD5
1448,GO_Molecular_Function_2021,alkali metal ion binding (GO:0031420),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,CAPN3
1449,GO_Molecular_Function_2021,titin binding (GO:0031432),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,CAPN3
1450,GO_Molecular_Function_2021,tRNA (guanine) methyltransferase activity (GO:0016423),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,TRMT10A
1451,GO_Molecular_Function_2021,phosphatidate phosphatase activity (GO:0008195),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,PLPP1
1452,GO_Molecular_Function_2021,pseudouridine synthase activity (GO:0009982),1/13,0.1838351154563208,0.5875372783554954,0,0,5.306903991370011,8.98838838517707,PUS10
1453,GO_Molecular_Function_2021,carboxylic ester hydrolase activity (GO:0052689),3/96,0.1868166250976092,0.5875372783554954,0,0,2.059157297467689,3.4544994396935422,CA2;PLA2G4A;ABHD5
1454,GO_Molecular_Function_2021,L-glutamate transmembrane transporter activity (GO:0005313),1/14,0.196493881366796,0.5875372783554954,0,0,4.898431665421957,7.97035565776603,SLC17A6
1455,GO_Molecular_Function_2021,lipid phosphatase activity (GO:0042577),1/14,0.196493881366796,0.5875372783554954,0,0,4.898431665421957,7.97035565776603,PLPP1
1456,GO_Molecular_Function_2021,LRR domain binding (GO:0030275),1/14,0.196493881366796,0.5875372783554954,0,0,4.898431665421957,7.97035565776603,DDIT3
1457,GO_Molecular_Function_2021,arylsulfatase activity (GO:0004065),1/14,0.196493881366796,0.5875372783554954,0,0,4.898431665421957,7.97035565776603,GALNS
1458,GO_Molecular_Function_2021,nucleoside diphosphate kinase activity (GO:0004550),1/14,0.196493881366796,0.5875372783554954,0,0,4.898431665421957,7.97035565776603,NME3
1459,GO_Molecular_Function_2021,1-phosphatidylinositol binding (GO:0005545),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,EEA1
1460,GO_Molecular_Function_2021,acidic amino acid transmembrane transporter activity (GO:0015172),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,SLC17A6
1461,GO_Molecular_Function_2021,lysophosphatidic acid acyltransferase activity (GO:0042171),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,ABHD5
1462,GO_Molecular_Function_2021,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,CAPN3
1463,GO_Molecular_Function_2021,muscle alpha-actinin binding (GO:0051371),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,MYPN
1464,GO_Molecular_Function_2021,nucleotide diphosphatase activity (GO:0004551),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,NUDT12
1465,GO_Molecular_Function_2021,peptidoglycan binding (GO:0042834),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,HK1
1466,GO_Molecular_Function_2021,G protein-coupled photoreceptor activity (GO:0008020),1/15,0.2089569326358909,0.5875372783554954,0,0,4.548312528895053,7.12096140997213,OPN1SW
1467,GO_Molecular_Function_2021,hydro-lyase activity (GO:0016836),2/55,0.2096787313090243,0.5875372783554954,0,0,2.4059054153393777,3.758454363892761,CA2;ENO2
1468,GO_Molecular_Function_2021,arachidonic acid epoxygenase activity (GO:0008392),1/16,0.2212272854003253,0.5920738461956021,0,0,4.24487594390507,6.403669857225148,CYP2E1
1469,GO_Molecular_Function_2021,calcium-dependent phospholipase A2 activity (GO:0047498),1/16,0.2212272854003253,0.5920738461956021,0,0,4.24487594390507,6.403669857225148,PLA2G4A
1470,GO_Molecular_Function_2021,phosphatidylinositol-5-phosphate binding (GO:0010314),1/16,0.2212272854003253,0.5920738461956021,0,0,4.24487594390507,6.403669857225148,PLA2G4A
1471,GO_Molecular_Function_2021,serine-type endopeptidase activity (GO:0004252),3/105,0.2227369171293833,0.5920738461956021,0,0,1.8766047135466564,2.8182173030421027,KLK14;PLAT;PRSS12
1472,GO_Molecular_Function_2021,intracellular calcium activated chloride channel activity (GO:0005229),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,ANO10
1473,GO_Molecular_Function_2021,intracellular chloride channel activity (GO:0061778),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,ANO10
1474,GO_Molecular_Function_2021,adrenergic receptor binding (GO:0031690),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,ARRDC3
1475,GO_Molecular_Function_2021,sulfuric ester hydrolase activity (GO:0008484),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,GALNS
1476,GO_Molecular_Function_2021,nucleobase-containing compound kinase activity (GO:0019205),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,NME3
1477,GO_Molecular_Function_2021,peptidase activator activity involved in apoptotic process (GO:0016505),1/17,0.2333079096532855,0.5920738461956021,0,0,3.979368932038835,5.791558410833886,MAL
1478,GO_Molecular_Function_2021,nuclease activity (GO:0004518),2/60,0.2382534656606133,0.5989736660065887,0,0,2.197939991043439,3.1527695000757845,RNASE4;ANG
1479,GO_Molecular_Function_2021,phosphatidylcholine transporter activity (GO:0008525),1/18,0.2452017295975243,0.6107339376086486,0,0,3.7450980392156863,5.264387020278373,ATP10B
1480,GO_Molecular_Function_2021,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",1/19,0.2569116245754598,0.6170466697392741,0,0,3.536857245595109,4.80667079179423,APOBEC3G
1481,GO_Molecular_Function_2021,arachidonic acid monooxygenase activity (GO:0008391),1/19,0.2569116245754598,0.6170466697392741,0,0,3.536857245595109,4.80667079179423,CYP2E1
1482,GO_Molecular_Function_2021,calcium activated cation channel activity (GO:0005227),1/19,0.2569116245754598,0.6170466697392741,0,0,3.536857245595109,4.80667079179423,ANO10
1483,GO_Molecular_Function_2021,protein tyrosine kinase activator activity (GO:0030296),1/19,0.2569116245754598,0.6170466697392741,0,0,3.536857245595109,4.80667079179423,NRG1
1484,GO_Molecular_Function_2021,acylglycerol O-acyltransferase activity (GO:0016411),1/20,0.2684404297418134,0.6279342149751724,0,0,3.350536535513541,4.406378558844449,ABHD5
1485,GO_Molecular_Function_2021,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (GO:0016712)",1/20,0.2684404297418134,0.6279342149751724,0,0,3.350536535513541,4.406378558844449,CYP2E1
1486,GO_Molecular_Function_2021,ribonuclease activity (GO:0004540),2/66,0.2727642300896944,0.6279342149751724,0,0,1.9912743506493509,2.5869590605728727,RNASE4;ANG
1487,GO_Molecular_Function_2021,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",1/21,0.2797909365950337,0.6279342149751724,0,0,3.182847896440129,4.05403350050483,PDE4C
1488,GO_Molecular_Function_2021,lysophospholipase activity (GO:0004622),1/21,0.2797909365950337,0.6279342149751724,0,0,3.182847896440129,4.05403350050483,PLA2G4A
1489,GO_Molecular_Function_2021,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,TNFAIP3
1490,GO_Molecular_Function_2021,mannosyltransferase activity (GO:0000030),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,PIGV
1491,GO_Molecular_Function_2021,bHLH transcription factor binding (GO:0043425),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,BHLHE40
1492,GO_Molecular_Function_2021,mRNA 3'-UTR AU-rich region binding (GO:0035925),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,CPEB1
1493,GO_Molecular_Function_2021,voltage-gated sodium channel activity (GO:0005248),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,SCN9A
1494,GO_Molecular_Function_2021,peptidase activator activity (GO:0016504),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,MAL
1495,GO_Molecular_Function_2021,retinoic acid binding (GO:0001972),1/22,0.2909658938246858,0.6279342149751724,0,0,3.031129603945138,3.7420786944258726,UGT2B4
1496,GO_Molecular_Function_2021,triglyceride lipase activity (GO:0004806),1/23,0.3019680078501122,0.6279342149751724,0,0,2.8932038834951457,3.4644212819803437,ABHD5
1497,GO_Molecular_Function_2021,cyclic nucleotide binding (GO:0030551),1/23,0.3019680078501122,0.6279342149751724,0,0,2.8932038834951457,3.4644212819803437,RAPGEF4
1498,GO_Molecular_Function_2021,cyclic-nucleotide phosphodiesterase activity (GO:0004112),1/23,0.3019680078501122,0.6279342149751724,0,0,2.8932038834951457,3.4644212819803437,PDE4C
1499,GO_Molecular_Function_2021,protein phosphatase 1 binding (GO:0008157),1/23,0.3019680078501122,0.6279342149751724,0,0,2.8932038834951457,3.4644212819803437,PPP1R3E
1500,GO_Molecular_Function_2021,serine-type peptidase activity (GO:0008236),3/125,0.3062056056454854,0.6279342149751724,0,0,1.5673626314946334,1.854971305757752,KLK14;PLAT;PRSS12
1501,GO_Molecular_Function_2021,alpha-actinin binding (GO:0051393),1/24,0.3127999435192308,0.6279342149751724,0,0,2.767271703953848,3.216099516586545,MYPN
1502,GO_Molecular_Function_2021,methyl-CpG binding (GO:0008327),1/24,0.3127999435192308,0.6279342149751724,0,0,2.767271703953848,3.216099516586545,TET1
1503,GO_Molecular_Function_2021,Notch binding (GO:0005112),1/24,0.3127999435192308,0.6279342149751724,0,0,2.767271703953848,3.216099516586545,GALNT11
1504,GO_Molecular_Function_2021,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",1/24,0.3127999435192308,0.6279342149751724,0,0,2.767271703953848,3.216099516586545,NME3
1505,GO_Molecular_Function_2021,protein phosphatase 2A binding (GO:0051721),1/24,0.3127999435192308,0.6279342149751724,0,0,2.767271703953848,3.216099516586545,STRN4
1506,GO_Molecular_Function_2021,ubiquitin binding (GO:0043130),2/74,0.3186402143369515,0.6349201307899257,0,0,1.7693001443001444,2.0235356015493275,NBR1;TNFAIP3
1507,GO_Molecular_Function_2021,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",2/75,0.324335772060407,0.6415170785606581,0,0,1.7449742038783134,1.964799015368068,IPMK;HK1
1508,GO_Molecular_Function_2021,ion gated channel activity (GO:0022839),1/26,0.3339637349658846,0.6509872804769781,0,0,2.545631067961165,2.791851810425802,ANO10
1509,GO_Molecular_Function_2021,phosphatidylinositol-4-phosphate binding (GO:0070273),1/26,0.3339637349658846,0.6509872804769781,0,0,2.545631067961165,2.791851810425802,PLA2G4A
1510,GO_Molecular_Function_2021,adenyl ribonucleotide binding (GO:0032559),6/306,0.3383161035061743,0.6547268477925244,0,0,1.2756578947368422,1.3825256285197796,NIM1K;PPP5C;PGK1;CARS2;PFKP;RAPGEF4
1511,GO_Molecular_Function_2021,phosphatase activity (GO:0016791),2/79,0.3469856614712604,0.6667081638269218,0,0,1.6539888682745825,1.7507006098083917,PPP5C;PLPP1
1512,GO_Molecular_Function_2021,sodium ion transmembrane transporter activity (GO:0015081),1/28,0.3544777790087701,0.6715739469005818,0,0,2.3568260817451754,2.4442869963919223,ASIC3
1513,GO_Molecular_Function_2021,5'-3' RNA polymerase activity (GO:0034062),1/29,0.3644973838196466,0.6715739469005818,0,0,2.2725381414701804,2.2935270878734726,POLR2J3
1514,GO_Molecular_Function_2021,transcription corepressor binding (GO:0001222),1/29,0.3644973838196466,0.6715739469005818,0,0,2.2725381414701804,2.2935270878734726,ZNF644
1515,GO_Molecular_Function_2021,mitogen-activated protein kinase binding (GO:0051019),1/29,0.3644973838196466,0.6715739469005818,0,0,2.2725381414701804,2.2935270878734726,NBR1
1516,GO_Molecular_Function_2021,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),1/29,0.3644973838196466,0.6715739469005818,0,0,2.2725381414701804,2.2935270878734726,POLR2J3
1517,GO_Molecular_Function_2021,phospholipase A2 activity (GO:0004623),1/29,0.3644973838196466,0.6715739469005818,0,0,2.2725381414701804,2.2935270878734726,PLA2G4A
1518,GO_Molecular_Function_2021,neuropeptide receptor activity (GO:0008188),1/30,0.374361960883141,0.6736992708995099,0,0,2.1940631625934603,2.1557375738800304,TACR3
1519,GO_Molecular_Function_2021,O-acyltransferase activity (GO:0008374),1/30,0.374361960883141,0.6736992708995099,0,0,2.1940631625934603,2.1557375738800304,PLA2G4A
1520,GO_Molecular_Function_2021,protein serine/threonine kinase inhibitor activity (GO:0030291),1/30,0.374361960883141,0.6736992708995099,0,0,2.1940631625934603,2.1557375738800304,PKIG
1521,GO_Molecular_Function_2021,cadherin binding (GO:0045296),6/322,0.3824038707105299,0.6736992708995099,0,0,1.210068287808128,1.1632119941691963,PPFIBP1;CAPZB;CDH12;CDH9;CDH18;PFKP
1522,GO_Molecular_Function_2021,Hsp70 protein binding (GO:0030544),1/31,0.3840739012660074,0.6736992708995099,0,0,2.120819848975189,2.029455552760207,CYP2E1
1523,GO_Molecular_Function_2021,monocarboxylic acid binding (GO:0033293),1/31,0.3840739012660074,0.6736992708995099,0,0,2.120819848975189,2.029455552760207,UGT2B4
1524,GO_Molecular_Function_2021,glucuronosyltransferase activity (GO:0015020),1/31,0.3840739012660074,0.6736992708995099,0,0,2.120819848975189,2.029455552760207,UGT2B4
1525,GO_Molecular_Function_2021,transition metal ion binding (GO:0046914),8/445,0.385686571444329,0.6736992708995099,0,0,1.167078363920166,1.111910838596273,EEA1;APOBEC3G;CA2;CHMP1A;TET1;ANG;PCK1;NUDT12
1526,GO_Molecular_Function_2021,histone methyltransferase activity (GO:0042054),1/32,0.3936355590849159,0.676634263519357,0,0,2.052301910429064,1.913422177728112,KMT5B
1527,GO_Molecular_Function_2021,chemokine binding (GO:0019956),1/32,0.3936355590849159,0.676634263519357,0,0,2.052301910429064,1.913422177728112,ITGA4
1528,GO_Molecular_Function_2021,magnesium ion binding (GO:0000287),3/146,0.3949129344704054,0.676634263519357,0,0,1.3357554497619644,1.241036973968432,NIM1K;PCK1;NUDT12
1529,GO_Molecular_Function_2021,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),1/33,0.4030492525689539,0.6818883581198026,0,0,1.9880663430420715,1.8065489469580225,TET1
1530,GO_Molecular_Function_2021,RNA polymerase core enzyme binding (GO:0043175),1/33,0.4030492525689539,0.6818883581198026,0,0,1.9880663430420715,1.8065489469580225,SPTY2D1
1531,GO_Molecular_Function_2021,metal ion binding (GO:0046872),9/517,0.4093360397842919,0.6870779100808223,0,0,1.129031836136762,1.0084725150292406,NIM1K;ANXA4;CDH12;PLA2G4A;CAPN3;PCK1;CDH9;CDH18;NUDT12
1532,GO_Molecular_Function_2021,retinoid binding (GO:0005501),1/34,0.4123172639873966,0.6870779100808223,0,0,1.9277238403451995,1.7078903924223006,UGT2B4
1533,GO_Molecular_Function_2021,purine ribonucleoside triphosphate binding (GO:0035639),8/460,0.4209906336231608,0.6870779100808223,0,0,1.1274687921233078,0.97542364256215,TUBB8;NIM1K;PPP5C;RAB35;PGK1;PCK1;CARS2;PFKP
1534,GO_Molecular_Function_2021,zinc ion binding (GO:0008270),6/336,0.4210498030871798,0.6870779100808223,0,0,1.1578947368421053,1.0015837586261345,EEA1;APOBEC3G;CA2;CHMP1A;TET1;NUDT12
1535,GO_Molecular_Function_2021,"catalytic activity, acting on a tRNA (GO:0140101)",1/35,0.4214418407558947,0.6870779100808223,0,0,1.870930896630497,1.6166217943767651,PUS10
1536,GO_Molecular_Function_2021,protein-lysine N-methyltransferase activity (GO:0016279),1/35,0.4214418407558947,0.6870779100808223,0,0,1.870930896630497,1.6166217943767651,KMT5B
1537,GO_Molecular_Function_2021,steroid hydroxylase activity (GO:0008395),1/36,0.4304251955593035,0.691974408904183,0,0,1.8173832639852057,1.532020891545139,CYP2E1
1538,GO_Molecular_Function_2021,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",1/36,0.4304251955593035,0.691974408904183,0,0,1.8173832639852057,1.532020891545139,CYP2E1
1539,GO_Molecular_Function_2021,ATP binding (GO:0005524),5/278,0.4321624561185975,0.691974408904183,0,0,1.16597610040233,0.9781999700726528,NIM1K;PPP5C;PGK1;CARS2;PFKP
1540,GO_Molecular_Function_2021,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",1/37,0.4392695072225643,0.6950793967227635,0,0,1.7668104998202083,1.453452775148989,GALC
1541,GO_Molecular_Function_2021,sodium channel regulator activity (GO:0017080),1/37,0.4392695072225643,0.6950793967227635,0,0,1.7668104998202083,1.453452775148989,FGF11
1542,GO_Molecular_Function_2021,aminoacyl-tRNA ligase activity (GO:0004812),1/38,0.4479769209098388,0.7042091126904005,0,0,1.718971398583049,1.3803573487095977,CARS2
1543,GO_Molecular_Function_2021,cation channel activity (GO:0005261),2/98,0.4502749716830814,0.7042091126904005,0,0,1.3253517316017316,1.0574939514390371,ANO10;ASIC3
1544,GO_Molecular_Function_2021,calcium ion binding (GO:0005509),6/348,0.4539375971617031,0.7058151072094276,0,0,1.1165743305632505,0.881865428114544,ANXA4;CDH12;PLA2G4A;CAPN3;CDH9;CDH18
1545,GO_Molecular_Function_2021,phosphatidylinositol-3-phosphate binding (GO:0032266),1/39,0.4565495489012655,0.7058151072094276,0,0,1.6736501447794243,1.3122388588228469,PLA2G4A
1546,GO_Molecular_Function_2021,tau protein binding (GO:0048156),1/40,0.4649894708467135,0.7147552437586625,0,0,1.6306530578375238,1.248657115542351,PPP5C
1547,GO_Molecular_Function_2021,translation initiation factor activity (GO:0003743),1/41,0.4732987346714721,0.7193071165346102,0,0,1.5898058252427183,1.1892200913753523,EIF4A2
1548,GO_Molecular_Function_2021,carboxylic acid binding (GO:0031406),1/41,0.4732987346714721,0.7193071165346102,0,0,1.5898058252427183,1.1892200913753523,PCK1
1549,GO_Molecular_Function_2021,rRNA binding (GO:0019843),1/42,0.4814793566077214,0.7276289153229049,0,0,1.550951140579367,1.1335776596813214,ANG
1550,GO_Molecular_Function_2021,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),1/44,0.4974625850584283,0.7475834378811018,0,0,1.478663355159178,1.0324544059455991,CCNI2
1551,GO_Molecular_Function_2021,histone-lysine N-methyltransferase activity (GO:0018024),1/45,0.5052690709932667,0.7509247519181699,0,0,1.4449838187702266,0.9864386905080664,KMT5B
1552,GO_Molecular_Function_2021,copper ion binding (GO:0005507),1/45,0.5052690709932667,0.7509247519181699,0,0,1.4449838187702266,0.9864386905080664,ANG
1553,GO_Molecular_Function_2021,kinase activity (GO:0016301),2/112,0.5202336271040956,0.7678408604577194,0,0,1.155844155844156,0.7553179013197989,IPMK;PGK1
1554,GO_Molecular_Function_2021,ribosome binding (GO:0043022),1/48,0.5279706698224623,0.7678408604577194,0,0,1.3525442401707637,0.8638896808431941,CPEB1
1555,GO_Molecular_Function_2021,manganese ion binding (GO:0030145),1/48,0.5279706698224623,0.7678408604577194,0,0,1.3525442401707637,0.8638896808431941,PCK1
1556,GO_Molecular_Function_2021,amino acid transmembrane transporter activity (GO:0015171),1/49,0.5353047075113027,0.7678408604577194,0,0,1.3242988133764833,0.827579685445765,SLC7A14
1557,GO_Molecular_Function_2021,lipase activity (GO:0016298),1/49,0.5353047075113027,0.7678408604577194,0,0,1.3242988133764833,0.827579685445765,ABHD5
1558,GO_Molecular_Function_2021,tRNA binding (GO:0000049),1/49,0.5353047075113027,0.7678408604577194,0,0,1.3242988133764833,0.827579685445765,TRMT10A
1559,GO_Molecular_Function_2021,inorganic cation transmembrane transporter activity (GO:0022890),1/51,0.5496337686462119,0.7678408604577194,0,0,1.2711974110032362,0.7608155883215465,ASIC3
1560,GO_Molecular_Function_2021,endonuclease activity (GO:0004519),1/51,0.5496337686462119,0.7678408604577194,0,0,1.2711974110032362,0.7608155883215465,ANG
1561,GO_Molecular_Function_2021,polyubiquitin modification-dependent protein binding (GO:0031593),1/51,0.5496337686462119,0.7678408604577194,0,0,1.2711974110032362,0.7608155883215465,TNFAIP3
1562,GO_Molecular_Function_2021,protein heterodimerization activity (GO:0046982),3/188,0.559898557230058,0.7678408604577194,0,0,1.030284356017255,0.5975645756427995,DDIT3;BHLHE40;IL12A
1563,GO_Molecular_Function_2021,GTP binding (GO:0005525),3/189,0.5634976580277229,0.7678408604577194,0,0,1.0246926552485027,0.5877556136473379,TUBB8;RAB35;PCK1
1564,GO_Molecular_Function_2021,L-amino acid transmembrane transporter activity (GO:0015179),1/53,0.5635223674103828,0.7678408604577194,0,0,1.2221807318894695,0.7009796231018437,SLC17A6
1565,GO_Molecular_Function_2021,transcription coregulator binding (GO:0001221),1/53,0.5635223674103828,0.7678408604577194,0,0,1.2221807318894695,0.7009796231018437,ZNF644
1566,GO_Molecular_Function_2021,nuclear receptor coactivator activity (GO:0030374),1/53,0.5635223674103828,0.7678408604577194,0,0,1.2221807318894695,0.7009796231018437,TRERF1
1567,GO_Molecular_Function_2021,phosphoric ester hydrolase activity (GO:0042578),1/53,0.5635223674103828,0.7678408604577194,0,0,1.2221807318894695,0.7009796231018437,PPP5C
1568,GO_Molecular_Function_2021,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),3/190,0.5670788821510988,0.7678408604577194,0,0,1.0191607587660472,0.578125934881116,ANXA4;BHLHE40;TAF4B
1569,GO_Molecular_Function_2021,iron ion binding (GO:0005506),1/54,0.5703057274985734,0.7678408604577194,0,0,1.1990596568358065,0.673371157044164,TET1
1570,GO_Molecular_Function_2021,pyrophosphatase activity (GO:0016462),1/54,0.5703057274985734,0.7678408604577194,0,0,1.1990596568358065,0.673371157044164,PLPP1
1571,GO_Molecular_Function_2021,protein phosphatase binding (GO:0019903),2/123,0.5708853981098285,0.7678408604577194,0,0,1.0501770956316412,0.5886944069011271,PPP1R3E;STRN4
1572,GO_Molecular_Function_2021,receptor tyrosine kinase binding (GO:0030971),1/56,0.583558810137948,0.7809816911796418,0,0,1.1553398058252426,0.6222776233636755,NRG1
1573,GO_Molecular_Function_2021,carboxylic acid transmembrane transporter activity (GO:0046943),1/57,0.5900317533445614,0.782559314109798,0,0,1.1346509477577438,0.5986179264768478,SLC7A14
1574,GO_Molecular_Function_2021,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",5/333,0.5905559136218921,0.782559314109798,0,0,0.9677129148340664,0.509685643364814,PLAG1;DDIT3;CREBRF;ZNF226;RLF
1575,GO_Molecular_Function_2021,GTPase activator activity (GO:0005096),5/336,0.5985067541337333,0.7892074355979131,0,0,0.958793521866178,0.4921654638856635,DOCK10;ARHGAP24;RAPGEF4;TBC1D10B;ARHGAP45
1576,GO_Molecular_Function_2021,sterol binding (GO:0032934),1/60,0.6088549977264024,0.7989365579922061,0,0,1.07679227689101,0.5342775572230495,INSIG2
1577,GO_Molecular_Function_2021,SH3 domain binding (GO:0017124),1/62,0.6209227003145538,0.8029222797800165,0,0,1.0413815056501672,0.4962689828734109,MYPN
1578,GO_Molecular_Function_2021,syntaxin binding (GO:0019905),1/62,0.6209227003145538,0.8029222797800165,0,0,1.0413815056501672,0.4962689828734109,NAPA
1579,GO_Molecular_Function_2021,protein serine/threonine phosphatase activity (GO:0004722),1/62,0.6209227003145538,0.8029222797800165,0,0,1.0413815056501672,0.4962689828734109,PPP5C
1580,GO_Molecular_Function_2021,methylation-dependent protein binding (GO:0140034),1/63,0.6268166496423921,0.8029222797800165,0,0,1.0245328322371856,0.4785605214492417,TDRD3
1581,GO_Molecular_Function_2021,protein kinase activator activity (GO:0030295),1/63,0.6268166496423921,0.8029222797800165,0,0,1.0245328322371856,0.4785605214492417,NRG1
1582,GO_Molecular_Function_2021,guanyl ribonucleotide binding (GO:0032561),3/214,0.6474333479850991,0.8241207811026174,0,0,0.9021257545116322,0.3921896346642995,TUBB8;RAB35;PCK1
1583,GO_Molecular_Function_2021,GDP binding (GO:0019003),1/67,0.6494929575976018,0.8241207811026174,0,0,0.9622437971952535,0.4152690947967788,RAB35
1584,GO_Molecular_Function_2021,methylated histone binding (GO:0035064),1/68,0.654944057271454,0.8252580108936299,0,0,0.9478336472974932,0.4011283706705182,TDRD3
1585,GO_Molecular_Function_2021,organic anion transmembrane transporter activity (GO:0008514),2/144,0.6565249603391703,0.8252580108936299,0,0,0.893908907993415,0.3761520106638782,SLC2A14;SLC17A6
1586,GO_Molecular_Function_2021,guanyl-nucleotide exchange factor activity (GO:0005085),2/149,0.6747903952781734,0.8417661897007992,0,0,0.8632829755278735,0.3395750879921049,DOCK10;RAPGEF4
1587,GO_Molecular_Function_2021,protein tyrosine kinase binding (GO:1990782),1/72,0.6759163456333555,0.8417661897007992,0,0,0.8942522448607503,0.3502660487062167,NRG1
1588,GO_Molecular_Function_2021,phospholipase activity (GO:0004620),1/73,0.6809577702055623,0.844136590715651,0,0,0.881787126932758,0.338831100291758,PLA2G4A
1589,GO_Molecular_Function_2021,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",1/75,0.6908073012837198,0.8524181836941314,0,0,0.8578675763141782,0.3173203810643892,RAB35
1590,GO_Molecular_Function_2021,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",1/76,0.6956178059576907,0.8544346566329627,0,0,0.84638619201726,0.3072000147079394,PLA2G4A
1591,GO_Molecular_Function_2021,GTPase regulator activity (GO:0030695),3/233,0.703155153019342,0.8581418308639622,0,0,0.8267950715196147,0.291178795104562,ARHGAP24;TBC1D10B;ARHGAP45
1592,GO_Molecular_Function_2021,hormone activity (GO:0005179),1/78,0.7050161510071958,0.8581418308639622,0,0,0.8243180767452613,0.2881276621921178,GAST
1593,GO_Molecular_Function_2021,ligand-gated cation channel activity (GO:0099094),1/80,0.7141252107290809,0.8653138814690214,0,0,0.8033673343984269,0.2704913447586785,ASIC3
1594,GO_Molecular_Function_2021,G protein-coupled peptide receptor activity (GO:0008528),1/82,0.7229538615816694,0.8720833576926864,0,0,0.7834511966119302,0.2541593040558922,EDNRB
1595,GO_Molecular_Function_2021,ion channel activity (GO:0005216),1/84,0.7315107083873675,0.8745616913608971,0,0,0.7644948726946621,0.2390142913311652,ASIC3
1596,GO_Molecular_Function_2021,UDP-glycosyltransferase activity (GO:0008194),1/84,0.7315107083873675,0.8745616913608971,0,0,0.7644948726946621,0.2390142913311652,UGT2B4
1597,GO_Molecular_Function_2021,mRNA 3'-UTR binding (GO:0003730),1/85,0.7356898221367492,0.8756662042247146,0,0,0.755355216520265,0.2318537807636771,CPEB1
1598,GO_Molecular_Function_2021,transcription cis-regulatory region binding (GO:0000976),7/549,0.7506182237481934,0.8848976544389507,0,0,0.8161679636598346,0.2341244024918322,ZNF263;DDIT3;SNAI1;CREBRF;BBX;ZNF799;ZNF442
1599,GO_Molecular_Function_2021,cytokine activity (GO:0005125),2/173,0.7517020923497427,0.8848976544389507,0,0,0.7412090833143464,0.2115523293516502,IL12A;NRG1
1600,GO_Molecular_Function_2021,small GTPase binding (GO:0031267),2/175,0.7573483863237755,0.8848976544389507,0,0,0.7325651227385331,0.2036032250066845,GCC2;RAPGEF4
1601,GO_Molecular_Function_2021,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",3/256,0.7613323949051357,0.8848976544389507,0,0,0.7507435207477694,0.2047166692406636,ZNF263;BHLHE40;SNAI1
1602,GO_Molecular_Function_2021,actin binding (GO:0003779),2/177,0.7628836837432942,0.8848976544389507,0,0,0.7241187384044527,0.1959825231257561,CAPZB;ANG
1603,GO_Molecular_Function_2021,phosphatidylinositol binding (GO:0035091),1/92,0.7631831071741136,0.8848976544389507,0,0,0.6970020270991145,0.1883698812676193,EEA1
1604,GO_Molecular_Function_2021,phosphatidylinositol bisphosphate binding (GO:1902936),1/94,0.7705010701384759,0.889548445782189,0,0,0.6819431395065595,0.1777922841581142,RAB35
1605,GO_Molecular_Function_2021,cysteine-type peptidase activity (GO:0008234),1/98,0.7844676289127124,0.8979650730958282,0,0,0.6536883194875388,0.1586828205964515,CAPN3
1606,GO_Molecular_Function_2021,protein kinase regulator activity (GO:0019887),1/98,0.7844676289127124,0.8979650730958282,0,0,0.6536883194875388,0.1586828205964515,CCNI2
1607,GO_Molecular_Function_2021,phosphatidylinositol phosphate binding (GO:1901981),1/102,0.7975867954525999,0.907773931366836,0,0,0.6276715050145791,0.1419570847939452,PLA2G4A
1608,GO_Molecular_Function_2021,cysteine-type endopeptidase activity (GO:0004197),1/105,0.8069010217844235,0.907773931366836,0,0,0.6094722429673886,0.1307648708463961,CAPN3
1609,GO_Molecular_Function_2021,cytokine receptor binding (GO:0005126),1/105,0.8069010217844235,0.907773931366836,0,0,0.6094722429673886,0.1307648708463961,IL12A
1610,GO_Molecular_Function_2021,growth factor receptor binding (GO:0070851),1/105,0.8069010217844235,0.907773931366836,0,0,0.6094722429673886,0.1307648708463961,IL12A
1611,GO_Molecular_Function_2021,thiol-dependent deubiquitinase (GO:0004843),1/106,0.8099098272417867,0.907773931366836,0,0,0.6036369240252736,0.1272661984256365,TNFAIP3
1612,GO_Molecular_Function_2021,GTPase binding (GO:0051020),2/201,0.8211921162419373,0.9166003289173492,0,0,0.6360046988187692,0.125291777153055,GCC2;RAPGEF4
1613,GO_Molecular_Function_2021,deubiquitinase activity (GO:0101005),1/112,0.8270061870127913,0.918477436497788,0,0,0.5708329688912214,0.1084257852423036,TNFAIP3
1614,GO_Molecular_Function_2021,omega peptidase activity (GO:0008242),1/113,0.8297026656838755,0.918477436497788,0,0,0.5657073509015257,0.1056107040537265,TNFAIP3
1615,GO_Molecular_Function_2021,DNA-binding transcription factor binding (GO:0140297),2/208,0.835602756023901,0.9191197524523556,0,0,0.6141722355314588,0.1103065317808049,DDIT3;BHLHE40
1616,GO_Molecular_Function_2021,protease binding (GO:0002020),1/118,0.8425694266443413,0.9191197524523556,0,0,0.5413935219760463,0.092740285124704,TNFAIP3
1617,GO_Molecular_Function_2021,transcription regulatory region nucleic acid binding (GO:0001067),2/212,0.8433595707039767,0.9191197524523556,0,0,0.6023500309214594,0.1026174806174319,ZNF263;DDIT3
1618,GO_Molecular_Function_2021,nuclear receptor binding (GO:0016922),1/120,0.8474405351439548,0.9191197524523556,0,0,0.5322400804982187,0.0881041526672738,TRERF1
1619,GO_Molecular_Function_2021,metallopeptidase activity (GO:0008237),1/121,0.8498194537854125,0.9191197524523556,0,0,0.5277777777777778,0.0858859952234156,CHMP1A
1620,GO_Molecular_Function_2021,GTPase activity (GO:0003924),2/216,0.850783711377831,0.9191197524523556,0,0,0.5909697778856657,0.0954991446617447,GNA11;RAB35
1621,GO_Molecular_Function_2021,endopeptidase activity (GO:0004175),3/315,0.869165623721771,0.9352222111246256,0,0,0.6069280881984465,0.0851044159060868,KLK14;PLAT;PRSS12
1622,GO_Molecular_Function_2021,G protein-coupled receptor binding (GO:0001664),1/143,0.8937409289483416,0.9578339039326847,0,0,0.4455079994530289,0.0500480721524214,GNA11
1623,GO_Molecular_Function_2021,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),16/1359,0.9013606834196884,0.9621667612694292,0,0,0.743467007055987,0.0772088902626162,ZNF263;PLAG1;ZNF23;ZNF34;ZNF37A;DDIT3;BHLHE40;SNAI1;CREBRF;BBX;ZNF514;ZNF799;ZNF226;ZNF644;ZNF564;ZNF442
1624,GO_Molecular_Function_2021,ubiquitin protein ligase binding (GO:0031625),2/265,0.9189938797281,0.9771120697504304,0,0,0.4796553256629302,0.0405192752053088,GPI;SLF2
1625,GO_Molecular_Function_2021,nucleoside-triphosphatase activity (GO:0017111),2/278,0.9314135706143324,0.9793838157039364,0,0,0.4567570111048372,0.0324534436182666,GNA11;RAB35
1626,GO_Molecular_Function_2021,protein homodimerization activity (GO:0042803),6/636,0.9319870697924711,0.9793838157039364,0,0,0.5971177944862155,0.0420587908018365,EEA1;BNIP3L;DDIT3;BHLHE40;CHMP1A;ANG
1627,GO_Molecular_Function_2021,ubiquitin-like protein ligase binding (GO:0044389),2/282,0.9348585005946244,0.9793838157039364,0,0,0.450139146567718,0.0303214167601226,GPI;SLF2
1628,GO_Molecular_Function_2021,G protein-coupled receptor activity (GO:0004930),2/283,0.9356938313602662,0.9793838157039364,0,0,0.4485141193326247,0.0298113696981404,OPN1SW;ADORA2A
1629,GO_Molecular_Function_2021,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),12/1149,0.9467667051064482,0.9833214041453072,0,0,0.6570806254537728,0.0359439973784796,ZNF263;ZNF37A;PLAG1;DDIT3;BHLHE40;SNAI1;ZNF514;ZNF23;ZNF34;ZNF226;ZNF644;ZNF564
1630,GO_Molecular_Function_2021,cis-regulatory region sequence-specific DNA binding (GO:0000987),12/1149,0.9467667051064482,0.9833214041453072,0,0,0.6570806254537728,0.0359439973784796,ZNF263;ZNF37A;PLAG1;DDIT3;BHLHE40;SNAI1;ZNF514;ZNF23;ZNF34;ZNF226;ZNF644;ZNF564
1631,GO_Molecular_Function_2021,sequence-specific DNA binding (GO:0043565),6/707,0.9649582251944828,0.9961581616705898,0,0,0.5346403633906449,0.0190708722593814,ZNF263;BHLHE40;SNAI1;BBX;TET1;ZNF23
1632,GO_Molecular_Function_2021,sequence-specific double-stranded DNA binding (GO:1990837),6/712,0.9666127895822152,0.9961581616705898,0,0,0.5307141792157447,0.0180216143056714,ZNF263;DDIT3;BHLHE40;SNAI1;BBX;ZNF23
1633,GO_Molecular_Function_2021,DNA binding (GO:0003677),7/811,0.970235830326002,0.9961581616705898,0,0,0.5426744166954008,0.0163975114901016,ZNF263;DDIT3;TET1;TAF4B;ANG;SPTY2D1;RLF
1634,GO_Molecular_Function_2021,double-stranded DNA binding (GO:0003690),5/651,0.9749814626433272,0.9972243857454562,0,0,0.4832766583768969,0.0122446941087455,ZNF263;BHLHE40;SNAI1;BBX;ZNF23
1635,GO_Molecular_Function_2021,mRNA binding (GO:0003729),1/263,0.9840077507867968,0.9995578042331956,0,0,0.2399762839991106,0.0038687788971828,CPEB1
1636,GO_Molecular_Function_2021,kinase binding (GO:0019900),2/461,0.9942223582372736,0.9995578042331956,0,0,0.2720623602976544,0.0015764372978941,PGAM1;SNAI1
1637,GO_Molecular_Function_2021,protein serine/threonine kinase activity (GO:0004674),1/344,0.9955736062117082,0.9995578042331956,0,0,0.1825412550595827,0.0008097930340520895,NIM1K
1638,GO_Molecular_Function_2021,protein kinase binding (GO:0019901),2/506,0.9969394386089472,0.9995578042331956,0,0,0.2471913007627293,0.0007577042438562535,PGAM1;NBR1
1639,GO_Molecular_Function_2021,ubiquitin-protein transferase activity (GO:0004842),1/392,0.9979366197058416,0.9995578042331956,0,0,0.1597348099222804,0.0003299341660930062,TNFAIP3
1640,GO_Molecular_Function_2021,RNA binding (GO:0003723),9/1406,0.9995578042331956,0.9995578042331956,0,0,0.3915295471786957,0.00017317099890502518,EIF4A2;TRMT10A;PUS10;APOBEC3G;PEG10;DQX1;WBP4;ANG;TDRD3
1641,KEGG_2021_Human,Glycolysis / Gluconeogenesis,8/67,8.975232628201996e-06,0.0016604180362173,0,0,8.814008306207207,102.42795810891256,GPI;PGAM1;PGK1;ALDOC;ENO2;PCK1;PFKP;HK1
1642,KEGG_2021_Human,HIF-1 signaling pathway,6/109,0.0070559483848678,0.6526752256002738,0,0,3.7532575370465,18.593203494204182,PGK1;ALDOC;ENO2;PFKP;PDK1;HK1
1643,KEGG_2021_Human,Pentose phosphate pathway,3/30,0.0109877395054109,0.66009361962758,0,0,7.116539992761491,32.10253554681002,GPI;ALDOC;PFKP
1644,KEGG_2021_Human,Fructose and mannose metabolism,3/33,0.0142722944784341,0.66009361962758,0,0,6.403908794788274,27.21299461803248,ALDOC;PFKP;HK1
1645,KEGG_2021_Human,Starch and sucrose metabolism,3/36,0.0180547332218872,0.6680251292098268,0,0,5.82084690553746,23.36690164232114,GPI;GBE1;HK1
1646,KEGG_2021_Human,Central carbon metabolism in cancer,4/70,0.0233406772028684,0.7196708804217782,0,0,3.886710239651416,14.60453774712939,PGAM1;PFKP;HK1;PDK1
1647,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,2/23,0.0489194015753988,0.9990390808854264,0,0,6.081941867656154,18.352753445150903,CA2;PCK1
1648,KEGG_2021_Human,Long-term depression,3/60,0.0661765064102334,0.9990390808854264,0,0,3.365849477112978,9.13972786169617,GNA11;PRKG2;PLA2G4A
1649,KEGG_2021_Human,Linoleic acid metabolism,2/29,0.0739288097534393,0.9990390808854264,0,0,4.728956228956229,12.31728851149992,PLA2G4A;CYP2E1
1650,KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.0751414522316401,0.9990390808854264,0,0,15.927184466019416,41.225652108301766,HK1
1651,KEGG_2021_Human,Galactose metabolism,2/31,0.0830036989145478,0.9990390808854264,0,0,4.402373488580385,10.956935775326192,PFKP;HK1
1652,KEGG_2021_Human,Drug metabolism,4/108,0.0872842131042949,0.9990390808854264,0,0,2.461789844142785,6.003285430302854,NME3;UGT2B4;CYP2E1;MPO
1653,KEGG_2021_Human,Gap junction,3/88,0.1563349640795424,0.9990390808854264,0,0,2.2538800536501244,4.182647754612852,TUBB8;GNA11;PRKG2
1654,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,2/48,0.1703988999389982,0.9990390808854264,0,0,2.7730095990965555,4.907154169458835,GPI;HK1
1655,KEGG_2021_Human,Sphingolipid metabolism,2/49,0.1759366687690103,0.9990390808854264,0,0,2.7138712351478307,4.71570729091976,GALC;PLPP1
1656,KEGG_2021_Human,Ether lipid metabolism,2/49,0.1759366687690103,0.9990390808854264,0,0,2.7138712351478307,4.71570729091976,PLA2G4A;PLPP1
1657,KEGG_2021_Human,Endocytosis,6/252,0.1979635968224675,0.9990390808854264,0,0,1.5600128369704749,2.5267092982948745,EEA1;ACAP1;CAPZB;CHMP1A;RAB35;VPS37C
1658,KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.2096787313090243,0.9990390808854264,0,0,2.4059054153393777,3.758454363892761,PRKG2;ABHD5
1659,KEGG_2021_Human,Glucagon signaling pathway,3/107,0.2309022226371664,0.9990390808854264,0,0,1.840328238536708,2.6974812427438493,PGAM1;PCK1;PFKP
1660,KEGG_2021_Human,Nitrogen metabolism,1/17,0.2333079096532855,0.9990390808854264,0,0,3.979368932038835,5.791558410833886,CA2
1661,KEGG_2021_Human,Steroid hormone biosynthesis,2/61,0.2439964834775227,0.9990390808854264,0,0,2.160576711424169,3.0477126760437936,UGT2B4;CYP2E1
1662,KEGG_2021_Human,Arachidonic acid metabolism,2/61,0.2439964834775227,0.9990390808854264,0,0,2.160576711424169,3.0477126760437936,PLA2G4A;CYP2E1
1663,KEGG_2021_Human,Fatty acid biosynthesis,1/18,0.2452017295975243,0.9990390808854264,0,0,3.7450980392156863,5.264387020278373,OXSM
1664,KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.2569116245754598,0.9990390808854264,0,0,3.536857245595109,4.80667079179423,GALNS
1665,KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.2797909365950337,0.9990390808854264,0,0,3.182847896440129,4.05403350050483,BCAT1
1666,KEGG_2021_Human,Mitophagy,2/68,0.2842689484002526,0.9990390808854264,0,0,1.9307359307359304,2.4285462400017384,BNIP3L;NBR1
1667,KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.3234643246985458,0.9990390808854264,0,0,2.651833872707659,2.9930359237917226,PLA2G4A
1668,KEGG_2021_Human,Gastric acid secretion,2/76,0.3300190653152328,0.9990390808854264,0,0,1.7213057213057212,1.908247875289172,CA2;GAST
1669,KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,2/76,0.3300190653152328,0.9990390808854264,0,0,1.7213057213057212,1.908247875289172,UGT2B4;CYP2E1
1670,KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,1/26,0.3339637349658846,0.9990390808854264,0,0,2.545631067961165,2.791851810425802,PIGV
1671,KEGG_2021_Human,Leishmaniasis,2/77,0.3356891078610717,0.9990390808854264,0,0,1.6982683982683984,1.8537785324798188,ITGA4;IL12A
1672,KEGG_2021_Human,Vascular smooth muscle contraction,3/133,0.340129777817509,0.9990390808854264,0,0,1.4703081934352291,1.5856215755046168,ADORA2A;GNA11;PLA2G4A
1673,KEGG_2021_Human,Synaptic vesicle cycle,2/78,0.341344946707612,0.9990390808854264,0,0,1.6758373205741626,1.8012934167943138,NAPA;SLC17A6
1674,KEGG_2021_Human,Collecting duct acid secretion,1/27,0.3443007181490842,0.9990390808854264,0,0,2.447597709733632,2.609726148351675,CA2
1675,KEGG_2021_Human,RNA degradation,2/79,0.3469856614712604,0.9990390808854264,0,0,1.6539888682745825,1.7507006098083917,ENO2;PFKP
1676,KEGG_2021_Human,Insulin signaling pathway,3/137,0.3570653810938343,0.9990390808854264,0,0,1.4261266955126648,1.4686771444747522,PPP1R3E;PCK1;HK1
1677,KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,0.367450296769759,0.9990390808854264,0,0,1.1740619203880724,1.1754323046703057,ZNF37A;ZNF514;IL12A;ZNF799;ZNF23;ZNF34;ZNF226;ZNF564;ZNF442
1678,KEGG_2021_Human,Ascorbate and aldarate metabolism,1/30,0.374361960883141,0.9990390808854264,0,0,2.1940631625934603,2.1557375738800304,UGT2B4
1679,KEGG_2021_Human,Citrate cycle (TCA cycle),1/30,0.374361960883141,0.9990390808854264,0,0,2.1940631625934603,2.1557375738800304,PCK1
1680,KEGG_2021_Human,Circadian rhythm,1/31,0.3840739012660074,0.9990390808854264,0,0,2.120819848975189,2.029455552760207,BHLHE40
1681,KEGG_2021_Human,RNA polymerase,1/31,0.3840739012660074,0.9990390808854264,0,0,2.120819848975189,2.029455552760207,POLR2J3
1682,KEGG_2021_Human,Insulin secretion,2/86,0.38597635725198,0.9990390808854264,0,0,1.5156153370439085,1.442834218527579,GNA11;RAPGEF4
1683,KEGG_2021_Human,Phospholipase D signaling pathway,3/148,0.4032516448645336,0.9990390808854264,0,0,1.3171964506346177,1.1962705494485406,PLA2G4A;PLPP1;RAPGEF4
1684,KEGG_2021_Human,Bile secretion,2/90,0.407802413077945,0.9990390808854264,0,0,1.4464285714285714,1.2974066569233136,CA2;UGT2B4
1685,KEGG_2021_Human,Pentose and glucuronate interconversions,1/34,0.4123172639873966,0.9990390808854264,0,0,1.9277238403451995,1.7078903924223006,UGT2B4
1686,KEGG_2021_Human,Phagosome,3/152,0.4198273178008265,0.9990390808854264,0,0,1.2815731368734014,1.1122924484944363,TUBB8;EEA1;MPO
1687,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,1/35,0.4214418407558947,0.9990390808854264,0,0,1.870930896630497,1.6166217943767651,NUDT12
1688,KEGG_2021_Human,GnRH signaling pathway,2/93,0.4239232854969161,0.9990390808854264,0,0,1.3985300413871842,1.2002223562184977,GNA11;PLA2G4A
1689,KEGG_2021_Human,Mucin type O-glycan biosynthesis,1/36,0.4304251955593035,0.9990390808854264,0,0,1.8173832639852057,1.532020891545139,GALNT11
1690,KEGG_2021_Human,African trypanosomiasis,1/37,0.4392695072225643,0.9990390808854264,0,0,1.7668104998202083,1.453452775148989,IL12A
1691,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,2/97,0.4450584904609829,0.9990390808854264,0,0,1.3393711551606289,1.0842873376613218,PLA2G4A;PLPP1
1692,KEGG_2021_Human,Allograft rejection,1/38,0.4479769209098388,0.9990390808854264,0,0,1.718971398583049,1.3803573487095977,IL12A
1693,KEGG_2021_Human,Necroptosis,3/159,0.4484502257296001,0.9990390808854264,0,0,1.223628163367577,0.9812978844622504,CHMP1A;TNFAIP3;PLA2G4A
1694,KEGG_2021_Human,Choline metabolism in cancer,2/98,0.4502749716830814,0.9990390808854264,0,0,1.3253517316017316,1.0574939514390371,PLA2G4A;PLPP1
1695,KEGG_2021_Human,Glycerophospholipid metabolism,2/98,0.4502749716830814,0.9990390808854264,0,0,1.3253517316017316,1.0574939514390371,PLA2G4A;PLPP1
1696,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.4502749716830814,0.9990390808854264,0,0,1.3253517316017316,1.0574939514390371,PLA2G4A;ASIC3
1697,KEGG_2021_Human,"Glycine, serine and threonine metabolism",1/40,0.4649894708467135,0.9990390808854264,0,0,1.6306530578375238,1.248657115542351,PGAM1
1698,KEGG_2021_Human,Nicotine addiction,1/40,0.4649894708467135,0.9990390808854264,0,0,1.6306530578375238,1.248657115542351,SLC17A6
1699,KEGG_2021_Human,Amoebiasis,2/102,0.4708592197469038,0.9990390808854264,0,0,1.272077922077922,0.9581241630669428,GNA11;IL12A
1700,KEGG_2021_Human,Chagas disease,2/102,0.4708592197469038,0.9990390808854264,0,0,1.272077922077922,0.9581241630669428,GNA11;IL12A
1701,KEGG_2021_Human,cGMP-PKG signaling pathway,3/167,0.4804448752999569,0.9990390808854264,0,0,1.1634623023754669,0.8528676414594576,EDNRB;GNA11;PRKG2
1702,KEGG_2021_Human,Type I diabetes mellitus,1/43,0.4895333217581785,0.9990390808854264,0,0,1.5139466789952227,1.0814162705247774,IL12A
1703,KEGG_2021_Human,Fat digestion and absorption,1/43,0.4895333217581785,0.9990390808854264,0,0,1.5139466789952227,1.0814162705247774,PLPP1
1704,KEGG_2021_Human,Porphyrin and chlorophyll metabolism,1/43,0.4895333217581785,0.9990390808854264,0,0,1.5139466789952227,1.0814162705247774,UGT2B4
1705,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",2/106,0.4909758671478049,0.9990390808854264,0,0,1.222902097902098,0.8699240066673678,GNA11;PDE4C
1706,KEGG_2021_Human,Insulin resistance,2/108,0.5008527415481384,0.9990390808854264,0,0,1.1997059544229356,0.8295284643781224,PPP1R3E;PCK1
1707,KEGG_2021_Human,Basal transcription factors,1/45,0.5052690709932667,0.9990390808854264,0,0,1.4449838187702266,0.9864386905080664,TAF4B
1708,KEGG_2021_Human,Glycosphingolipid biosynthesis,1/45,0.5052690709932667,0.9990390808854264,0,0,1.4449838187702266,0.9864386905080664,FUT3
1709,KEGG_2021_Human,Calcium signaling pathway,4/240,0.5120731206070983,0.9990390808854264,0,0,1.0775451423507256,0.7211878720908447,EDNRB;ADORA2A;GNA11;TACR3
1710,KEGG_2021_Human,Type II diabetes mellitus,1/46,0.5129546746127259,0.9990390808854264,0,0,1.4128011506652285,0.9431405436903249,HK1
1711,KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.5205212618421974,0.9990390808854264,0,0,1.382017728999578,0.9023532939606308,HK1
1712,KEGG_2021_Human,Other types of O-glycan biosynthesis,1/47,0.5205212618421974,0.9990390808854264,0,0,1.382017728999578,0.9023532939606308,GALNT11
1713,KEGG_2021_Human,Pyruvate metabolism,1/47,0.5205212618421974,0.9990390808854264,0,0,1.382017728999578,0.9023532939606308,PCK1
1714,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.5279706698224623,0.9990390808854264,0,0,1.3525442401707637,0.8638896808431941,BCAT1
1715,KEGG_2021_Human,Intestinal immune network for IgA production,1/48,0.5279706698224623,0.9990390808854264,0,0,1.3525442401707637,0.8638896808431941,ITGA4
1716,KEGG_2021_Human,Glutamatergic synapse,2/114,0.5297343544790236,0.9990390808854264,0,0,1.135088126159555,0.7212118577842006,PLA2G4A;SLC17A6
1717,KEGG_2021_Human,Leukocyte transendothelial migration,2/114,0.5297343544790236,0.9990390808854264,0,0,1.135088126159555,0.7212118577842006,ITGA4;RAPGEF4
1718,KEGG_2021_Human,Axon guidance,3/182,0.5379355723632812,0.9990390808854264,0,0,1.0651465798045603,0.6604084330550823,SEMA3B;SEMA3E;LRRC4C
1719,KEGG_2021_Human,Cholesterol metabolism,1/50,0.5425251558593591,0.9990390808854264,0,0,1.2972062611452349,0.7932686422257892,ANGPTL8
1720,KEGG_2021_Human,Cysteine and methionine metabolism,1/50,0.5425251558593591,0.9990390808854264,0,0,1.2972062611452349,0.7932686422257892,BCAT1
1721,KEGG_2021_Human,Malaria,1/50,0.5425251558593591,0.9990390808854264,0,0,1.2972062611452349,0.7932686422257892,IL12A
1722,KEGG_2021_Human,Ovarian steroidogenesis,1/51,0.5496337686462119,0.9990390808854264,0,0,1.2711974110032362,0.7608155883215465,PLA2G4A
1723,KEGG_2021_Human,AMPK signaling pathway,2/120,0.5574624257853146,0.9990390808854264,0,0,1.077041602465331,0.6293802199598942,PCK1;PFKP
1724,KEGG_2021_Human,Transcriptional misregulation in cancer,3/192,0.574187246447176,0.9990390808854264,0,0,1.0082725815624838,0.5593893484914839,DDIT3;PLAT;MPO
1725,KEGG_2021_Human,Platelet activation,2/124,0.5752938417441473,0.9990390808854264,0,0,1.0415158611879924,0.5758273939324905,PRKG2;PLA2G4A
1726,KEGG_2021_Human,Pyrimidine metabolism,1/56,0.583558810137948,0.9990390808854264,0,0,1.1553398058252426,0.6222776233636755,NME3
1727,KEGG_2021_Human,Legionellosis,1/57,0.5900317533445614,0.9990390808854264,0,0,1.1346509477577438,0.5986179264768478,IL12A
1728,KEGG_2021_Human,Lysosome,2/128,0.5925969969732754,0.9990390808854264,0,0,1.0082457225314367,0.5275552091231197,GALNS;GALC
1729,KEGG_2021_Human,Purine metabolism,2/129,0.5968400058515851,0.9990390808854264,0,0,1.000255649861949,0.5162381408840119,PDE4C;NME3
1730,KEGG_2021_Human,VEGF signaling pathway,1/59,0.6026783100627779,0.9990390808854264,0,0,1.095413458319384,0.5546863828588946,PLA2G4A
1731,KEGG_2021_Human,Glycerolipid metabolism,1/61,0.6149359682965099,0.9990390808854264,0,0,1.0587918015102482,0.5148238902084207,PLPP1
1732,KEGG_2021_Human,Lysine degradation,1/63,0.6268166496423921,0.9990390808854264,0,0,1.0245328322371856,0.4785605214492417,KMT5B
1733,KEGG_2021_Human,GnRH secretion,1/64,0.6326192495149936,0.9990390808854264,0,0,1.0082190373452509,0.4616499259356477,GNA11
1734,KEGG_2021_Human,Measles,2/139,0.637451031947032,0.9990390808854264,0,0,0.9267703099819888,0.4173041125320559,TNFAIP3;IL12A
1735,KEGG_2021_Human,Cortisol synthesis and secretion,1/65,0.6383319113292317,0.9990390808854264,0,0,0.9924150485436892,0.4454920325728876,GNA11
1736,KEGG_2021_Human,Inflammatory bowel disease,1/65,0.6383319113292317,0.9990390808854264,0,0,0.9924150485436892,0.4454920325728876,IL12A
1737,KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,1/66,0.6439560246307365,0.9990390808854264,0,0,0.9770973363206372,0.4300448087579985,CARS2
1738,KEGG_2021_Human,Acute myeloid leukemia,1/67,0.6494929575976018,0.9990390808854264,0,0,0.9622437971952535,0.4152690947967788,MPO
1739,KEGG_2021_Human,cAMP signaling pathway,3/216,0.6536304815894248,0.9990390808854264,0,0,0.8935633344038171,0.3799548355263202,ADORA2A;PDE4C;RAPGEF4
1740,KEGG_2021_Human,Fc epsilon RI signaling pathway,1/68,0.654944057271454,0.9990390808854264,0,0,0.9478336472974932,0.4011283706705182,PLA2G4A
1741,KEGG_2021_Human,Retinol metabolism,1/68,0.654944057271454,0.9990390808854264,0,0,0.9478336472974932,0.4011283706705182,UGT2B4
1742,KEGG_2021_Human,Adipocytokine signaling pathway,1/69,0.6603106500811824,0.9990390808854264,0,0,0.9338473253379022,0.3875885443188478,PCK1
1743,KEGG_2021_Human,Renin secretion,1/69,0.6603106500811824,0.9990390808854264,0,0,0.9338473253379022,0.3875885443188478,PRKG2
1744,KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.6655940417420977,0.9990390808854264,0,0,0.9202664040148212,0.3746177604320472,IL12A
1745,KEGG_2021_Human,Adherens junction,1/71,0.6707955183283433,0.9990390808854264,0,0,0.9070735090152566,0.3621862251202019,SNAI1
1746,KEGG_2021_Human,Cell adhesion molecules,2/148,0.6712013843395757,0.9990390808854264,0,0,0.8692403486924035,0.346554010983892,ITGA4;LRRC4C
1747,KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.6809577702055623,0.9990390808854264,0,0,0.881787126932758,0.338831100291758,IPMK
1748,KEGG_2021_Human,PPAR signaling pathway,1/74,0.6859210192891623,0.9990390808854264,0,0,0.8696635190849847,0.3278568765219631,PCK1
1749,KEGG_2021_Human,Pertussis,1/76,0.6956178059576907,0.9990390808854264,0,0,0.84638619201726,0.3072000147079394,IL12A
1750,KEGG_2021_Human,Non-alcoholic fatty liver disease,2/155,0.6956607582229721,0.9990390808854264,0,0,0.8291740938799762,0.3009016019939308,DDIT3;CYP2E1
1751,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,1/77,0.7003537047966828,0.9990390808854264,0,0,0.8352069494123658,0.2974754745825666,ITGA4
1752,KEGG_2021_Human,Peroxisome,1/82,0.7229538615816694,0.9990390808854264,0,0,0.7834511966119302,0.2541593040558922,NUDT12
1753,KEGG_2021_Human,Complement and coagulation cascades,1/85,0.7356898221367492,0.9990390808854264,0,0,0.755355216520265,0.2318537807636771,PLAT
1754,KEGG_2021_Human,ErbB signaling pathway,1/85,0.7356898221367492,0.9990390808854264,0,0,0.755355216520265,0.2318537807636771,NRG1
1755,KEGG_2021_Human,Taste transduction,1/86,0.7398040928660019,0.9990390808854264,0,0,0.7464306110793832,0.2249516941378767,SCN9A
1756,KEGG_2021_Human,Parkinson disease,3/249,0.7446752911840918,0.9990390808854264,0,0,0.7723842059267498,0.227704275518848,TUBB8;ADORA2A;DDIT3
1757,KEGG_2021_Human,ECM-receptor interaction,1/88,0.7478421014569192,0.9990390808854264,0,0,0.7291968902280251,0.2118779405280425,ITGA4
1758,KEGG_2021_Human,Hypertrophic cardiomyopathy,1/90,0.75563257316613,0.9990390808854264,0,0,0.7127377186284135,0.1997091339024779,ITGA4
1759,KEGG_2021_Human,Morphine addiction,1/91,0.7594373666125999,0.9990390808854264,0,0,0.7047824523552679,0.193940221800787,PDE4C
1760,KEGG_2021_Human,Th1 and Th2 cell differentiation,1/92,0.7631831071741136,0.9990390808854264,0,0,0.6970020270991145,0.1883698812676193,IL12A
1761,KEGG_2021_Human,Salivary secretion,1/93,0.7668707084602452,0.9990390808854264,0,0,0.6893907415224426,0.1829898513951472,PRKG2
1762,KEGG_2021_Human,IL-17 signaling pathway,1/94,0.7705010701384759,0.9990390808854264,0,0,0.6819431395065595,0.1777922841581142,TNFAIP3
1763,KEGG_2021_Human,Tuberculosis,2/180,0.7709817089882872,0.9990390808854264,0,0,0.7118050488837006,0.1851338232104336,EEA1;IL12A
1764,KEGG_2021_Human,Dilated cardiomyopathy,1/96,0.7775936031471251,0.9990390808854264,0,0,0.6675183103389541,0.1679150668823834,ITGA4
1765,KEGG_2021_Human,Circadian entrainment,1/97,0.7810575050675569,0.9990390808854264,0,0,0.6605312837108953,0.1632215748505137,PRKG2
1766,KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.7810575050675569,0.9990390808854264,0,0,0.6605312837108953,0.1632215748505137,IPMK
1767,KEGG_2021_Human,Prostate cancer,1/97,0.7810575050675569,0.9990390808854264,0,0,0.6605312837108953,0.1632215748505137,PLAT
1768,KEGG_2021_Human,Aldosterone synthesis and secretion,1/98,0.7844676289127124,0.9990390808854264,0,0,0.6536883194875388,0.1586828205964515,GNA11
1769,KEGG_2021_Human,Hematopoietic cell lineage,1/99,0.7878248066711901,0.9990390808854264,0,0,0.6469850075952711,0.1542926872582235,ITGA4
1770,KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.7911298578918188,0.9990390808854264,0,0,0.6404171161452715,0.150045346926481,CPEB1
1771,KEGG_2021_Human,Melanogenesis,1/101,0.7943835893862122,0.9990390808854264,0,0,0.6339805825242718,0.1459352449436801,EDNRB
1772,KEGG_2021_Human,Pancreatic secretion,1/102,0.7975867954525999,0.9990390808854264,0,0,0.6276715050145791,0.1419570847939452,CA2
1773,KEGG_2021_Human,Toll-like receptor signaling pathway,1/104,0.8038447475751705,0.9990390808854264,0,0,0.6154208690734282,0.13437661041075,IL12A
1774,KEGG_2021_Human,C-type lectin receptor signaling pathway,1/104,0.8038447475751705,0.9990390808854264,0,0,0.6154208690734282,0.13437661041075,IL12A
1775,KEGG_2021_Human,NF-kappa B signaling pathway,1/104,0.8038447475751705,0.9990390808854264,0,0,0.6154208690734282,0.13437661041075,TNFAIP3
1776,KEGG_2021_Human,Amyotrophic lateral sclerosis,4/364,0.8186212771489193,0.9990390808854264,0,0,0.7018881626724764,0.1404714912251159,TUBB8;DDIT3;NRG1;ANG
1777,KEGG_2021_Human,TNF signaling pathway,1/112,0.8270061870127913,0.9990390808854264,0,0,0.5708329688912214,0.1084257852423036,TNFAIP3
1778,KEGG_2021_Human,Toxoplasmosis,1/112,0.8270061870127913,0.9990390808854264,0,0,0.5708329688912214,0.1084257852423036,IL12A
1779,KEGG_2021_Human,Serotonergic synapse,1/113,0.8297026656838755,0.9990390808854264,0,0,0.5657073509015257,0.1056107040537265,PLA2G4A
1780,KEGG_2021_Human,Cholinergic synapse,1/113,0.8297026656838755,0.9990390808854264,0,0,0.5657073509015257,0.1056107040537265,GNA11
1781,KEGG_2021_Human,MAPK signaling pathway,3/294,0.8369470308886899,0.9990390808854264,0,0,0.6514322173343632,0.115951348536217,PPP5C;DDIT3;PLA2G4A
1782,KEGG_2021_Human,Rap1 signaling pathway,2/210,0.8395234845577221,0.9990390808854264,0,0,0.6082042957042957,0.1063875992395402,ADORA2A;RAPGEF4
1783,KEGG_2021_Human,Human immunodeficiency virus 1 infection,2/212,0.8433595707039767,0.9990390808854264,0,0,0.6023500309214594,0.1026174806174319,APOBEC3G;GNA11
1784,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",1/119,0.8450240564828745,0.9990390808854264,0,0,0.5367780154681586,0.0903881481582796,GNA11
1785,KEGG_2021_Human,Lipid and atherosclerosis,2/215,0.8489582224245941,0.9990390808854264,0,0,0.5937747698311079,0.0972278289240323,DDIT3;IL12A
1786,KEGG_2021_Human,Thyroid hormone signaling pathway,1/121,0.8498194537854125,0.9990390808854264,0,0,0.5277777777777778,0.0858859952234156,PFKP
1787,KEGG_2021_Human,Huntington disease,3/306,0.8561099048921686,0.9990390808854264,0,0,0.6252459122133712,0.0971360275129127,TUBB8;POLR2J3;TAF4B
1788,KEGG_2021_Human,Oocyte meiosis,1/129,0.8675666210004981,0.9990390808854264,0,0,0.4945894012944983,0.0702628410428488,CPEB1
1789,KEGG_2021_Human,Relaxin signaling pathway,1/129,0.8675666210004981,0.9990390808854264,0,0,0.4945894012944983,0.0702628410428488,EDNRB
1790,KEGG_2021_Human,FoxO signaling pathway,1/131,0.8716665234141813,0.9990390808854264,0,0,0.4869305451829723,0.0668791096208886,PCK1
1791,KEGG_2021_Human,Apelin signaling pathway,1/137,0.8832224957559813,0.9990390808854264,0,0,0.4653055396916048,0.0577807732146213,PLAT
1792,KEGG_2021_Human,Yersinia infection,1/137,0.8832224957559813,0.9990390808854264,0,0,0.4653055396916048,0.0577807732146213,ITGA4
1793,KEGG_2021_Human,Fluid shear stress and atherosclerosis,1/139,0.886839156560122,0.9990390808854264,0,0,0.4585150790300643,0.0550638311620742,PLAT
1794,KEGG_2021_Human,Chemical carcinogenesis,2/239,0.8875901098223618,0.9990390808854264,0,0,0.5329881089374761,0.0635562899532566,UGT2B4;CYP2E1
1795,KEGG_2021_Human,Apoptosis,1/142,0.8920558596258995,0.9990390808854264,0,0,0.4486905827537928,0.0512523662763243,DDIT3
1796,KEGG_2021_Human,Salmonella infection,2/249,0.9008123191992264,0.9990390808854264,0,0,0.5111467479888533,0.0533935437801877,TUBB8;GCC2
1797,KEGG_2021_Human,Neuroactive ligand-receptor interaction,3/341,0.9011997407903656,0.9990390808854264,0,0,0.5594896208777441,0.0582027866066511,EDNRB;ADORA2A;TACR3
1798,KEGG_2021_Human,Retrograde endocannabinoid signaling,1/148,0.9017809878138904,0.9990390808854264,0,0,0.4302445897452832,0.0444802327199101,SLC17A6
1799,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,1/150,0.9048245433943342,0.9990390808854264,0,0,0.424426055037901,0.0424486445690648,RAPGEF4
1800,KEGG_2021_Human,Oxytocin signaling pathway,1/154,0.9106324915250164,0.9990390808854264,0,0,0.4132453412864606,0.0386863243264868,PLA2G4A
1801,KEGG_2021_Human,Cushing syndrome,1/155,0.91202840631682,0.9990390808854264,0,0,0.4105409153952843,0.0378043079975513,GNA11
1802,KEGG_2021_Human,JAK-STAT signaling pathway,1/162,0.921209749280658,0.9990390808854264,0,0,0.3925506040322418,0.0322156576295946,IL12A
1803,KEGG_2021_Human,Prion disease,2/273,0.9268655360874332,0.9990390808854264,0,0,0.4653040686251018,0.0353383441983175,TUBB8;DDIT3
1804,KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.931624489203384,0.9990390808854264,0,0,0.3715971825623453,0.0263185391846528,DDIT3
1805,KEGG_2021_Human,Influenza A,1/172,0.9326934172908456,0.9990390808854264,0,0,0.3694051742084445,0.0257396837511326,IL12A
1806,KEGG_2021_Human,NOD-like receptor signaling pathway,1/181,0.9415943740024292,0.9990390808854264,0,0,0.3507731032002876,0.0211097701858763,TNFAIP3
1807,KEGG_2021_Human,Alcoholism,1/186,0.946021744588559,0.9990390808854264,0,0,0.3412052829528558,0.0189333871051289,ADORA2A
1808,KEGG_2021_Human,RNA transport,1/186,0.946021744588559,0.9990390808854264,0,0,0.3412052829528558,0.0189333871051289,EIF4A2
1809,KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.948515888799418,0.9990390808854264,0,0,0.3357088755766715,0.0177444761630856,MPO
1810,KEGG_2021_Human,Pathogenic Escherichia coli infection,1/197,0.95461944644397,0.9990390808854264,0,0,0.3218743808202893,0.0149486519988379,TUBB8
1811,KEGG_2021_Human,Focal adhesion,1/201,0.9573950709265562,0.9990390808854264,0,0,0.3153721682847896,0.0137310362770349,ITGA4
1812,KEGG_2021_Human,Epstein-Barr virus infection,1/202,0.9580621169221336,0.9990390808854264,0,0,0.313787051796036,0.0134434728832093,TNFAIP3
1813,KEGG_2021_Human,Regulation of actin cytoskeleton,1/218,0.9674233419445294,0.9990390808854264,0,0,0.2904120621001297,0.009618183323302,ITGA4
1814,KEGG_2021_Human,Human cytomegalovirus infection,1/225,0.9708334321476942,0.9990390808854264,0,0,0.2812355524734165,0.0083246758460018,GNA11
1815,KEGG_2021_Human,Thermogenesis,1/232,0.9738875593233378,0.9990390808854264,0,0,0.272615194945292,0.0072132410800785,PRKG2
1816,KEGG_2021_Human,Coronavirus disease,1/232,0.9738875593233378,0.9990390808854264,0,0,0.272615194945292,0.0072132410800785,IL12A
1817,KEGG_2021_Human,Ras signaling pathway,1/232,0.9738875593233378,0.9990390808854264,0,0,0.272615194945292,0.0072132410800785,PLA2G4A
1818,KEGG_2021_Human,PI3K-Akt signaling pathway,2/354,0.9748088283674672,0.9990390808854264,0,0,0.356737012987013,0.0091017527176846,ITGA4;PCK1
1819,KEGG_2021_Human,Shigellosis,1/246,0.97907227752823,0.9990390808854264,0,0,0.2568522554652929,0.0054323767253972,HK1
1820,KEGG_2021_Human,Alzheimer disease,2/369,0.9794284079829704,0.9990390808854264,0,0,0.3418910789482997,0.0071065939986801,TUBB8;DDIT3
1821,KEGG_2021_Human,Pathways in cancer,3/531,0.9896644857566168,0.9990390808854264,0,0,0.3546416938110749,0.0036844777332108,EDNRB;GNA11;IL12A
1822,KEGG_2021_Human,Cytokine-cytokine receptor interaction,1/295,0.9903668547011268,0.9990390808854264,0,0,0.2135041718952953,0.0020666871178285,IL12A
1823,KEGG_2021_Human,Human papillomavirus infection,1/331,0.994558494313216,0.9990390808854264,0,0,0.1898597626752966,0.0010359440892851,ITGA4
1824,KEGG_2021_Human,Pathways of neurodegeneration,2/475,0.9952545091643114,0.9990390808854264,0,0,0.2638175777710661,0.0012549238731213,TUBB8;DDIT3
1825,KEGG_2021_Human,Olfactory transduction,1/440,0.9990390808854264,0.9990390808854264,0,0,0.1419156511931353,0.00013643502390317725,PRKG2
